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 This dissertation presents a systematic study on gold nanoparticles: from their 
chemical synthesis, modification of surface functionalities, optical properties studies with 
emphasis on the absorption and scattering properties, to applications of gold 
nanoparticles in biomolecular detection, imaging and photothermal therapy. In chapter 2, 
we studied the kinetics of gold nanoparticle growth under Brust-Shiffrin reaction 
conditions. In chapter 3, we further examined the reaction mechanism and growth 
kinetics of gold nanoparticles using oleylamine as both a reducing reagent and particle 
growth passivation ligand. From these two projects, important understanding was 
revealed on gold nanoparticle formation and growth mechanism. Chapter 4 describes the 
synthesis of a monofunctional gold nanoparticle through a solid phase place exchange 
reaction. From Chapter 5, we moved to the optical property study of gold nanoparticles, 
particularly the absorption and scattering phenomenon. In this work a systematic analysis 
on the extinction coefficient of gold nanoparticles was performed, providing meaningful 
references for applications based on optical absorption properties of gold nanoparticles. 
In Chapter 6 and Chapter 7, we developed a one-step homogeneous immunoassay for 
protein detection and analysis based on the strong light scattering of gold nanoparticles 
and dynamic light scattering detection technique. In Chapter 8, we further improved the 
stability of gold nanoparticle bioconjugates using a poly(ethylene glycol)-coated gold 
nanoparticles and further tested this nanoparticle in the one-step homogeneous 
immunoassay. Finally in Chapter 9, we demonstrated the application of gold 
nanoparticles for in vitro bioimaging and photothermal therapy of a lung cancer cell. In 
summary, this dissertation presents a comprehensive study on the synthesis, surface 
 iv 
modification, property study of gold nanoparticles and their applications in biomolecular 
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CHAPTER 1. INTRODUCTION TO GOLD 
NANOPARTICLES 
1.1 Chemical Synthesis of Gold Nanoparticles 
Gold nanoparticles (GNPs or AuNPs), also referred as gold colloids, are particles 
with sizes in nanometer scale, typically between 1 nm and 100 nm.1
 
 They have metallic 
gold (0) cores, can be capped by various types of surface ligands such as small molecules 
or macromolecules, and are different in their shapes. The history of GNPs could trace 
back to the 4th or 5th century B.C. in Egypt and China, when GNPs were referred to as 
“soluble gold” and used in antibiotic applications.2 Around 4th century AD in Europe, the 
famous Lycurgus Cup, which has GNPs embedded in, was created. This cup appears as 
green color when irradiated by a white light from outside (reflected lights) but appears to 
be red when irradiated from inside (transmitted lights) (Figure 1-1). 
Figure 1- 1. Lycurgus cup (4th century A.D.) (left: green color when viewed from 




In medieval Europe, GNPs were used as a panacea following the flourish of 
alchemy. Since then, chemical synthesis of GNPs was discussed and significant 
progresses were made. In 1685, a recipe invented by Andreas Cassius marked the first 
reliable method to prepare GNPs in solution. In this recipe, GNPs were prepared by 
dissolving gold in aqua regia followed by the addition of an aqua regia solution of tin. 
This colorant in glasses, “Purple of Cassius”, became very famous in the 17th century. In 
1856, Michael Faraday synthesized the first pure sample of colloidal gold by using 




Figure 1- 2. GNPs with different sizes dispersed in water (Ted Pella, Inc.) (®Copyright 
Ted Pella, Inc.) 
  
In 1951, J. Turkevich pioneered and in 1970s G. Frens refined a very simple 
method to conveniently synthesize aqueous GNPs.4 This method uses tri-sodium citrate 
to reduce HAuCl4 in boiling water and produces nearly mono-dispersed spherical GNPs. 
These GNPs are negatively charged with a loose layer of citrate anions on the surface. 
This method can be used to synthesize GNPs with pre-chosen sizes in a broad range from 
16 nm up to 200 nm (Figure 1-2). The size versatility is achieved by tuning the relative 
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ratio of HAuCl4 salt and the reducing agent in the reaction mixture, as well as with 
careful control over the reaction temperature and the orders of reagents being added to 
the solution. 
Since 1980s, chemical synthesis of GNPs has experienced an exponential growth 
due to the development of nanoscience and nanotechnology. Novel gold chemistry was 
discovered such as phosphate-gold, thiol-gold, and amine-gold bonding and interactions. 
In 1981, Schmid et al. reported the small 1.4 nm [Au55(PPh3)12Cl6] gold cluster with a 
cuboctahdral structure for the Au55 gold core. The structure and special quantum 
electronic properties of these gold culsters were studied extensively.5 Later on, thiol 
ligands were found to have a strong affinity with metal gold surface and can help in 
stabilizing GNPs in both solution and dry states. In 1994, Brust and Schiffrin developed a 
two-phase reduction process for the synthesis of thiol ligands-protected GNPs. These 
GNPs were protected with a self-assembled monolayer of thiol molecules and soluble in 
organic solvents. 6  Since then, various modifications of this reaction were made to 
synthesize well-dispersed small GNPs in organic solvents. 7  In 1998, Murray et al. 
conducted a systematic study on this reaction and adapted the initial Brust-Schiffrin 
reaction to synthesize alkanethoil-protected GNPs with diameters between 1.5 to 5.2 nm. 
In this two phase synthesis, AuCl4- is transferred from aqueous phase into organic phase 
(toluene) by using a phase transfer agent (tetraoctylammonium bromide). Thiol ligands 
were dissolved in the organic phase. Following the reduction of the gold anions with 
aqueous sodium borohydride solution, GNPs were formed in the organic phase. The 
organic phase changes color from orange to deep brown within a few seconds upon 
sodium borohydride addition. This approach allows for the convenient synthesis of well 
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dispersed stable GNPs in organic solvents. Seed-mediated growth method can be used to 
increase the GNP sizes up to 40 nm.8 The narrow size distribution of GNPs could be 
improved by digestive ripening treatments, i.e. heating a colloidal suspension near the 
boiling point in the presence of excess alkanethiols.9 Other ligands, such as amines which 
also have a high affinity with the GNP surface, were reported for the synthesis of GNPs 
typically with larger sizes than thiolated GNPs. The amine-stabilized GNPs can be either 
water soluble or organic solvents soluble, providing tunable solubilities for different 
applications.10 
 In addition to spherical GNPs, there have been tremendous progresses made in the 
synthesis of non-spherical GNPs. El-Sayed M.A. developed a method for the synthesis of 
gold nanorods.11 Xia Y. et al. discovered hollow gold nano-cages.12 Hallas N. et al. 
reported a silica-core and gold-shell nanostructure, while Ostafin A.E. et al. developed a 
gold-core with a silica-shell nanostructure.13 More recently Hafner J. synthesized star 
shaped GNPs with interesting optical properties.14 Although the formation mechanism of 
these novel structures is not well understood yet, GNPs with tunable size, shape, and 
surface chemistry can now be synthesized conveniently through a wide range of chemical 
methods. 
1.2 Biomolecular Conjugation of GNPs 
 To use GNPs for biological applications, GNPs are often conjugated with 
biomolecules. It is expected that the biomolecule-GNP conjugates remain well dispersed 
in aqueous solutions, and maintain the intact activity and specificity of biomolecules. 
There are different approaches available for biomolecular conjugation of GNPs. 
According to the nature of binding chemistry between the GNP and biomolecules, 
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methods to prepare biomolecule-GNP conjugates can be classified to be three types: 
physical adsorption, covalent coupling reactions, and bio-recognition reactions. 
 The most frequently used method to conjugate antibodies or other type of proteins 
on GNPs is based on physical adsorption of proteins onto negatively charged citrate-
protected GNP surface. This physisorption method was first discovered in 1940s and 
became widely used to prepare protein-GNP conjugates in biomedical therapies and cell 
imaging applications since then. Through non-covalent and non-specific interactions, 
proteins can adsorb onto many inorganic or organic surfaces. Such physisorption of 
molecules onto a solid support is a result of the combination of weak bonds between 
biomolecules and the substrate surface. These weak bonds include electrostatic 
interactions, van der Waals interactions, and/or hydrogen bondings. A classical example 
of this physisorption effect is the immobilization of proteins on plastic microtiter plate 
used for Enzyme-Linked ImmunoAbsorbant Assay (ELISA). Protein can absorb onto 
GNPs through similar interactions.15 
 The advantages of the physisorption method include its simplicity and 
applicability to almost any type of biomolecules. However, these are several limitations 
for the physical adsorption method. First, there is a concern about the colloidal stability 
of biomolecule-conjugated GNPs prepared through the physisorption method. Indeed, 
bare charged GNPs are not stable and tend to precipitate out in high ionic strength 
solutions. After GNPs are conjugated with a saturated number of proteins on the surface, 
the colloidal stability could be significantly improved in high ionic strength solutions 
such as biological fluids. However, non-specific interaction-induced GNP aggregation 
can still occur and result in shorter shelf-life and poor reproducibility of the experimental 
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results. This is the reason why stabilizing agents, such as bovine serum albumin (BSA) or 
surfactants, are present in most commercial products of GNP-protein conjugate 
suspensions. Second, there is no control on the orientation of biomolecules which are 
physically adsorbed onto the GNP surface. Third, the possible denaturation of proteins is 
also a concern for biomolecule-GNP conjugates prepared through the physisorption 
method. These limitations of non-covalent physisorption method justify the need of 
covalent conjugation method for preparing more robust biomolecule-GNP conjugates. 
 Covalent coupling through gold-thiol chemistry is one of the most extensively 
used methods for making biomolecule-GNP conjugates. Because thiol groups have high 
affinity to the GNP surface, when thiol ligands are added into a citrate-protected GNP 
solution, thiol ligands will replace the citrate molecules on GNPs and lead to thiol 
ligands-protected GNPs. Through this exchange reaction, thiolated deoxynucleic acid 
(DNA) molecules could be conjugated covalently onto GNPs. This method was 
demonstrated in making single strand DNA-conjugated GNPs by Mirkin C.A. et al. and 
Alivisatos A.P. et al. in 1996. 
 This thiol exchange reaction method was also used to covalently conjugate 
proteins or peptides onto GNPs. In this case, a thiolated bi-functional linker molecule is 
required. The linker molecule is used as the bridge molecule to covalently couple GNPs 
and biomolecules. The linker molecule has two end groups and a variable part in the 
middle. The thiol end group on the linker molecule is used to immobilize the linker 
molecule onto the GNP surface through the thiol exchange reaction. The second end 
group is used to covalently react with proteins or peptides. Commonly used functional 
groups are carboxylic acids and amines. The carboxylic acid groups can be activated 
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through the carbodiimide chemistry and conjugated to the amine groups exposed on the 
protein surface. 16  Through the linker molecule, proteins and peptides can thus be 
conjugated covalently to GNPs. As every protein could have several accessible amine 
groups from lysine residues, this covalent conjugation approach often results in a random 
and multiple orientation of proteins at the surface of GNPs. 
 Bioconjugated GNPs prepared through covalent coupling usually have much 
improved colloidal stability and resistance to non-specific interactions in biological fluids 
than noncovalently-conjugated GNPs. Another advantage of the covalent coupling 
method is that the middle part of the linker molecule can be varied to further improve the 
performance of protein-GNP conjugates. Thiolated poly(ethylene glycol) (PEG) 
polymers with end groups such as carboxylic groups are excellent linker molecules.17 The 
PEG part could serve multiple functions. First, the polymer molecules form a shielding 
layer on the GNP surface and improve the colloidal dispersion and stability of the 
bioconjugated-GNPs. Second, the PEG spacer separates biomolecules from the GNP 
surface so as to avoid or reduce the possible denaturation of proteins. Third, PEG 
polymer can minimize non-specific interactions between GNPs and biomolecules in 
biological fluids.18 Because of these advantages, PEG-protected GNPs have been studied 
and used extensively for GNP-bioconjugate preparation.19 
 Despite the several advantages of the covalent conjugation method, there are also 
some problems associated with this method. One problem is the lack of control over the 
orientation of biomolecules on the GNP surface. Another problem is the possible loss of 
bioactivity of the biomolecules after their amine groups are used for the covalent bond 
formation. The amine groups may be important for the bioactivity when they are present 
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in the active sites or ligand binding sites. These problems can limit the application of the 
covalent coupling method. 
New methods based on bio-recognition reactions have been developed in order to 
prepare robust biomolecule-GNP conjugates while also to avoid or reduce the above 
mentioned problems associated with the covalent coupling method. The biotin-
streptavidin coupling is an excellent example. Each streptavidin has four biotin binding 
sites positioned in pairs on opposite domains of the protein. The biotin-streptavidin 
coupling is known to be the strongest bio-interaction with a binding affinity as high as 
1015 M-1. To prepared streptavidin-GNP conjugates, thiolated biotin molecules are first 
covalently attached to GNPs through thiol-gold chemistry. Streptavidin is then added and 
coupled with biotins on the surface of the GNP through the highly specific and strong 
biotin-streptavidin interaction.20  
The streptavidin-conjugated GNPs can be used as a general GNP platform to 
prepare other protein-GNP conjugates. In such cases, the streptavidin molecules on GNPs 
are used as anchors to conjugate biotinylated proteins to GNPs. A variety of proteins or 
peptides could be conjugated to GNPs by this way. Koh et al. prepared the streptavidin-
coated GNPs and conjugate them with biotinylated antibodies or biotinylated actin. The 
conjugation process was monitored by TEM and the proteins around the GNP were 
imaged by using negative staining technique. 21  Other biomolecules, in addition to 
streptavidin molecules, could also be used for similar purpose. Brisson A. and Mornet S. 
used a modified protein of Annexin-A5 as the anchor molecule to conjugate antibodies to 
GNPs.22 The modified Annexin-A5 proteins bind only to the crystallizable fragment (Fc 
region) of antibodies. As a result, antibodies may be conjugated to GNPs with controlled 
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orientation. The antigen-binding fragments, Fab regions, of the antibodies will be 
exposed on the GNP surface. The proper orientation of the Fab regions of the antibodies 
ensures a good bioactivity of the conjugates. 
The methods to prepare biomolecule-GNP conjugates through bio-recognition 
reactions produce conjugates with good colloidal dispersity and stability as well as 
desired orientation and bioactivity for conjugated biomolecules. However, the process of 
bio-recognition methods is more complex than the physisorption method or the covalent-
coupling method. The advantages as well as the limitations of each conjugation method 
should be considered in order to select the appropriate method for specific application. 
1.3 Optical Properties of GNPs 
When one or more dimensions of materials are reduced to the nanometer scale, 
properties of materials could change dramatically from their bulk states. In the nanometer 
size range, GNPs present many new interesting properties, especially optical 
properties.23-25 When irradiated by lights, the coherent collective oscillation of electrons 
(6s electrons of the conduction band) on the GNP surface induces large electromagnetic 
fields, which will resonate with the incident electromagnetic waves at specific 
frequencies. Such effect has been defined as the well-known Surface Plasmon Resonance 
(SPR) effect (Figure 1-3).25b  
The SPR effect results in much enhanced absorption and scattering for GNPs. The 
absorption and scattering cross sections of GNPs are orders of magnitudes larger than 
that of non-metallic materials such as polymer latex particles, fluorescent dyes or 
biomacromolecules. The absorption cross section of GNPs is 4 to 6 orders of magnitudes 
larger than the strongest absorbing small organic molecules.23 The scattering cross 
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section is 4 to 9 orders of magnitudes larger than that of the fluorescence of many widely 
used organic dyes. These strong absorption and scattering properties make GNPs as ideal 
probes for biomolecular imaging and detections.23 As GNPs are not luminescent or not 
strong luminescent materials, most of the absorbed photon energy will be dissipated into 
the local environment through heat. In other words, GNPs are excellent photon-thermal 








Figure 1- 3. Schematic of plasmon oscillation for a sphere, showing the displacement of 
the conduction electron charge cloud relative to the nuclei. (Copyrigh ® 2007, Springer 
New York) 
 
1.3.1 SPR induced absorption property of GNPs 
1.3.1.1 SPR absorption of spherical GNPs   
Spherical GNPs have a strong SPR absorption band in the visible light region, 
typical around 520-600 nm (Figure 1-4).25a The SPR band of spherical GNPs was first 
explained by Mie in 1908 and had several derived versions.24 For particles with sizes 
much smaller than the wavelength of the incident light (diameter <0.05λ), the absorption 




















                                                                                        (1-1) 
where D is the particle diameter, nmed is the refractive index of the surrounding media, λ0 
is the incident light wavelength, and m is the relative refractive index which is defined as 
the refractive index of the bulk gold at the incident light wavelength λ0 divided by nmed. 
For visible light irradiation from 400 nm to 800 nm, the absorption of GNPs in sizes up to 
20-40 nm in diameter can be described well with equation (1-1). For larger spherical 
GNPs (diameter >0.05λ), the absorption is dependent on dipole oscillations as well as 
higher-order multipole oscillations including quadrupole and octopole modes. As a result, 
the full expression of Mie equation should be used to calculate the absorption cross 











Figure 1- 4. Size effects on the SPR absorption of spherical GNPs. The UV-vis 
absorption spectra of colloidal GNPs with diameters varying between 9 and 99 nm show 
that the absorption maximum red-shifts with increasing particle size in part a, while the 
plasmon bandwidth follows the behavior illustrated in part b. In part c the absorption 
coefficients of these GNPs at their respective plasmon absorption maxima are plotted 
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against their volume on a double logarithmic scale. The solid line is a linear fit of the data 
points. (Copyright ® 1999 American Chemical Society) 
 
According to Mie theory, the peak position, intensity and bandwidth of the SPR 
absorption band of GNPs are dependent on the size, shape and dielectric constant of 
GNPs as well as the dielectric constant of the surrounding media. El-Sayed et al. reported 
the experimental results of the size effect on the SPR absorption band of spherical GNPs 
(Figure 1-4). When the size of spherical GNPs increases from 9 to 99 nm, the peak 
wavelength of the absorption band shows a red-shift (Figure 1-4a). In addition, the 
bandwidth of the SPR band has the minimum at 20 nm and will increase for both smaller 
and larger GNP (up to 50 nm) (Figure 1-4b). 25,26 In Figure 1-4c, a linear correlation 
between the molar absorption coefficient and the particle volume is shown. Theses results 
are in agreement with theoretical calculations based on Mie theory. 
Fernig D.G. et al. reported that the SPR absorption spectrum of a monodispersed 
spherical GNP solution could be used to calculate the size and concentration of the 
GNPs.27 The average diameter of GNPs in aqueous solution can be calculated from their 
UV-Vis absorption spectra: 




Bd spr −=                                                                                                  (1-2) 
where Aspr is the SPR peak absorbance value of the GNP solution; A450 is the absorbance 
value of the GNP solution at λ=450 nm; B1=3.00, B2=2.20 as determined by curve fitting. 
This equation provides a very convenient way to calculate the diameter of monodispersed 
GNPs in aqueous solution from 5 to 80 nm. They also derived the following equation to 















N                                                                     (1-3) 
where N is the number density (nanoparticles/mL), A450 is the absorbance at λ=450 nm, 
and d is the particle diameter in nanometer. Based on this equation, one can conveniently 
estimate the concentrations of GNPs in water. 
 
 
Figure 1- 5. A typical surface plasmon absorption spectrum of gold nanorods. The long 
wavelength band in the near infrared region around 800 nm is due to the longitudinal 
oscillation of electrons and the short wavelength band in the visible region around 520 
nm is due to the transverse electronic oscillation. 
 
1.3.1.2 SPR absorption of gold nanorods (GNRs) 
Non-spherical GNPs have different SPR absorption bands from spherical GNPs. 
For gold nanorods (GNRs), they have two SPR bands: one weak band peaked at ~530 nm 
and another strong band peaked at a longer wavelength in the range from 630 to 1100 nm 
(Figure 1-5).28  The weak band is due to the transverse electronic oscillation while the 
strong band is due to the longitudinal oscillation of electrons. The peak position of the 
longitude SPR band for GNRs is found to be very sensitive to the aspect ratio, which is 
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defined as the ratio of the length of the GNR over the width. When the aspect ratio 
increased from 2.4 to 7.4, the peak wavelength of the longitude SPR band can be red-
shifted from 600 nm to 1000 nm (Figure 1-6).28 Such tunability in the near-IR region is 
particularly attractive for biological applications as discussed later. 29 
 
 
Figure 1- 6. (A) Gold nanorods mirograph obtained by Transmission Electron 
Microscopy (Copyright ® Royal Society of Chemistry 2001).30 (B) Tuning the SPR 
bands of gold nanorods by synthetically controlling the aspect ratios. (Copyright ® 1999 
American Chemical Society) 
 
The optical absorption spectra of GNRs could be calculated with modified Mie 
theory. According to Gans treatment for the dipole approximation, the extinction cross 
section for elongated ellipsoids is given by:31,32  















εωσ                                                              (1-4)  
Where Pj are the depolarization factors along the three A, B and C axis of the nanorod, 





















PPP −==                                                                                                            (1-6) 








 −=                                                                                     (1-7) 
The tunable absorption spectra of GNRs in the near-IR (NIR) region provide a 
special advantage in using GNR for biological applications. In the NIR region, especially 
650-900 nm, water and tissues (mainly hemoglobin and oxyhemoglobin in the tissue) 
have minimal absorption in this window (Figure 1-7). 33 By selectively delivering GNPs 
into target cells and tissues, photon irradiation at NIR wavelength will pose minimum 
effect on non-targeted cells and tissues. In addition, NIR light can penetrate tissue much 
deeper than visible light irradiation. A penetration depth of up to 10 cm could be reached 









Figure 1- 7. Optical absorption spectra of tissue components in the ultraviolet to infrared 
range. (Hb: hemoglobin; HbO2: oxyhemoglobin) (Copyright ® Duke University)  
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1.3.2 Light scattering property of GNPs 
1.3.2.1 Light scattering property of spherical GNPs    
 GNPs have interesting light scattering properties. When GNPs are illuminated by 
a narrow beam of white light, GNPs scatter lights in various colors ranging from green, 
yellow to red as the GNP size increases (Figure 1-8A). 34 For example, Figure 1-8B 
shows the scattered green lights from 58 nm GNPs and Figure 1-C shows the scattered 
yellow lights from 78 nm GNPs. The light scattering property of GNPs and its potential 
applications were investigated by Yguerabide J. et al in 1998. Since then the scattering of 
GNPs have been studied intensively from both theoretical and experimental aspects.34 
 
 
Figure 1- 8. (A) Photographs showing the appearance of light-scattering suspensions. 
Composition, particle diameter, and particle molar concentration are as follows from left 
to right: silver, 40 nm (2×10-12 M); gold, 40 nm (1.3×10-11 M), 78 nm (1.7×10-12 M), 118 
nm (5×10-13 M), and 140 nm (3×1013 M); solution of fluorescein (2×10-6 M). Scattering 
photographs of the (B) 58-nm and (C) 78-nm diameter GNPs under an optical 






Theories have been developed to explain the scattering property of GNPs. For 
small nanoparticles (diameter<0.05λ), in this case of GNPs, only dipole oscillations 
contribute significantly to the scattering. Rayleigh theory can be used to explain the 


















                                                                                        (1-8) 
where D is the particle diameter, nmed is the refractive index of the surrounding media, λ0 
is the incident light wavelength, and m is the relative refractive index of the bulk gold at 
irradiation wavelength λ0 divided by nmed.34 For large GNPs (diameter>0.05λ), the 
scattering is considered to be the sum of dipole and higher order oscillations. In Mie 











C π                                                                                (1-9)                                      
where 0/2 λπ mednk = . The different terms in the sum correspond to different dielectric 
and magnetic multipoles and n is the term index. The term index with n=1 corresponds to 
the electric dipole. The coefficients Bessel function na  and Ricatti function nb  are 
generally complex numbers, which depends on the size- and incident light wavelength-
related refractive index of the particle.34  
   In 1998, Yguerabide et al. calculated the scattering and absorption cross sections 
of spherical GNPs at different sizes from 20 to 300 nm according to the above theories 
and compared them with experimental results.34 They calculated that the scattering peak 
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wavelength, intensity and the relative ratio of scattering to absorption were all related 
with the GNP size. The results are summarized in Table 1-1, Figure 1-9, and Table 1-2. 
The SPR scattering peak wavelength (λmax) has two separated trends when the 
GNP size increases. From size 20 to 160 nm, the λmax shows a red-shift from 535 nm to 
635 nm. From 160 to 300 nm, the λmax illustrates a blue-shift from 635 nm to 565 nm 
when the GNP size increases (Table 1-1 and Figure 1-9).34 Table 1-2 presents the 
experimental results of λmax for 52, 78, 87 and 118 nm GNPs, which is in a relatively 
good agreement with the red-shift trend as predicted in the theoretical calculations. Thus 
by changing the size, the light scattering profile of GNPs can be tuned.34 
 
Table 1- 1. Calculated light absorption and scattering properties of spherical GNPs 







*IU(0) and IU(90) is the scattering light intensities measured at 0 and 90o with respect to 
the direction of an unpolarized incident light beam. φs is the portion of light scattering in 
the whole extinction which is the sum of both scattering and absorption. ε is the 




The scattering cross section (Csca) of GNPs depends dramatically on their 
diameter. From equation (1-8), the scattering cross section of a small GNP is proportional 
to the 6th power of its diameter. As a result, when the size of GNP increases, the 
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scattering intensity increases dramatically. The scattering cross section Csca increases 
monotonically from 20 nm to 300 nm, as shown in Table 1-1.  A 300 nm GNP has a cross 
section which is ~4×104 times larger than that of a 20 nm GNP. It needs to mention that 
this number is small than the 6th power of the relative diameter ratio (300 nm/20 nm)6 
because at large sizes the Csca is not proportional to the 6th power of the size anymore. 









Figure 1- 9. Normalized calculated light scattering cross section versus wavelength for 
homogenous and spherical GNPs with different sizes according to Mie theory. (Copyright 
® 1998 Springer New York) 
 
Table 1- 2.  Experimentally determined number of fluorescein molecules (NF) needed to 
produce the same intensity of light as a GNP at a given diameter (Copyright ® 1998 
Springer New York) 
            
*Dia: diameter of GNPs; Cscad is the experimental scattering cross section of GNPs. 
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Increasing the size of a GNP not only results in a shift of its SPR scattering peak 
and an increase in its scattering cross section, but also increases the relative portion of 
scattering in the whole extinction. Comparing equation (1-8) with equation (1-1), the 
amplitude increases according to D6 and D3, respectively for the scattering cross section 
and the absorption cross section. As a result, when the GNP size increases, the scattering 
cross section increases much larger than the absorption cross section. In Table 1-1, the 
contribution of scattering to the extinction (ϕs) is only 1.4% at the scattering peak (λ=535 
nm) for 20 nm GNPs, but increases to 54.6% at the scattering peak (λ=555 nm) for 50 nm 
GNPs.34  
 
                   
Figure 1- 10. Angular dependent scattering intensity diagrams for both small particles 
and large particles when irradiated with unpolarized light. (Copyright © 2009 Indian 
Academy of Sciences) 
  
In the detection of scattered lights from GNPs, the scattering intensity is the sum 
of scattered lights that can be captured by the detector. The angular dependence of the 
scattering intensity is related with the polarization of the incident light as well as the GNP 
size. When a polarized light is irradiated on small GNPs (diameter<0.05λ), the scattering 























I med                                                                            (1-10) 
where I0 is the intensity of the incident light, r is the distance of the detection point to the 
particle, and α is the angle between the detection direction r and the direction of 
polarization of the incident beam.34 In the case of unpolarized light illumination, the 























I med                                                                        (1-11) 
where θ is the angle between the incident laser beam and the direction of detection. The 
shape of the scattering diagram is determined by the (1+cos2θ) term and plotted in Figure 
1-10. 35 It can be seen that the scattered light intensity is two times great at θ=0 than that 
at θ =90o and varies according to (1+cos2 θ) at intermediate angles. 
For larger particles (diameter within 0.05λ-0.5λ), under unpolarized light 















                                                                                        (1-12) 
where S1 and S2 are functions depending on the scattering angle and the Bessel functions 
an and Ricatti functions bn (equation 1-9).35 In this case, the scattered light from different 
parts of the particle will reach the detector by traveling different path lengths. The net 
effect is that the scattering diagram for large particles is reduced intensity at back 
scattering angles (Figure 1-10). The scattering intensity is not symmetric for back and 
forward scattering. As a result, larger GNPs can be more sensitively detected at forward 
angles than at 90o or back scattering angles. 
   
 22 
                            
Figure 1- 11. Logarithmic plots showing the dependence of relative light scattering 
intensity on GNP concentration for GNPs with different sizes (in the unit of nm) 
(Copyright ® 1998 Springer New York) 
 
The light scattering property of GNPs can be used to detect GNPs. In fact, the 
strong light scattering of GNPs comparing with other materials makes them to be 
detected very sensitively. The scattering cross sections of spherical GNPs is 4-6 orders of 
magnitude larger than that of small fluorescence molecules, polystyrene beads or 
biomacromolecules, as shown in Table 1-2.34 For example, a 52 nm GNP produces the 
same light intensity from scattering as the luminescence light emitted by 4.4×104 
fluorescein molecules. GNPs can be detected at very low concentrations, as shown in 
Figure 1-11.34 For mono-dispersed GNPs in solution, it was reported that their scattering 
intensity is linearly correlated to the GNP concentration in log scales with a dynamic 
range of ~3 orders. Detection limits for spherical GNPs as low as 10-14 M (52 nm), 
2.5×10-15 M (78 nm), 1.6×10-16 M (87 nm) and 4×10-16 M (118 nm) were reported.  
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The very low detection limits of GNPs by light scattering make them 
advantageous to be used as ultra sensitive probes for biological applications. Another 
advantage of GNPs in these applications is the tunability of their scattering peak 
wavelengths by changing their size and shape.  
 
                              
Figure 1- 12. Calculated SPR scattering spectra of GNRs at various aspect ratios. 
(Copyright ® 2005 Elsevier B.V.) 
 
1.3.2.2 Scattering property of gold nanorods 
Lu et al. calculated the theoretical resonant light scattering property of GNRs at 
various sizes and aspect ratios using the quasi-static theory.36 The scattering cross section 






πσ                                                                                             (1-12) 
where a is the half of the rod length, b is the half of the rod width, A and B are functions 
depending on the dielectric constants of the rod and the surrounding media as well as a 
and b. The numerical calculation results of the light scattering spectra of GNRs are 
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shown in Figure 1-12.36 It can be seen that the SPR peak red-shifts with increased GNR 
aspect ratio. 
 El-Sayed et al. calculated the effects of GNR size and aspect ratio on the relative 
ratio of scattering to absorption by using the discrete dipole approximation (DDA) 
method. As shown in Figure 1-13, the relative ratio of scattering to absorption increases 
along the size increase of GNRs, but not changes much by varying the aspect ratio. 37 
These results show that the scattering and absorption property of GNRs can be tuned by 
changing the size and/or the aspect ratio. 
 
 
Figure 1- 13. Effects of GNR effective radius (a) and aspect ratio (b) on the relative ratio 
of scattering to absorption. (the effect radius effr  for GNRs is defined by 
3/1)4/3( πVreff = , where V is the volume of a GNR) 
 
1.3.3 Photothermal energy conversion of GNPs under laser irradiation 
When irradiated with a laser beam at a wavelength around the SPR band, GNPs 
absorb photon energy strongly due to their large absorption cross sections. Because GNPs 
are not strong luminescent materials, most of the absorbed energy will be released as heat 
to the local environment of GNPs. This energy dissipation process involves the initial 
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ultrafast electron-electron scattering (<20 fs), followed by the relative slower cooling due 
to electron-phonon (~2 ps) and phonon-phonon coupling (>50 ps).38 According to Fermi 
liquid theory, for electrons with an initial energy E close to the Fermi energy EF, the 






                                                                                                        (1-13) 
For single scattering process, ee−τ is usually on the order of 10 fs. However, the sum of all 
electron-electron scattering events before the formation of a Fermi electron distribution 
makes ee−τ to be several hundreds of femtoseconds. As reported by El-Sayed et al, the 
internal electron-electron thermalization has a fast lifetime of 500 and 450 fs, 
respectively for 9 nm and 48 nm spherical GNPs. The following slower external electron 
thermalization (electron-phonon interactions) takes place in a time regime of 1.6 and 1.7 
ps, respectively. These results are shown in Figure 1-14. 25 
Because the energy dissipation rate is much slower comparing with the energy 
absorption rate, as a consequence, the absorbed energy from the laser cannot be 
dissipated quickly enough from the GNP surface to the environment. This leads to a large 
increase of the temperature around the GNP surface as well as its vicinity environment. 
In the case of pulsed laser irradiations, the temperature on the GNP surface could reach as 
high as more than 1000 oC. In such a high temperature, GNPs may change their shapes, 
for example, from gold nanorods to spheres.39  
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Figure 1- 14. Electron-electron and electron-phonon relaxation times for spherical GNPs 
at 530 nm after excitation with 630 nm femosecond pulses. (Copyright @ 1999 American 
Chemical Society) 
 
In the case of continuous wave laser irradiations, the photothermal conversion of 
GNPs and the following thermal effect to their local environment have also been studied. 
Govorov et al. calculated the surface temperature increases of a spherical GNP as a 






∂ρ                                                                  (1-14) 
where T(r, t) is temperature as a function of coordinate r and time t, ρ(r), c(r), and k(r) 
are the mass density, specific heat, and thermal conductivity, respectively. Q(r, t) is the 
local heat intensity function and partially depends on the dielectric constants of GNP and 
also the media. The effects of GNP size, laser wavelength and power to photothermal 
conversion reaction are shown in Figure 1-15. 40  The surface temperature of GNPs 
increases along with increased GNP size or laser power density. Following the 
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temperature increases on the GNP surface, the surrounding media can be heated up due to 
heat transfer. Water around a GNP can be heated up within a distance of 10s nm to the 
GNP surface (Figure 1-15a, insert). In another example, Huang et al. calculated that cells 
loaded with GNPs will be affected by the photothermal conversation reaction of GNPs.40 
This results in an elevated temperature around 70-80oC for cells. These theoretical 
calculations agree with experimental results obtained from cells which loaded with GNPs, 
GNRs or gold nanoshells.41  
 
 
Figure 1- 15. Calculated temperature increase at the surface of a single GNP in water as 
a function of the irradiation wavelength (a) and the illumination power at the plasmon 
resonance (b). (insert: spatial distribution of temperature at different time) (Copyright ® 
2007 Elsevier B.V.) 
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1.4 Applications of GNPs in Biological Systems 
Advances in the synthesis, modification, biomolecular conjugation, and further 
understanding of the properties of GNPs have enabled many important applications of 
GNPs in biological systems. This is a fast growing field since last decade. In addition to 
biomolecular detection, GNPs are also used in bio-imaging and photothermal therapy. 
GNPs have been shown to be very promising to help in the diagnostic and treatment of 
diabetes, cancer, Alzheimer’s diseases, and rheumatoid arthritis.42 The following is a 
brief review on examples of GNPs applied in biological systems. 
1.4.1 Applications of GNPs in biomolecular detection and assays 
Biomolecular detection in biofluids or tissue samples is very important for early 
detection, diagnosis and prognosis of diseases, as well as in drug development. Proteins 
are one type of biomolecules produced by human body and can be within or located on 
the cell surface or released into body fluids. An abnormal change of protein levels is 
often a sign of disease occurrence. For example, a large increase on the level of protstate 
specific antigen (PSA) in human serum from the normal range (<4 ng/mL) may be 
associated with the occurrence and progression of prostate cancer. DNAs are another type 
of important biomolecules which has a significant role in diagnosis and therapy. For 
example, screening the gene sequences of a patient is necessary to determine the position 
of mutated genes. This process requires analytical methods with ultra-sensitivity, fast 
procedure, and using small volumes of samples. Traditional methods such as Enzyme 
Linked Immunosorbent Assay (ELISA) and Polymerase Chain Reaction (PCR) 
techniques have been used for decades for protein or DNA detection. Since 1990s, new 
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analytical have been investigated and developed by introducing GNPs as novel optical 
probes with better sensitivity, simpler procedure and less cost than traditional methods.  
 
 
Figure 1- 16. (A) Schematic representation of GNP aggregation reactions (B) SPR band 
shows a red-shift when GNPs form aggregates in a colorimetric assay. (Copyright ® 
2008 John Wiley & Sons, Inc.)  
 
1.4.1.1 Biomolecular assays based on the light absorption property of GNPs 
Aggregation of individual GNPs in solution usually introduces a red-shift and 
broadening of the SPR band. This is a result of surface plasmon coupling between 
neighboring GNPs when the distance between them is reduced to be within 2-3 times of 
the particle size. An example is shown in Figure 1-16.43 The aggregation of GNPs is 
introduced by bimolecular recognition reactions between the receptor molecules on the 
GNP surface and the analyte molecules in solution. As a consequence, the SPR peak of 
the GNP solution shifts from ~520 nm to a higher wavelength around 600 nm. This 
change is also visible as the solution color changes from purplish to blue. The extent of 
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the aggregation reaction, and thus the spectrum shift, is associated to the available analyte 
molecules in the solution. In 1996, Mirkin et al. showed that thiolated ssDNA conjugated 
13 nm GNPs could form aggregates through hybridization of ssDNA on GNPs surface 
with target DNA molecules in solution. 44  Since then, bimolecular assays based on 
detecting the SPR absorption spectra changes after the aggregation reaction of GNP 
probes have been applied for a large variety of biomolecules, including nucleic acids, 
proteins, saccharides. 45 
 
 
Figure 1- 17. Absorption spectra enhancement effect of aptamer-conjugated GNPs with 
CCRF-CEM cells (CCL-119 T-cell, human acute lymphoblastic leukemia) at various cell 
concentrations. (data presented were subtracted from the pure GNP absorption spectrum) 
(Copyright ® 2008 American Chemical Society) 
 
In addition to the detection of small biomolecules, GNPs are also applied in cell 
detection. Tan et al. recently applied the spherical GNPs for cancerous cell detection 
using aptamers-coated GNPs. The aptamers bound specifically to cancer cell surface and 
bring GNPs to form aggregates on cell surface. As shown in Figure 1-17, this local 
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aggregation resulted in two effects on the SPR band: a red-shift of the SPR band and an 
intensity enhancement of the SPR band intensity. Such GNP probes based assay had very 
high sensitivity for cell detection as few as 90 cells in 300 µL sample solution.46 
 
 
Figure 1- 18. Whole blood tests for rabbit IgG using gold nanoshells (106 nm core 
diameter with a 25 nm thick gold shell) (Copyright ® 2003 American Chemical Society) 
 
Besides spherical GNPs, nanoshells and nanorods are also used in biomolecular 
assays. As discussed in 1.3.1.2, these non-spherical GNP probes have a unique advantage 
because they have SPR band in the NIR region. Figure 1-18 shows an example of using 
gold nanoshells for the detection of rabbit IgG in whole blood by Hafner et al. Antibody 
conjugated gold nanoshells formed aggregates through crosslinking with rabbit IgG 
molecules in the blood sample. This introduced a decrease of the SPR peak absorbance at 
720 nm. After 10 minutes of incubation, the absorbances decreases were statistically 
distinguishable in samples with different rabbit IgG concentrations ranging from 440 






Tailoring the aggregation reaction yields versatile formats for GNPs-based 
biomolecular assays. As shown in Figure 1-19,43 there are a variety of designs used in the 
GNP aggregation assay. In a most common format, shown as pathway A, receptor-
conjugated GNPs form aggregates through crosslinking by target molecules. Other 
formats of assays, such as competitive assays (shown as Figure 1-19B), are also reported. 
In this case, two GNP probes which have a pair of recognizing biomolecules were used. 
Without the addition of analyte, these two GNP probes will form aggregates and 
introduce red-shift of the SPR band. Because the analyte has a specific binding with one 
of the two GNP probes through bio-recognition reactions, the aggregation reaction is 
partially or fully hindered by the addition of the analyte depending on its 
concentrations.43  
These assays have higher sensitivity than conventional biomolecular assays but 
easier. Typically, the detection limit is in the range of nM to µM when performed without 
any signal amplification steps. The detection limit varies with the design of the system, 
the binding affinity between the receptor molecule on GNP surface and the analyte 
molecule, as well as other assay conditions. If extra signal amplification steps are used 
the sensitivity can be further improved to fM for DNA or low pM range for protein 
detection. 48 However, these amplification steps complicate the assay procedure and often 
cause problems in the reproducibility of the assays. To solve this problem, alternative 
methods based on the light scattering property of GNPs have been explored.  
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Figure 1- 19. GNP aggregation reaction applied in biomolecules detection. A) GNPs are 
brought together by crosslinking molecules that have multiple binding sites for the 
corresponding receptors on GNPs (pathway A). Biological recognition events (or 
processes) that remove (or break) crosslinking molecules cause GNP de-aggregation 
(pathway B). Biological recognition events (or processes) that can modify crosslinking 
molecules (pathway C) or receptors on GNP surface (pathway D) can indirectly control 
GNP aggregation and dissociation. (B) Competitive GNP assays based on GNP probe 
aggregation reaction. Without analyte molecules, the two types of multi-valent GNP 
probes aggregate. With analyte molecules, the aggregation reaction was hindered. 
(Copyright ® 2008 Elsevier B.V.)  
  
1.4.1.2 Biomolecular assays based on the light scattering property of GNPs 
 The strong light scattering property of GNPs enables GNPs to be detected by light 
scattering techniques sensetively. In 1998, Vance et al. found that the hyper-Rayleigh 
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scattering (the scattering produces frequency doubled light) intensity of spherical GNPs 
is linearly dependent on GNP concentrations.49 When GNPs form aggregates, the light 
scattering intensity increases dramatically due to the SPR coupling of neighboring GNPs. 
The aggregation reaction detected by light scattering techniques is correlated to the 
analyte concentration, similarly in absorption property based GNP assays. In 2006, Ray 
et al. first demonstrated that the hyper-Rayleigh light scattering intensity could be used 
for DNA detection.50  As shown in Figure 1-20, when target DNA was present and 
hybridized with single-strand DNA (ssDNA) on GNP probes, the hyper-Rayleigh 
scattering intensity at 650 nm (with a 1300 nm incident laser irradiation) was increased 
dramatically. This assay also had very good selectivity. In the comparison study, the 
sample which added by single-base mismatched target DNA showed no increases in the 
scattering intensity (Figure 1-20).51  
 
 
Figure 1- 20. Plot of hyper-Rayleigh scattering intensity versus concentration of target 
DNA. (Squares: target DNA; circles: target DNA with one base-pair mismatch). 
(Copyright ® 2006 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim) 
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 Other than the nonlinear hyper-Rayleigh scattering, other scattering phenomena of 
GNPs such as the resonance scattering can also be used in biomolecular detection 
applications. In 2006, Qin et al. used an antibody-labeled 9 nm GNPs to detect proteins 
Apolopoprotein Al (ApoAl) and Apolipoprotein B by measuring the resonance light 
scattering intensity. Detections limit were determined to be 2 ng/mL and 0.96 ng/mL, 
respectively for these two proteins. 51  Liu et al. reported the ssDNA-stabilized GNP 
probes for target DNA detection with a linear response between the light scattering 
intensity and the concentration of target DNA from 0.7-110 pM. 52 Du et al. reported a 
better sensitivity of 10 fM-1 nM for DNA detection by adding a silver enhancement step 
before the light scattering intensity detection.53 As shown in Figure 1-21, the scattering 
light intensity at 315 nm is increased linearly with the target DNA concentration.  
 
 
Figure 1- 21. Light scattering spectra of GNPs modified with two probe DNAs for the 
detection of the complementary DNA target at different concentrations. (Copyright ® 
2006 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim) 
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Other than their use for homogenous solution assays, GNPs can also be used as 
for heterogeneous biomolecular assays. Such heterogeneous format assays are similar to 
the design of solid phase sandwich type immunoassays (such as ELISA) but use 
biomolecules labeled GNPs as the detection probes. Figure 1-22 is an example to use 
GNPs in a heterogeneous assay for DNA detection. DNA hybridization reaction is used 
for target DNA binding. The substrate was washed extensively to lower down the back 
ground scattering intensities. After that, the light intensity from the resonance light 
scattering is collected and used for target DNA quantifications. This technique was first 
invented by Yguerabide et al. in 1998 and now commercially available from Invitrogen 
Similar concept in a heterogeneous format was also demonstrated by Wang et al. for 
protein detection with sensitivity in the range of ng/mL.54 
 
 
Figure 1- 22.  Schematic light scattering detection assay of the GeniconRLSTM two-
color DNA microarray kit.55 
  
Dynamic light scattering (DLS), also known as photon correlation spectroscopy 
or quasi elastic light scattering, is a technique used widely for particle size and size 
distribution studies based on monitoring the scattering intensity variation of the sample 
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solution at a specific angle. DLS is used routinely to analyze the size and size distribution 
of polymers, proteins, colloids and nanoparticles. Recently, DLS is used to measure the 
light scattering intensity in GNPs-based light scattering assays. In 2007, O’Neal et al. 
used DLS to measure the light scattering intensity of gold nanoshells in whole blood. As 
shown in Figure 1-23, DLS can detect gold nanoshells down to pM range. The same 
group also did in vivo study on the uptake of gold nanoshells by mice using DLs as the 
detection technique. A linear increase in scattering intensity was found when more gold 
nanoshells were injected into the mouse. These studies show that DLS is a very sensitive 
and convenient technique in detecting GNPs. 56 
 
 
Figure 1- 23. Dynamic Light Scattering intensity area ratio of gold nanoshells to Triton 
X-100 in 3% murine blood versus gold nanoshells concentrations. (Copyright ® 2007 
Elsevier B.V.) 
 
1.4.2 Application of GNPs for enhanced cell imaging and analysis 
 GNPs have been used as immuno-staining agents in cell studies under Scanning 
Electron Microscopy (SEM) and Transmission Electron Microscopy (TEM) since 1950s 
due to the high contrast of gold under electron beam. These techniques are cumbersome 
in the sample preparation procedure and require well-trained professionals in the 
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operation. In 1998, Yguerabide et al. used a different imaging technique, dark field 
optical imcroscopy, to observe the cells stained with GNPs. Due to the strong light 




Figure 1- 24. Dark filed imaging for cells after uptake of anti-EGFR (Epithermal Growth 
Factor Receptor) antibody conjugated spherical GNPs (upper row) and gold nanorods 
(bottom row). Micrographs are shown for noncancerous cells (left column), and two 
cancerous cells (middle and right columns) (Copyright ® 2006 Amrican Chemical 
Society) 
 
Figure 1-24 is an example reported by El-Sayed et al.on cancer cell imaging using 
GNPs.29 Epithelial Growth Factor Receptor (EGFR) is a cell-surface receptor. The over 
expression of EGFR can be associated with a number of cancers. In this example, anti-
EGFR antibody conjugated GNPs were used to stain both noncancerous and cancerous 
cells. The cancerous cells which over-expressed EGFR on the surface showed much 
brighter color under a dark field microscopy.57 Clear differences can be seen in the dark 
field images from cancerous and noncancerous cells. For cancerous cells, GNPs 
selectively aggregated on the cell surface due to the specific binding of the antibodies on 
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the GNP surface to EGFR on cell surface. For noncancerous cells, GNPs did not form 
aggregates as severe as for cancerous cells due to fewer EGFR on cell surface. As a result, 
cancerous cells were much brighter than noncancerous cells. 
 There are many unique advantages to use GNPs in cell imaging and analysis, 
comparing with other cell imaging agents such as fluorescence dyes. For example, GNPs 
are resistant to photobleaching. Photobleaching is a serious problem for fluorescence 
dyes especially if a long observation time is required in certain cell studies. In contrast, 
GNPs are much stable and thus very suitable to trace cell-related reactions at long time 
scales. Another advantage of GNPs is the much larger light scattering coefficient than the 
light emission efficiency of fluorescence dyes.  A single GNP could be easily seen under 
dark field imaging using an optical microscopy with simple setups. These unique 
advantages enable GNPs as very promising imaging contrast agents for cell studies. 
 
 
Figure 1- 25. Cells irradiated in the absence of gold nanoshells maintained both viability 
(a) (as indicated by the calcein fluorescence) and membrane integrity (c) (as indicated by 
the lack of intracellular flouroscein dextran uptake), while cells irradiated in the presence 
of gold nanoshells showed cell death and membrane corrupt. (Copyright ® 2003, The 
National Acedemy of Sciences) 
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1.4.3 GNPs enhanced photothermal therapy 
The photothermal conversion property of GNPs makes them very promising to be 
used as “cellular bombs” in destroying disease cells through photothermal therapy. When 
GNPs are delivered specifically to disease cells by bio-recognition reactions, a laser 
irradiation can introduce photothermal conversion and create a high temperature around 
GNPs. Cells nearby the GNPs will be affected and then lose their biological activity 
during the laser irradiation process.  
 In 2003, Halas et al. used antibody-conjugated gold nanoshells for 
photothermalysis of human breast cancer cells. In an in-vitro test, as shown in Figure 1-
25, tumor cells loaded with gold nanoshells were found to become dead after laser 
irradiation, while normal cells were not affected under the same experimental condition. 
In an in-vivo study, solid tumors treated with gold nanoshells had an increase in the 
temperature up to ∆T=37.4 oC. Tumors showed irreversible tissue damage within 4-6 
minutes of laser irradiation by a 4 W/cm2 laser at 820 nm irradiation. 58  
El-Sayed et al. also used both 40 nm spherical GNPs and 40 GNRs for in-vitro 
photothermalysis of two squamous carcinoma cells lines. The uptake of the 40 nm GNPs 
was confirmed by dark field imaging. When irradiated by a laser at 430 nm, the 
cancerous HOC and HSC cells (two oral squamous carcinoma cells) suffered damage 
within 4 minutes of irraditation at laser energy thresholds (19 W/cm2 and 25 W/cm2), 
while damage was observed from healthy HaCaT cells (one benign epithelia cell) at a 
much higher laser energy threshold (57 W/cm2). 59 
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Figure 1- 26. Plots of celluar damage versus laser power density (left) and laser exposure 
time (right) for SK-BR-3 cells loaded with gold nanocages. 
 
In 2008, Xia et al. reported a quantitative study on the cellular damage of breast 
cancer in the GNP-assisted photothermalysis. Gold nanocages with average length of 65 
nm and SPR band at 800 nm were conjugated with anti-HER2 antibodies to target breast 
cancer cells (SK-BR-3) through the over-expressed EGFR on cell surface. As shown in 
Figure 1-26, cells loaded with gold nanocages responded immediately to the laser 
irradiation and the cellular damage was irreversible at power densities greater than 1.6 
W/cm2. The percentage of dead cells increased with increasing exposure time up to 5 min 
and then became steady.60  
1.5 Summary of the Dissertation 
 The synthesis, surface modification, biomolecular conjugation, and applications 
of GNPs in bio-sensing, bioimaging and photothermal therapy have been studied 
extensively over the last two decades and these research areas are still in fast growing. 
However, there are remaining many questions and challenges. 
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First, the synthetic mechanism of GNPs with respect to reaction conditions is not 
well-understood. Nanoparticle growth in solution is a rather complicated process 
governed by many thermodynamic and kinetics factors. We addressed these questions in 
Chapter 2 and Chapter 3.  
In Chapter 2, we conducted both experimental and theoretical study on the 
kinetics of Brust-Schiffrin reaction for the synthesis of gold nanoparticles. Using a large 
excessive amount of thiol ligands, the nanoparticle growth was stopped at different 
intermediate stages. Our study revealed and confirmed that the reproducibility of Brust-
Schiffrin reaction for the synthesis of gold nanoparticles with diameter around 2 nm is 
rather poor due to the intrinsic complexity of this two-phase reaction. The analysis results 
of each intermediate product by TEM showed that nanoparticles grew very rapidly at 
early stage of reaction and reached a maximum value of 2.6 nm at reaction time of 
around 10 minutes. Further increase of reaction time led to a decrease of nanoparticle 
size. In addition to the experimental study, we proposed a kinetic model for nanoparticle 
growth in solution by assuming that the nanoparticle core expands through incremental 
addition of gold atoms to the existing nanoparticle nuclei. This model not only gave a 
relatively good fitting to the experimental data, but also provided further insight into the 
nucleation and core expansion stage of the nanoparticle growth, which has not been 
revealed in previous modeling studies.  
In Chapter 3, we investigated the kinetic growth procedure of the 7.8 nm 
oleylamine protected GNPs. The time-dependent size and SPR band changes of GNPs 
were monitored by UV-Vis and TEM, respectively. The chemical structure changes of 
these oleylamine ligands before and after the GNPs synthesis reaction was investigated in 
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detail. It was found that experimental results supported the transition of oleylamine to 
oleyamide during the reaction. Oleylamine ligands formed large complex aggregates with 
gold salt instantly upon mixing these two agents together. At an elevated temperature of 
80 oC, the complex decomposed first into very small particles and then the small particles 
recombined together into larger and thermally stable particles with an average core size 
around 9-10 nm. The oleylamide ligands formed a protecting monolayer around the 
nanoparticles through a hydrogen bonding network between the amide groups. The 
recombination of small particles into larger ones was found to follow a logistic model, as 
confirmed by a nonlinear regression fitting of the UV-Vis absorption data of the reaction 
solution with the mathematical model. 
Second, to have controlled surface functionality on the GNP surface, especially 
mono-functionality, remains difficult. The well-known place exchange reaction in 
solution produces multiple functionalized GNPs. In Chapter 4, we used a solid phase 
assisted place exchange reaction in the preparation of single-functional GNPs. This is 
based on the ligands absorbing property of solid resins and the place exchange reaction of 
thiol molecules to GNPs. Bi-functional thiol ligands are first trapped by the ionic resin. 
This is due to electrostatic interactions between the carboxylic groups on one end of these 
ligands and the surface charged groups on ionic resin surface. GNPs at size ~2 nm were 
then added and the place exchange reaction was performed in such condition where the 
mobility of the bi-functioal thiol ligans was restricted. As a result, single carboxyl group 
functional GNPs were synthesized and verified by diamine coupling reactions. These 
novel mono-functional GNPs could be used as the building blocks for functionalized 
materials syntheses and applications. 
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Third, the optical property of GNPs, especially in the analytical perspective, has 
more to be revealed out. In Chapter 5, we investigated systematically the SPR absorption 
and scattering property of GNPs, and determined the detection limits of GNPs in DLS 
measurements. Three different types of GNPs with sizes range from 3.76 nm to 250 nm 
were prepared and studied: citrate-stabilized nanoparticles in eleven different sizes; 
oleylamide-protected gold nanoparticles with a core diameter of 8 nm, and a decanethiol-
protected nanoparticle with a diameter of around 4 nm. A linear relationship between the 
logarithms of extinction coefficients and core diameters of gold particles was found 
independent of the capping ligands on the particle surface and the solvents used to 
dissolve the nanoparticles. This linear relation may be used as a calibration curve to 
determine the concentration or average size of an unknown nanoparticle or nanoparticle-
biomolecule conjugate sample. Detection of GNPs by DLS revealed out that DLS is a 
very sensitive technique in measuring GNP size, concentration and aggregations. 
The last challenge is to prepare stable and also bio-functionalized GNPs and apply 
to biological applications. Current reports already demonstrated that GNPs have great 
potentials in biological applications. However, robust and reproducible GNPs-based 
techniques have not been very successful. Motivated by to develop GNPs-based 
techniques for realistic applications, we explored the great potential applications of GNPs 
in immunoassay (Chapter 6, Chapter 7 and Chapter 8), bio-imaging and photothermal 
therapy (Chapter 9) based on the strong light scattering property of GNPs.   
In Chapter 6, we developed a one-step, washing-free and amplification-free assay 
for protein analysis using GNPs and DLS technique. Specific biomolecular interaction-
induced nanoparticle aggregation is monitored by DLS, and the degree of aggregation is 
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correlated to protein analyte concentration. We then investigated the kinetics of 
nanoparticle aggregation and developed two formats of assays using mouse IgG as the 
target protein. Effects of reaction time, temperature, and GNP probe concentration on the 
aggregation process were revealed. In this one-step assay, mouse IgG can be detected at 
concentrations from 7.8 pg/mL to 50 ng/mL (or approximately 52 fM to 0.33 nM) 
without any amplification process. A second format of assay developed in this study is a 
competitive assay conducted by using both mouse IgG and goat anti-mouse IgG-
conjugated GNPs. This competitive assay avoided the problem of “hook effect” as often 
encountered in non-competitive assays. In this work, we demonstrated here that by using 
GNPs as a light scattering enhancer and selecting the proper assay formats, low cost, 
easy-to-conduct, and highly sensitive bioassays can be developed for protein detection 
and analysis.  
 In Chapter 7, GNPs were used for in-vitro diagnostic of protein cancer 
biomarkers. The concept was proved by using two GNP probes, 40 nm spherical GNPs 
and 40 nm by 10 nm gold nanorods, with two paired antibodies for prostate specific 
antigen (PSA) conjugated onto each probe respectively. When the two probes were added 
into the PSA antigen solutions, the two GNP probes formed aggregates through the 
sandwich type conjunction with the bi-valent antigen in the center. The extent of the 
aggregation reaction was found to be correlated with PSA concentrations. Such 
aggregation reaction was detected by Dynamic Light Scattering (DLS) very sensitively. 
This work demonstrated a one-step washing-free and amplification-free immunoassay for 
cancer biomarker PSA detection. The novel immunoassay showed advantages of higher 
sensitivity, simplified procedure and cost reduction over conventional assays. 
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 In Chapter 8, robust PEG-coated GNPs were prepared through the place exchange 
reaction of thiolated PEG polymers and citrate-protected GNPs. These robust GNPs were 
subjected to test their resistance from aggregation in solutions with a high ionic strength 
or at different pH values. The robust 40 nm and 100 nm PEG-coated GNPs were used to 
covalently bond with free-PSA antibodies to form robust GNP probes. The conjugate of 
antibodies to GNPs were verified by DLS. These probes were used in the development of 
free-PSA immunoassays. Better sensitivity down to 0.046 ng/mL for f-PSA was achieved. 
In Chapter 9, GNPs were used for in-vitro bio-imaging and photothermal therapy 
of tumor cells. Based on their strong scattering properties, antibody coated 40 nm GNPs 
were conjugated with A547 lung cancer cells. This can be imaged clearly under dark field 
microscopy. Cells after GNPs uptake were irradiated with a continuous laser beam with 
the wavelength at 633 nm. The viability loss of cancer cells during the laser irradiation 
was monitored in real time under a confocal microscopy. It is found that GNPs can 
accelerate the death of cells as soon as the laser irradiation started. Power and irradiation 
time were found to greatly affect the cell death rate. At a 3.75 mW/cm2 irradiation power 
density, the fastest cell death rate was observed. The irradiation time of 60 seconds was 
found to introduce 98% viability drop of cells, with much reduced irradiation time and 
much higher viability drop comparing with literature results for other cancer cells. In 
contrast, cells without GNPs maintained a high bio-activity. In this work, the combined 
bio-imaging and photothermal therapy of lung cancer cell A549 were demonstrated. 
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CHAPTER 2. KINETIC STUDY OF GOLD 
NANOPARTICLE GROWTH IN SOLUTION BY BRUST-
SCHIFFRIN REACTION 
2.1 Introduction 
GNPs represent one of the most extensively studied nanomaterials because of 
their many unique size- and aggregation-dependent properties such as surface plasmon 
resonance, surface enhanced Raman scattering, quantized charging effect, etc.1-3 A 
convenient wet chemical method to prepare GNPs is through Brust-Schiffrin reaction.4,5 
This reaction leads to thiolate monolayer-protected GNPs with sizes typically in the range 
of 1-5 nm. The size of the nanoparticles can be controlled by adjusting the ratio of thiol 
ligands and gold salts in the reaction mixture, the reaction conditions,5 or by post-
synthesis thermal annealing treatment.6,7 The thiolate-protected GNPs exhibit good 
solubility in a wide range of solvents, and are sufficiently stable for most application 
purposes. Therefore, alkanethiol monolayer-protected GNPs have gained significant 
attention since its first report.  
However, despite the extensive use of Brust-Schiffrin reaction for gold 
nanoparticle synthesis, many aspects of this reaction are still not well understood. One of 
the remaining significant challenges in nanoparticle synthesis is the precise control of 
nanoparticle size and size distribution. This problem arises from the rather complicated 
kinetics and thermodynamics of the nanoparticle growth in solution.8-12 In general, a 
nanoparticle growth in solution includes three basic steps: nucleation, core size expansion, 
and passivation.13 As for Brust-Schiffrin reaction, this reaction involves a multi-step 
process:5,13 First, in the presence of thiol ligands, Au (III) is reduced to Au(I) by 
oxidizing thiols to disulfides. If more than 2 equiv of thiols are present, the resulting 
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Au(I) and excess thiol will combine into a polymeric Au(I)-thiolate complex. In the 
presence of sodium borohydride, all Au(I) are reduced to gold atoms. The free gold atoms 
quickly coalesce together into small nuclei. Free gold atoms are then continuously added 
to the existing nuclei or small nanoparticles coalesce together into larger particles. The 
role of thiol ligands in this reaction is to passivate nanoparticle growth and to protect the 
so-formed nanoparticles from aggregation by forming an alkanethiolate monolayer on the 
nanoparticle surface.  
AuCl4-  +  RSH  →  (AuISR)n (polymer)                                                               (2-1) 
(AuISR)n  +  NaBH4   →    Aux(SR)y                                                                    (2-2) 
Among all the steps involved in this reaction, each step alone poses significant 
challenges for kinetic study. The nucleation process often occurs extremely fast and 
cannot be easily monitored by commonly available instrumentation techniques. For the 
core size expansion stage, an important question is whether the incremental addition of 
gold atoms to the existing nuclei plays a dominant role or whether the coalescence of 
smaller nanoparticles into larger nanoparticles is the major expansion pathway.14,15 
Finally, the passivation of nanoparticle growth by thiol ligands is also a rather 
complicated issue. Despite the fact that the self-assembled monolayer process has been 
studied extensively,16-21 the kinetics of thiol ligand adsorption onto gold substrates 
remains unclear in many cases. With the substrate dimension reduced from two-
dimensional flat surface to highly curved three-dimensional nanosphere, the kinetic study 
of thiol adsorption to GNPs becomes even more challenging.22-24 
As a first step leading to a further understanding of nanoparticle growth in 
solution, we designed and conducted a simplified experiment to study the kinetics of 
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Brust-Schiffrin reaction. Recently, it was reported by Murray and coworkers that ultra 
small gold nanoclusters with diameters below 1 nm could be synthesized by the addition 
of large excess amount of thiol ligands or under very low temperature reaction 
condition.25 The purpose of large excess amount of thiol ligands is to increase the 
passivation speed of thiol ligands so that the nanoparticle growth can be stopped at a very 
early stage. Referring to this concept, we conducted the following experiment. Using the 
conditions as reported in Murray’s work,5 a room temperature Brust-Schiffrin reaction 
was set up using one to one ratio of 1-butanethiol ligands versus gold salt. After the 
addition of reducing agent, sodium borohydride, a portion of the reaction mixture was 
taken out from time to time and added with approximately 300 fold excess of more 
butanethiol. The reaction was continued for another one hour to allow completion of the 
reaction. The purpose for adding large excessive thiol ligands to the reaction mixture was 
to increase the adsorption rate of thiol ligands to the nanoparticles, so as to stop the 
nanoparticle growth effectively at different reaction stages. In this way, we can exclude 
or minimize the kinetic effect of thiol ligands adsorption on nanoparticle growth and 
obtain a better picture on the nucleation and core size expansion stages. Following the 
experimental study, two kinetic models were proposed to explain the kinetic behavior of 
Brust-Schiffrin reaction. Both models showed a fairly good fit with the experimental data, 
with one model revealing more detailed information on nanoparticle growth mechanism.  
2.2  Materials and Methods 
2.2.1 Chemicals, solvents and materials 
All Solvents and organic chemicals (ACS Reagents) were purchased from Aldrich 
(Milwaukee, WI) or VWR (West Chester, PA) except for the hydrogen 
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tetrachloroaurate(III) hydrate (HAuCl4), which was purchased from Strem Chemicals 
(Newburyport, MA). 
2.2.2 Synthesis of butanethiolate-protected GNPs (BtGNP) 
Butanethiolate-protected GNPs (BtGNP) were synthesized according to the Brust-
Schiffrin reaction.4,5 All the reactions were conducted at room temperature. Briefly, 
tetraoctylammonium bromide (1500 mg, 2.74 mmol, 2.5 equivalents) was stirred 
vigorously in 80 ml toluene in a 500 mL round bottom flask. HAuCl4•xH2O (310 mg, 
0.912 mmol, 1 equivalent) in 25 mL deionized water was added. As the AuCl4- was 
transferred from the aqueous phase to the organic phase, the solution changed from a 
bright yellow to a red-brown color. The organic phase was separated and 1.1 equiv. of 1-
butanethiol (74.9 mg, 0.832 mmol) was added to the solution. The solution was stirred at 
room temperature for 10 min followed by the addition of NaBH4 (380 mg, 7.84 mmol, 10 
equivalents) in 25 ml deionized water over 10 s. The resulting solution quickly turned 
dark black. Following the complete addition of NaBH4, 10 mL aliquots were removed 
from the reaction solution at time intervals of: 1, 2, 3, 5, 10, 30 60, and 180 min and 
added to a separate flask followed by the addition of 3 mL 1-butanethiol (2.526 g, 28.00 
mmol). Each reaction was allowed to continue for 1 h at room temperature with 
continuous stirring. Nanoparticles were collected by removing the solvent using a rotary 
evaporator under vacuum at 48°C. The dark nanoparticle product was then purified by 
successive washing with 25 mL of ethanol and centrifugation.  After four to five times of 
washing, the residual ethanol was blown off using a stream of nitrogen gas and the 
BtGNPs were dispersed in dichloromethane for size analysis.  
2.2.3 Particle size analysis 
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For TEM analysis, approximately 1  L of sample in dichloromethane was added 
on a 300 mesh Formvar-coated copper grid using an Eppendorf micropipette and 
immediately wicked off using filter paper. After allowing the sample to air dry for 5-10 
min, images were obtained using a JEOL 100CX transmission electron microscope at 80 
keV. The average particle core diameter D and standard deviation σ were determined 
according to equation (2-3) and (2-4) from the analysis of 100 particles randomly 
appeared on TEM image. The diameters were measured using a LUPE 30X magnifier 
































σ                                                                                                        (2-4) 
2.3 Results and Discussions 
2.3.1  Average core diameter  
According to the previous work by Hostetler et al,5 using a one-to-one ratio of 
thiol ligands versus gold salt and a room temperature reaction condition, nanoparticles 
with approximately 2 nm core diameters can be obtained as the major product. We have 
also used this condition routinely in our own lab to synthesize butanethiolate-protected 
nanoparticles.26-29 Therefore we chose this condition as an example in our kinetic study. 
After the extraction of gold salt into organic solvent using tetraoctylammonium bromide 
and immediately following the addition of sodium borohydride into the solution, aliquots 
of the reaction mixture were taken out after 1, 2, 3, 5, 10, 30, 60, and 180 minutes of 
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reaction and added to approximately 300-fold excess of additional butanethiol ligand. At 
the end of the reaction, each product was collected and purified by washing and 
centrifugation. Each sample was characterized by a transmission electron microscope and 
the average size and size distribution of each product were analyzed according to the 
method described in the experimental section.   
 
Table 2- 1. Average core diameter (d), standard deviation (σ), and number of Au atoms 
per particle (N) of nanoparticles collected at different reaction stages 
 Batch 1 Batch 2 Batch 3 
t (min) d (nm) σ (nm) N d (nm) σ (nm) N d (nm) σ (nm) N 
1 2.10 0.29 286 2.26 0.35 355 2.36 0.47 403 
2 2.48 0.35 469 2.29 0.38 375 2.35 0.38 400 
3 - - - 2.41 0.36 426 2.45 0.40 453 
5 2.43 0.35 442 2.48 0.36 467 2.48 0.36 467 
10 2.60 0.37 541 2.56 0.34 516 2.60 0.33 541 
30 2.45 0.33 450 2.54 0.34 504 2.33 0.41 387 
60 2.58 0.28 527 2.19 0.36 325 2.38 0.38 415 
180 2.59 0.57 534 2.21 0.31 330 2.39 0.38 420 
 
This experiment was repeated three times. The average diameters of each 
nanoparticle product collected at different reaction times were summarized in Table 2-1 
and Figure 2-1. From the comparison of these three experimental data sets, there are three 
results to be noticed: first, from one batch of sample to the other batch of sample, the 
average diameter of the nanoparticles under the same reaction conditions varies 
significantly. In other words, the reproducibility of Brust-Schiffrin reaction for the 
synthesis of GNPs in the range of 2 nm is very poor. As a matter of fact, we have noticed 
such poor reproducibility in our extensive previous studies.26-29 Second, despite the large 
variation of nanoparticle size from one batch of synthesis to the other, it was observed 
that the nanoparticles core diameter exhibited a general trend of fast increase within a few 
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minutes of reaction time and all three samples reached a maximum average core diameter 
of 2.6 nm after 10 minutes of reaction. At a reaction time of one minute, the nanoparticle 
diameter has already increased to more than 2 nm. Third, after the nanoparticle size 
reached this maximum value, the nanoparticle size either decreased or remained at this 
maximum value with elongated reaction time. The average diameter of nanoparticles 
obtained after three hours of reaction is around 2.2 nm.  
 
Time (min)





















Figure 2- 1. Diagram of nanoparticle average core diameter change over reaction time. 
(Copyright ® 2006 American Scientific Publishesr) 
 
The poor reproducibility of Brust-Schiffrin synthesis is due to the rather 
complicated kinetics of this reaction.5, 8-13 First of all, this reaction is an inhomogeneous 
two-phase reaction (water plus toluene), which means that the stirring speed has a great 
effect on the reaction kinetics. Second, it was also noticed that the rate of addition of 
reducing agents in solution could affect the concentration of nuclei formed in solution,12 
therefore, the size of the nanoparticle product. Third, the nucleation is a fast process and 
any slight variation of the experimental condition such as stirring speed of the reaction 
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solution could change the nuclei concentration, so as to the size of the nanoparticles 
dramatically. A very small experimental error from the reagent concentration could also 
bring such dramatic effects. This poor reproducibility makes the scale up for industrial 
production of nanoparticles using Brust-Schiffrin reaction very challenging.  
Although the variation of nanoparticle size from one sample to the other is large, 
one can still see a general trend of rapid size increase within 10 minutes of reaction time. 
From the data collected here, it is difficult to judge when the nucleation process started. 
Because of the very rapid size increase, it is difficult to control the nanoparticle size at 
this stage of reaction. However, it is interesting to note that all three samples reached the 
same maximum diameter of 2.6 nm at 10 minutes of reaction time. This suggests that the 
maximum nanoparticle size in a Brust-Schiffrin reaction is mainly determined by the 
ratio of chemical agents used in the study, but not much affected by the specific reaction 
conditions. After reaching the maximum size, the nanoparticles either remained at this 
size or even decreased. It is unclear at this time what is the exact mechanism behind the 
size decrease, however, we believe this is possibly due to the etching effect of thiol 
ligands, as pointed in some previous reports.30-32 Because of the rather complicated nature 
of self-assembled monolayer formation on three-dimensional nanocluster surface, the 
mathematic modeling study described in this paper will not address this effect.  
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Figure 2- 2. The particle size distributions of batch 2 synthesis product obtained after (a) 
5 minutes, (b) 10 minutes, and (c) 30 minutes of reaction time. (Copyright ® 2006 
American Scientific Publishesr) 
2.3.2 Nanoparticle polydispersity 
The polydispersity of each nanoparticle sample collected at reaction time of 5, 10 
and 30 minutes was analyzed and summarized in Table 2-1 and Figure 2-2. Only the 
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results from batch 2 synthesis are shown here. Essentially, it was noticed that the 
polydispersity for all the samples collected at different reaction time intervals and from 
different batches of synthesis is approximately 14%. Different from the average core 
diameter of the nanoparticles, the polydispersity of the nanoparticle product is much less 
affected by the conditions applied to the reaction, such as stirring speed, the addition rate 
of reducing agents, the concentration of each agents, etc. A statistical model governed by 
a certain nanoparticle growth mechanism such as coalescence of smaller nanoparticles 
into larger ones may play a more important role in polydispersity property of nanoparticle 
product grown in solution.   
2.3.3 Kinetic modeling study 
We used two kinetic models in this work to explain the observed experimental 
results. The first one was proposed by Hiramatsu et al. based on the synthesis of 
oleylamine-protected GNPs.10 In this model, the nanoparticle growth is expressed as the 
AuCl4- concentration change that follows a first-order kinetic. This model also assumes a 
constant gold nanoparticle concentration throughout the whole reaction, which was 
estimated from the maximum size of nanoparticles in the final product. The number of 
gold atoms in a nanoparticle at a give reaction time is: 
 










                                                                                             (2-5) 
 [AuCl4-]0 is the initial concentration of gold salt or gold atom concentration. [AuNP] is 
the concentration of GNPs, also nanoparticle nuclei concentration at any given reaction 
time.  
 61 













Figure 2- 3. Non-linear regression fitting curve from kinetic equation (5) with respect to 
experimental data. (k=0.007s-1) (Copyright ® 2006 American Scientific Publishesr) 
 
existing gold atoms or nanoparticle nuclei
additional gold atoms  
Figure 2- 4. The incremental addition model of nanoparticle growth process 
 
We used the implementation of non-linear regression found in the software 
program MATHEMATICA for the curve fitting. This implementation uses the 
Levenberg-Marquart gradient search method to find the least squares minimum for the 
model.33 The fitting result of this model to the experimental results is shown in Figure 2-3. 
In the graph, the experimentally obtained average diameters of nanoparticles were 
converted to number of gold atoms by assuming a spherical geometry as shown in Figure 
 62 
2-4.34,35 The k value obtained from this fitting is 0.007s-1. The 95% confidence interval 
for the value of k is (0.0058, 0.0082). For the fitting, the F-statistics is 161.58, which 
yields a p-statistic value36 less than 0.00001, an indication of good non-linear regression 
fitting. Although this model fits well into the experimental results, it does not provide 
more detailed information on the mechanism of nanoparticle growth. For example, this 
model cannot tell whether nanoparticles grow mainly by incremental addition of gold 
atoms to the existing nuclei or by coalescence of smaller nanoparticles into larger ones. 
This model also failed to identify and explain the nucleation process. To obtain a further 
understanding on these questions, we proposed a second kinetic model by assuming that a 
nanoparticle grows by incremental addition of gold atoms to existing nuclei as shown in 
Figure 2-4. The concentration of nuclei remains constant throughout the reaction. In this 
case, the number of gold atoms in a nanoparticle at any reaction time can be expressed in 
equation (2-6): 
     


























































a = [AuCl4-]0                      b =  [AuNP]                                                                        (2-7) 
The number of gold atoms added to an existing nanoparticle nuclei per unit time 
is related to the concentration of gold atoms in solution, which is [AuCl4-]0-[AuNP]n, and 
the number of reactive sites on an existing gold nanoparticle surface. The number of 
reactive sites is roughly equivalent to the number of gold atoms on the surface, which is 
equivalent to ρn2/3 (ρ is a constant), assuming a nearly spherical structure of the 
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nanoparticle core. Here k is the product of reaction rate constant and ρ, therefore, is also a 
constant. The solution of this kinetic equation is given in equation (2-7). 













Figure 2- 5. Non-linear regression fitting curve from kinetic equation (6) with respect to 
experimental data. (k=15.2712, a= 0.01 M, b= 0.000018812 M) (Copyright ® 2006 
American Scientific Publishesr) 
 
The value of a was set at 0.01 M, as used in the experiment. The non-linear 
regression found in the software program MATHEMATICA was used to find the 
optimum values for b and k. The value obtained for b from curve fitting was 0.000018812 
M and the value obtained for k was 15.2712. The fitting curve and the experimental data 
are shown in Figure 2-5. The 95% confidence interval for b is (0.000018465, 
0.000018497). The 95% confidence interval for k is (9.9416, 20.6008). The F-statistic for 
this model is 44.2477, which provides a p value for the F-distribution of less than 
0.00001. This indicates a relatively good fit of the model to the data. Experimentally, the 
b value, the concentration of GNPs, was found to be 0.0000181 M, very close to the 
results obtained by the model. 
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The good fitting between the model and the experimental data indeed suggests 
that incremental addition of gold atoms onto existing nanoparticle nuclei is likely a major 
pathway for nanoparticle growth. At later stage of the reaction, nanoparticle-nanoparticle 
aggregation and coagulation may start to present a significant effect on the growth 
process. It is interesting to note that the incremental addition model proposed here reveals 
clearly a “nucleation” stage of the nanoparticle growth (Figure 2-5). The time for nuclei 
formation was found to be around 10-20 seconds according to the model. Within 20 
seconds, the rate of nanoparticle growth is almost zero. After about 50 seconds, the 
nanoparticle starts to grow rapidly. The mechanism for nucleation is due to or at least 
partially associated with the number of surface sites available for addition of more gold 
atoms. Since gold atoms coalesce together by van der Waals interactions, a larger surface 
area will attract more gold atoms to the nanoparticle surface per unit time.  
2.4 Conclusion 
In summary, we conducted both experimental and modeling studies to understand 
the nanoparticle growth kinetics in solution. These studies revealed and confirmed that 
the reproducibility of Brust-Schiffrin reaction for the synthesis of GNPs with diameter 
around 2 nm is rather poor due to the intrinsic complexity of this two-phase reaction. 
Although it is unlikely that a single mathematical model can be found to explain the 
kinetics of such complex reaction, the incremental addition model proposed in our study 
revealed some important information on the nucleation and growth stage. From this study, 
we also conclude that in order to gain a more comprehensive understanding on wet 
chemical synthesis of nanoparticle materials, it is important to first disseminate and 
examine the different stages of nanoparticle growth separately and then collectively. With 
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Brust-Schiffrin reaction being used extensively for gold nanoparticle synthesis, a full 
understanding of this process is critical for both fundamental research as well as mass 
production of nanoparticle materials for practical applications.  
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(where d is the particle diameter, N is the number of gold atoms, M is the atomic weight of gold and ρ is the 
Au density.) 
35 Although typical GNPs exhibit truncated octahedron crystalline structures with certain “magic” 
numbers of gold atoms in the core, we found that the spherical geometry treatment gives very similar 
number of gold atoms in a nanoparticle as the one predicted from the truncated octahedron crystalline 
structures.  
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CHAPTER 3. A STUDY ON GOLD NANOPARTICLE 
SYNTHESIS USING OLEYLAMINE AS BOTH REDUCING 
AGENT AND PROTECTING LIGAND 
3.1 Introduction 
GNPs have promising application potentials in many fields, ranging from 
bioconjugate probes, sensors, electronics and optics, to photon-thermal energy converters, 
and catalysis.1-5 Since the first synthesis of gold colloids 150 years ago,6 there have been 
numerous methods developed for the wet chemical synthesis of gold nanoclusters, 
nanoparticles, and colloids.7-9 To list a few, Turkevich et al used sodium citrate as the 
reducing agent to make citrate-stabilized GNP with size ranging from a few nanometers 
to tens of nanometers.10 Brust and Schiffrin developed a two-phase reaction to prepare 
alkanethiolate-protected GNP with core size ranging from 2 to 5 nm.11,12 Other than thiol 
ligands, other types of ligands have also been used extensively as capping agents for gold 
nanoparticle synthesis.13-15 Recently, a study was reported on the use of an amine-borane 
complex as a mild reducing agent to make monodispersed gold and silver nanoparticles.16 
In spite of these extensive work, understanding on the mechanism and growth kinetics of 
nanoparticles under different chemical environment and conditions is still very limited. 
Such understandings are critical for the development of nanoparticles with controlled 
sizes, shapes and expectant properties.  
 Among the different methods for gold nanoparticle synthesis as mentioned above, 
we are particularly interested in amine compound-based gold nanoparticle synthesis. 
Gomez et al revealed that Au(I) complex could undergo decomposition with alkylamines 
and form amine-protected GNPs.17 Osterloh et al. synthesized nearly monodispersed 
amine-protected gold and silver nanoparticles using an oleylamine ligand.18 Aslam et al 
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recently reported the synthesis of an oleylamine (OA)-stabilized GNPs which were 
soluble in both water and organic solvents.19 A significant difference between amine 
chemistry versus thiol chemistry-based synthesis is that amine ligands can serve as both 
the reducing agent and capping ligands for nanoparticle synthesis. This means amine-
based gold nanoparticle synthesis can often be conducted in a single-phase reaction 
system. For thiol chemistry-based synthesis, an additional reducing agent other than thiol 
ligands, usually sodium borohydride, needs to be added to the reaction. Since sodium 
borohydride is only soluble in a polar solvent such as water and most thiol ligands are 
only soluble in nonpolar organic solvents such as toluene, thiol chemistry-based 
nanoparticle synthesis are often conducted on a two-phase reaction system, such as the 
case of Brust-Schiffrin reaction.11,12 The kinetic control of a two-phase reaction is 
typically much more difficult than single-phase reactions. As revealed in one of our 
recent studies, the average core size of the nanoparticles synthesized using Brust-
Schiffrin reaction varies significantly from batch to batch.20 This difficulty poses 
significant challenges to the understanding of nanoparticle growth kinetics.  
 We herein report a mechanism and kinetic study of an oleylamine-protected gold 
nanoparticle growth using a procedure reported by Aslam et al.19 Although this method 
was reported a few years ago, not much is understood on the growth process and the 
monolayer structure of the nanoparticles. The interesting aspect of this synthetic protocol 
is that the reaction is done using water as a single phase solvent: both gold salt and 
oleylamine were dissolved in water, and the product is soluble in both water and organic 
solvents. After the reaction, relatively monodispersed GNPs in the size range of tens of 
nanometers were obtained in high yield by precipitation. Because of the simplicity of the 
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procedure and the use of water as solvent, this reaction may become a very useful method 
for large scale commercial production of GNPs. From our study, we obtained important 
and detailed information on the nanoparticle growth process, as well as the chemical 
structural change of the amine ligands during the reaction. Our results lead to a different 
explanation on the protecting effect of oleylamine ligands on the nanoparticles than some 
reported studies. We also found for the first time that the nanoparticle growth kinetics 
follows a logistic model,21 a model that has been used to explain many natural growth 
and decay processes.22-24 Results obtained from our study will be valuable in assisting 
further design and synthesis of nanoparticle materials with controlled sizes and properties.  
3.2 Experimental 
3.2.1 Chemicals, solvents and materials 
Oleylamine (C19H37NH2; tech., 70%) and all solvents (ACS Reagents) were 
purchased from Aldrich (Milwaukee, WI) except for the hydrogen tetrachloroaurate (III) 
hydrate (HAuCl4·xH2O), which was purchased from Strem Chemicals (Newburyport, 
MA). 
3.2.2 Synthesis and kinetic study of oleylamine-protected GNPs (OAGNPs) 
Nanoparticles were synthesized according to a reported procedure.19 
HAuCl4·xH2O (51.5 mg, 0.15 mmol) was dissolved in 120 mL nanopure water and 
heated up to 80 oC. An aliquot of 2 mL yellow gold salt solution was taken out and UV-
Vis spectrum of the solution was recorded immediately. Oleylamine (300 μL, 0.66 mmol) 
was then added to the solution and at time intervals of 5 s, 3, 6, 9, 12, 17, 22, 27, 32, 37, 
42, 47, 52, 57, 62, 72, 82, 92, 102, 112, 122, 132, 142, 152, 162, 172, 182, 192, 202, 212 
min following the addition, 2 mL of reaction mixture were taken out and UV-Vis spectra 
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were recorded from 200 to 800 nm for each sample at a scanning rate of 600 nm/min. To 
obtain the final product, after reacting for three hours, the reaction mixture was cooled 
down to room temperature and 300 mL of methanol was added to the solution to allow 
the product precipitate out. After placing the solution at room temperature for 24 hours, 
the product was collected by centrifugation, washing with copious amount of methanol 
and drying in air.  
3.2.3 Infrared spectroscopy 
The infrared spectrum of the nanoparticle product was recorded using a 
PerkinElmer Spectrum™ 100 FT-IR spectrometer with a universal ATR sampling 
accessory. Analyses were performed on solid samples deposited on a diamond coated 
ZnSe crystal (d = 1 mm) by evaporation of several drops of nanoparticle solution in 
toluene. A background was taken without sample deposited before each measurement. 
3.2.4 Nuclear Magnetic Resonance (NMR) 
1H NMR spectra of free ligand oleylamine and OAGNPs in CDCl3 were obtained 
on a Varian Mercury 300 MHz spectrometer using a line-broadening factor of 1 Hz and 
relaxation delay of 1 s at pulse 45 degrees and an acquisition time of 1.997 s.  
3.2.5 UV-Vis Spectroscopy 
UV-Vis absorption spectra of the nanoparticle product and reaction intermediates 
were recorded on sample solution using a Cary 300 Bio double-beam UV-Vis 
spectrophotometer with a scan range of 200-800 nm and a 1 nm resolution. Sample cell 
used in the study was a 1 cm quartz curvette. All experimental data were corrected for 
water background absorption. 
3.2.6 Transmission Electron Microscopy (TEM) 
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TEM images were obtained by a FEI TECNAI F30 electron microscope. The 
accelerating voltage during measurement was 300 keV. The 400 mesh carbon/formvar-
coated copper grids were first treated with a poly-L-lysine (M.W. 93800, Sigma) solution 
(0.0381 g/mL in 1:3 H2O: MeOH mixture solvents). TEM sample grids were then 
prepared by extracting 5 μL reaction solution from the reaction mixture after oleylamine 
addition at reaction time intervals of 1, 4, 7, 10, 15, 20, 25, 30, 35, 40, 60, 80, 100, 120, 
140, 160 and 180 min, casting the solution onto polylysine treated grids and vacuum 
dried. ImageJ software was used to analyze the average size and size distribution of 
nanoparticles in TEM images for each sample.  
3.2.7 Modeling of OAGNPs growth kinetics by MATHEMATICA 
The UV-Vis absorption spectra of nanoparticle intermediate product were further 
analyzed using Cary WinUV software and the reaction kinetic was modeled using the 
nonlinear regression functions of the Statistics package of the program 
MATHEMATICA.25 For samples collected at different time intervals, the absorbance of 
the samples at the surface plasmon resonance band 530 nm were recorded. The 
absorbance of the reaction solution versus reaction time was plotted and the data was 
fitted with a logistic model using MATHEMATICA. 
3.3 Results and Discussions 
3.3.1. Monolayer structure of the OAGNP  
As described in the experimental section, the synthesis of GNPs in aqueous 
solution using oleylamine as both reducing agent and stabilization agent is an extremely 
simple protocol. After three hours of reaction at 80 oC, the nanoparticle product was 
collected by simple precipitation and washing. Different from what was reported by 
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Aslam et al.,19 we found that after the nanoparticles were precipitated out from methanol, 
the nanoparticles lost their solubility in water. The dried nanoparticles have good 
solubility in THF, toluene, and relatively good solubility in dichloromethane. TEM 
analysis of the end reaction product revealed mainly spherical nanoparticles with an 
average core diameter around 9.5 nm, with a polydispersity around ± 1 nm. The 
reproducibility of this reaction is very good. The average core size of the nanoparticles 
from three different batches of synthesis is 9.5 ± 1.1 nm. 
 
Figure 3- 1. IR spectra of (a) oleylamine and (b) oleylamide-protected GNPs. (Copyright 
® 2007 American Scientific Publishers) 
 
 To better understand the nanoparticle growth and passivation by organic ligands, 
we first analyzed the ligand monolayer structure of the nanoparticles using FT-IR and 
NMR spectroscopy. Figure 3-1a and b are the IR spectra of neat oleylamine and OAGNP 
product. The IR spectrum of oleylamine contains the following major bands: N-H stretch 
around 3380-3250 cm-1, C-H stretch at 3100-2850 cm-1, N-H bending at 1615 cm-1, C-H 
bending at 1500-1300 cm-1, and weak C-N stretch at 1100-1050 cm-1. Two major 
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differences were observed from the IR spectrum of OAGNP: the N-H bending of 
oleylamine at 1615 cm-1 disappeared, and two new peaks appeared at 1654 and 1567 cm-1. 
These two peaks are representative vibration bands of amide bonds, as typically seen in 
the IR spectra of peptides and proteins.26 The comparison of Figure 3-1a and b suggests 
that the amine group from free ligands was converted into amide when Au (III) was 
reduced to Au (I) or Au (0). Amide is an oxidized form of amine. In both Osterloh18 and 
Aslam’s19 studies, the structural change of the oleylamine ligand during gold nanoparticle 
formation was not mentioned. However, Sun et al. discovered in a polyamine-induced 
gold nanoparticle formation that the amine groups were converted to amide groups.27 Our 
finding not only corroborates with this reported study, but is also further supported by the 
NMR spectroscopic analysis as discussed in the following.  
  
 
Figure 3- 2. NMR spectra of oleylamine (left) and oleylamide-protected GNPs (right). 

































Figure 3- 3. The hydrogen bonding network formed between oleylamide ligands as a 
protecting layer on the GNPs. (Copyright ® 2007 American Scientific Publishers) 
 
The 1H NMR spectra of oleyamine and OAGNP product are shown in Figure 3-2. 
The major peak assignment for pure oleylamine is the following: a small broad single 
peak at 1.13 ppm for NH2, a triplet at 2.61 ppm for CH2-NH2, a multiplet at 1.37 ppm for 
CH2-CH2-NH2, a triplet at 5.25 ppm for -CH=CH-, a quartet at 1.96 ppm for CH2-
CH=CH- and a triplet at 0.86 ppm for the CH3 groups. In the spectrum of OAGNP, a few 
major changes were observed: first, the NH2 peak at 1.13 ppm disappeared and a new 
broad peak at 8.27 ppm appeared. The relative intensity of this new peak versus the CH3 
peak is about 2:3. It is known that the chemical shift of amide NH2 is generally around 6 
ppm. However, amides tend to form intermolecular hydrogen bonding in solid state, and 
the hydrogen bonding can cause the downfield shift of the proton NMR signal.28 In 
addition to the direct observation of amide bond formation, a few other changes were also 
noticed to accompany this conversion: for example, a triplet at 2.61 ppm that belongs to 
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CH2-NH2 disappeared, and a new multiplet can be attributed to CH2-CO-NH2 appeared at 
2.97 ppm. Judging from both NMR and FT-IR spectrum of OAGNP, we believe that 
oleylamine was converted to oleylamide during nanoparticle formation and oleylamide 
ligands formed a complementary hydrogen bonding network around the gold nanoparticle 
surface as shown in Figure 3-3. The network formed a protective ligand monolayer to 
stabilize the nanoparticles. To further verify the existence of H-bonding network, 200 μL 
trifluoroacetic acids were added into 4 mL as-prepared OAGNP water solution. 
Nanoparticles were instantly precipitated out of the solution. Trifluoroacetic acids 
destroyed the H-bonding network and destabilized the nanoparticles. 
 It was further noticed that each proton peak in the spectrum of OAGNP, including 
the α proton next to the amide group, is rather sharp, suggesting that the amide groups 
are not directly complexed to the surface gold atoms. The oleylamide-protected gold 
nanoparticle is more like a nano-sphere floating inside a hydrophilic micelle-like 
compartment formed by oleylamide ligands. This is a distinct difference from thiol 
ligands-protected GNPs. As described in many reported studies, when thiol ligands are 
directly chemically bonded or complexed with surface gold atoms, the α proton NMR 
signals next to thiol groups are generally broadened significantly due to Knights shift or 
electromagnetic coupling interactions of the proton nuclei in close proximity to a metal 
surface.29-32 The results observed from our study bear some significant differences from 
some reported studies, where it is believed that the amine ligands are bound on 
nanoparticle surface by weak covalent bonds or electrostatic interactions.13, 33  
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Figure 3- 4. Color change of the reaction solution observed during OAGNPs growth at 
different reaction time (unit in minutes). (Copyright ® 2007 American Scientific 
Publishers) 
 
Figure 3- 5. (left) UV-Vis Spectra of gold salt HAuCl4·xH2O solution in deionized water 
at 80 oC (-■-) and the reaction solution after oleylamine was added to the solution for 10 
s (-▲-) and  3 min (-○-); (right) UV-Vis spectra of the reaction solution taken at different 
time from 32 to 212 min (time increased from 32 to 37, 42, 47, 52, 57, 62, 72, 82, 92, 102, 
112, 122, 132, 142, 152, 162, 172, 182, 192, 202, 212 min along the arrow). (Copyright 
® 2007 American Scientific Publishers) 
3.3.2 Growth kinetics and mechanism study of the OAGNP product 
During the nanoparticle synthesis, a continuous color change was observed from 
the reaction solution as shown in Figure 3-4. The aqueous solution of gold salt is a bright 
yellow colored solution. After the addition of oleylamine, the solution immediately 
changed to light brown, and then to burgundy with increasing intensity throughout the 
reaction. UV-Vis absorption spectra of the reaction solution were recorded at very early 
stages of reaction and shown in Figure 3-5 (left). From the spectra, one can see that after 
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oleylamine was added to the solution, the absorption band of gold (III) salts at 320 nm 
disappeared very quickly. This is due to the complex formation of oleylamine with gold 
(III).17,19 The UV-Vis spectra presented here confirmed that the complexation of 
oleylamine with Au (III) is a rather fast process. Within 1 minute of reaction time, the 
reduction and complexation should be completed. After the addition of oleylamine, the 
UV-Vis absorption spectra of the reaction solution was collected at different time 
intervals and presented in Figure 3-5 (right). From these spectra, one can see that at a 
reaction time of around 40 minutes, a surface plasmon resonance band appeared at 530 
nm. The absorbance of the band continued to increase during the reaction. The 
wavelength of the SPR band did not show much significant shift during the reaction. 
From the absorbance increase of the SPR band, it is difficult to judge whether the 
increase was only due to the concentration increase of the nanoparticles or also reflected 
the size change of the nanoparticles. It is known that the SPR absorption of GNPs 
increases with increased size.12 
 
 
Figure 3- 6. Transmission electron microscopy images of intermediate product of gold 
nanoparticle growth collected at different reaction stages (unit in minutes, indicated in 




 To answer this question, we analyzed the reaction intermediate product using 
TEM. During the reaction, a small aliquot (~ 2 µL) of reaction mixture was taken out of 
the reaction flask and immediately deposited on formvar-coated copper grids. TEM 
images of reaction intermediates collected at different reaction stages are shown in Figure 
3-6. At early stages of reaction, only very large non-spherical aggregates were observed. 
The size of the aggregates varies from a few hundreds of nanometers to even microns. 
The density of the aggregates appeared on the TEM grids was very scarce. After a few 
minutes of reaction, the size of the aggregates started to decrease, at the same time, some 
small particles (less than 1-3 nm) started to appear. At reaction time of around 20 min, all 
the large aggregates disappeared and only small particles were present. Then the small 
particles started to recombine together into larger nanoparticles with an average diameter 
around 10 nm. In the next 20 min of reaction time, we saw from the TEM images a large 
number of small particles (1-3 nm) and a very small amount of larger particles around 10 
nm. At reaction time of about 40 minutes, the number of nanoparticles at 10 nm size 
range increased dramatically and the number of small particles decreased. Referring to 
the UV-Vis absorption spectroscopic study of the reaction solution, this is also the stage 
where one started to observe obvious Surface Plasmon Resonance (SPR) band in the UV-
Vis absorption spectra. As the reaction continues, the number of nanoparticles at 9-10 nm 
size range in the reaction solution would continue to increase, as seen from Figure 3-5 at 
time 40, 80, 100 and 180 minutes. This result indeed suggests that the observed SPR band 
absorbance increase from the UV-Vis absorption spectra of the reaction solution was due 
to the increased concentration of GNPs in the size range of 10 nm, since GNPs less than 3 
 80 
nm do not exhibit obvious SPR band.12 It should be the case that small particles 
combined together into larger nanoparticles of which the final size was controlled by an 
equilibrium state. To summarize the results obtained from TEM and UV-Vis 
spectroscopic analysis, we believe the nanoparticle growth follows a process as outlined 
in Figure 3-7.   
 Referring to reported work,17 the large aggregates formed at very early stage of 
the reaction should be an amine-Au (III) or amide-Au (I) or Au (0) complex. The 
disappearance of Au (III) salt absorption band at 340 nm at very early stage of the 
reaction also pointed out this possibility. The amine or amide-Au complex is a kinetically 
controlled product rather than a thermally stable product. Upon continuous heating, the 
thermally unstable complex was converted into thermally more stable nanoparticle 
product. The size of the final product of nanoparticles is determined by the stabilization 
effect of oleylamide ligands. Indeed, as noted by Aslam et al,19 the average core size of 
the nanoparticles synthesized from this reaction can be tuned using different ratio of 




Figure 3- 7. An illustration of the gold nanoparticle formation process using oleylamine 
as both reducing and capping agents. (Copyright ® 2007 American Scientific Publishers) 
 
 
3.3.3. Modeling of the nanoparticle growth kinetics 
Using the UV-Vis absorption data presented in Figure 3-5, we plotted the 
absorbance change of the reaction solution at 530 nm versus reaction time as shown in 
Figure 3-8. At a glance, it appears that the SPR band absorbance increase of the reaction 
solution follows a well known mathematical model, the logistic model. The logistic 
model was first proposed by P. F. Verhulst21 and has been found to be applicable to many 
scientific phenomena such as population dynamics.22-24 We repeated the synthesis of 
OAGNP under exactly the same conditions two additional times and the absorbance of the 
SPR bands of the solution at different reaction stage are included in Figure 3-8. From the 
three batches of data, it can be seen that the reproducibility of the reaction is very good. 
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The average of the three sets of data was fit to a logistic model by a nonlinear regression 
function and the fitting curve is shown in Figure 3-8 (solid line).  
 
Figure 3- 8. Plots of the SPR band absorbance of reaction solution versus reaction time 
(min) for three different batches of nanoparticle synthesis and the curve fitting of the 
experimental data with a logistic model. (Copyright ® 2007 American Scientific 
Publishers) 
 
The best fit for the combined data sets was found to be the function 
f(t)=0.0301696/(0.00554857+e-1.80796+0.0301696t). This gives a p-value34 of less than .00001, 
which is indicative of a very good fit. The good fitting of experimental data with the 
logistic model suggests that the final size of the nanoparticle product is controlled by an 
equilibrium state. After the nanoparticle growth reaches a certain size, the combination of 
the particles into larger ones will form equilibrium with the dissociation of larger 
particles into smaller ones. This equilibrium state is achieved when the oleylamide 
ligands form a most stable protecting monolayer around the GNPs through combined 
hydrogen bonding network formation between the amide groups and the van der Waals 
interactions between the long hydrocarbon chains of oleylamide ligands. 
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3.4 Conclusions 
From this study, we discovered some interesting details on the structure and growth 
mechanism of a gold nanoparticle product that was synthesized in solution using an 
organic amine ligand as both reducing agent and capping agent. This reaction has 
promising potential for large scale and environmental friendly production of gold 
nanoparticle materials due to its simplicity and the use of water as reaction solvent. The 
important findings of this work include: (1) the amine ligands were oxidized into amides 
when gold (III) was reduced and the amide ligands formed a hydrogen bonding network 
as a protecting layer around the GNPs; (2) the nanoparticle growth follows a process of 
thermal decomposition of large amine or amide-Au complex aggregates into smaller 
particles and the recombination of these smaller particles into more thermally stable 
larger particles; and (3) the concentration (population) increase of the thermally stable 
nanoparticles in solution follows a logistic model. Although the detailed reason behind 
the last finding remains unclear, it is interesting to note that the growth of nanoparticles 
in solution bears some close resemblance to natural population growth models. A further 
study along this line may lead to a better understanding and methods for controlled 
nanoparticle synthesis.  
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CHAPTER 4. MONOFUNCTIONAL GOLD 
NANOPARTICLES PREPARED FROM A NONCOVALENT 
INTERACTION-BASED SOLID PHASE MODIFICATION 
APPROACH 
4.1 Introduction 
The ability to prepare gold and other metal nanoparticles with a controlled surface 
chemistry is critically important for the preparation of more complex nanostructures. 
Since the initial results by Brust and Schiffrin, numerous methods have been published 
for the preparation of monolayer protected GNPs of different sizes with a variety of 
surface functional groups.1-3  Until recently, the ability to control the surface functionality 
has been limited to the place exchange reaction between existing bound ligands on the 
nanoparticle surface and bifunctional ligands in solution.3,4 It has recently been 
demonstrated by several authors that polymeric solid supports such as Wang resin may be 
used for the controlled surface functionalization of GNPs.4-8 Previous techniques relied 
on the covalent bonding of a bifunctional ligand onto the solid support and subsequent 
place exchange with GNPs in solution. Under the proper conditions, nanoparticles with a 
single or very small number of functional groups can be cleaved from the solid support as 
the major product.  
In this communication we present an alternative method for the solid-phase 
preparation of monofunctionalized GNPs using noncovalent interactions. The purpose of 
this work was to reduce the cost and time for the synthesis and to find milder reaction 
conditions so that a wider range of nanoparticles could be modified by this method.   
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4.2 Experimental  
4.2.1 Preparation of monofunctional BtGNPCOOH particles using amine-functional 
silica Gel 
Electrostatic absorption of 11-mercaptoundecanoic acid onto amino 
functionalized silica gel was performed by suspending 3 g of silica gel in 10 mL of 1:1 
dichloromethane with methanol followed by addition of the appropriate amount of 11-
mercaptoundecanoic acid as indicated in Table 4-1. The reaction mixtures were then 
shaken vigorously for 30 minutes at room temperature. The silica gel was then filtered 
and thoroughly washed with dichloromethane and methanol to remove any unbound free 
thiol ligands. Ellman’s agent (5,5’-dithio-bisnitrobenzoic acid) was used to monitor the 
absorption of thiol ligands to dried silica gel. The dried silica gel with bound 11-
mercaptoundecanoic acid was suspended in 2 mL of dichloromethane. To the suspension, 
30 mg of 2.2 nm BtGNP in 6 mL of dichloromethane was added. The exchange reaction 
was allowed to proceed for 8-12 hours at room temperature with gentle shaking. During 
this time the silica gel turned dark black. After filtering and washing with warm 
dichloromethane to remove unbound nanoparticles, the silica gel was dried under vacuum. 
The nanoparticles were then cleaved from the gel by suspending the gel in 4.0 mL of 5% 
acetic acid in dichloromethane and shaking the suspension for 5 minutes at room 
temperature. Functionalized GNPs were collected by filtration and dried by gentle 
nitrogen flow.  
The crude product was purified by washing the sample several times with 
petroleum ether with occasional sonication followed by centrifugation. After each cycle, 
the wash solution was tested for organic impurities by spotting a TLC plate and checked 
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for impurities with a UV lamp. After drying, the nanoparticles were further purified by 
GPC using Sephadex LH-20 gel. Using dichloromethane as the solvent, Sample A (which 
had the highest concentration of 11-mercaptoundecanoic acid) split into two bands. The 
first band (about half of the sample) consisted of nanoparticles which could be collected 
in pure dichloromethane. About half of the second band could be collected when the 
solvent mixture was changed to 9:1 dichloromethane with acetic acid. The remaining 
sample could not be collected unless pure acetic acid was added to the column. For 
sample B, most of the sample was soluble in pure dichloromethane while a small portion 
was collected when a 9:1 solution of dichloromthane with acetic acid was added to the 
column. Sample C was found to be soluble in pure dichloromethane and was collected in 
one portion. The total yield of the BtGNPCOOH nanoparticles obtained for sample C was 
about 50% (calculated from the amount of nanoparticles added to the solid phase place 
exchange reaction. For 3g of silica gel, 15mg of monofunctional GNPs were obtained 
from 30 mg of nanoparticles added in the solid phase place exchange reaction).  
4.2.2 Preparation of monofunctional BtGNP COOH nanoparticles using Rink resin 
Solid phase synthesis using Rink resin was performed using the same procedure 
as for the silica gel except for the following changes. First, the resin was initially 
suspended for 30 minutes in a. 20% solution of piperidine in DMF to remove the 
fluorenylmethyloxycarbonyl (FMOC) protecting groups. Second, a 50:1 molar ratio 
between the amino groups on the resin and the 11-mercaptoundecanoic acid was used to 
load the resin. Third, the nanoparticles were cleaved from the resin using a 20% acetic 
acid in dichloromethane for 5 minutes with stirring. It was estimated that about half the 
nanoparticles could be cleaved off the resin.   
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The crude product was further purified by the following procedure. The dark 
residue was washed with petroleum ether 10-15 times with occasional sonication 
followed by centrifugation. After each cycle, the washing solution was tested for organic 
impurities by spotting a TLC plate and checked for impurities with a UV lamp. To the 
sample, a solvent mixture of 9:1 dichloromethane:methanol was added and the sample 
was briefly sonicated. It was found that approximately half the sample was soluble in this 
solvent mixture. The remaining portion only became soluble when a trace amount of 
acetic acid was added to the sample. The sample in the 9:1 dichloromethane:methanol 
solution was further purified by passing the sample through a small column of reverse 
phase C18-modified silica gel in the same solvent mixture. It was found that more than 
90% of the samples could be recollected. 
4.3 Results and Discussions 
The synthetic strategy used in this investigation is shown in Figure 4-1. The solid 
support used in this study was amino group functionalized silica gel. The bifunctional 
ligands, 11-mercaptoundecanoic acid, were then loaded onto the support directly through 
electrostatic interaction between the positively charged amino groups from silica gel and 
negatively charged carboxylic acid groups from the 11-mercaptoundecanoic acid ligands. 
The solid-phase modification was performed using three different ratios of 11-
mercaptoundecanoic acid relative to that of the total number of amino groups on the silica 
gel as shown in Table 4-1. The amine to thiol ratio was calculated according to the 
weight percentage of nitrogen (2.1%) of the modified silica gel provided by the supplier. 
It is to be noted that the amino group to thiol ligand ratio is very high to ensure that only 
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Figure 4- 1. Solid-phase method for the preparation of monofunctional GNPs using 
noncovalent interactions. (Copyright ® 2006 Wiley-VCH-Verlag Gmbh & Co. KgaA, 
Weinheim)  
 
Table 4- 1. Experimental conditions used for the solid phase modification of GNPs 
Sampl
 
Concentration of 11-mercaptoundecanoic acid (mol 
1  
Amine to thiol 
 A 7.5 x 10-5 6,000:1 
B 2.5 x 10-5 18,000:1 
C 8.3 x 10-6 54,000:1 
 
After loading the thiol ligands onto the silica gel and washing away any unbound 
thiol molecules, the surface-bound thiol groups were then allowed to undergo the place 
exchange reaction with BtGNPs which were prepared using the Schiffrin reaction with an 
average diameter of 2.2 nm. It was observed that after 8-12 hours of shaking at room 
temperature, the silica gel clearly began to acquire a brown color. Sample A exhibited the 
darkest color, while sample C was the lightest. After washing off any unbound 
nanoparticles, the silica gel-bound nanoparticles were cleaved using a solution of 5% 
acetic acid in dichloromethane for 5 minutes. The crude product was purified by washing 
with petroleum ether followed by GPC to yield monocarboxyl GNPs with a yield of 60-
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90% (Calculated from the amount of nanoparticles loaded into the GPC column). Since 
the nanoparticles were not covalently bound to the silica gel, the cleavage step could be 
completed using very mild conditions in a much shorter period of time compared to 
previous work using covalent bond-based solid-phase synthesis.  
During the purification process it was observed that there were solubility 
differences between the products obtained from the three different experimental 
conditions. When sample A was purified by GPC, it was observed that about 50% of the 
sample could be recollected using dichloromethane as the mobile phase. A second band 
consisting of about 25% of the particles could then be collected when the solvent was 
switched to 9:1 dichloromethane with acetic acid. The remaining sample could not be 
collected unless pure acetic acid was added to the column. For sample B it was found that 
most of the sample was soluble in dichloromethane, but a small portion remained 
insoluble unless the 9:1 dichloromethane with acetic acid solution was used. For the case 
of sample C, it was observed that acetic acid was not needed for solubility. The solubility 
results indicate a clear difference between the products from the three experimental 
conditions. The increased solubility of the nanoparticle product in pure dichloromethane 
from sample C indicates that these nanoparticles have less carboxylic acid groups 
compared to the nanoparticles collected in sample B and especially compared to sample 
A. The higher number of carboxylic acid groups from samples A and B is a clear sign of 
multiple place exchange reactions between the BtGNP nanoparticles and the bound 11-
mercaptoundecanoic acid ligands on the silica gel surface.   
To further evaluate the success of this noncovalent interaction-based solid-phase 
synthesis, the nanoparticles were reacted with ethylenediamine (EDA). If the 
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nanoparticles contain a single carboxylic acid group, then one would expect a very low 
percentage of nanoparticle trimers and larger aggregates.6 Figure 4-2 shows the TEM 
images of the monofunctional GNPs after reacting with EDA for samples A and C. The 
results indicate that a majority of the nanoparticles from Sample A appeared as trimers or 
larger aggregates. In contrast, the TEM image for sample C indicates that less than 5-10% 
of the nanoparticles appeared as trimers or larger aggregates, suggesting that these 
nanoparticles have very few surface functional groups. In both TEM images, there are 
also a substantial amount of single particles. These particles are believed to be particles 
that have reacted with EDA (because large excess of EDA was added to drive the 
reaction to completion), but not with other particles.   
 
    
Figure 4- 2. TEM images of EDA coupled BtGNPCOOH COOH nanoparticles that were 
prepared using amino group functionalized silica gel. (Copyright ® 2006 Wiley-VCH-
Verlag Gmbh & Co. KgaA, Weinheim) 
 
 
In addition to amino group functionalized silica gel, Rink resin was also used for 
the surface functionalization of GNPs.  Rink resin is an amino group functionalized resin 
consisting of a lightly crosslinked polystyrene matrix. To use the Rink resin, the amino 
groups were first deprotected using a 20% solution of piperidine in DMF. The Rink resin 
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was then used as a polymer support for the attachment of 11-mercaptoundecanoic acid 
ligands and subsequent preparation of monofunctional nanoparticles. Following the same 
synthesis and purification protocol as used in the case of silica gel support, the collected 
nanoparticle product was found to be soluble in a solution of 9:1 dichloromethane with 
methanol.    
 
 
Figure 4- 3. TEM image of EDA coupled BtGNPCOOH COOH nanoparticles that were 
prepared using Rink resin. (Copyright ® 2006 Wiley-VCH-Verlag Gmbh & Co. KgaA, 
Weinheim) 
 
Table 4- 2. XPS results of monofunctional GNPs prepared using Rink resin as the solid 
support. 
element binding energy (eV) normalized area total area assignment 
O 531.7 33.77 717.21 COOH9 
 532.7 211.31  H2O10 
 533.8 232.05  SiO211 
S 162.3 499.96 518.59 S-Au12 
 163.9 18.64  S-H12 
 
Figure 4-3 is the TEM image of these nanoparticles after coupling with EDA. As 
can be seen there are a large number of nanoparticle pairs and single particles with only a 
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few trimers. In addition to TEM analysis, these nanoparticles were also characterized by 
X-Ray Photoelectron Spectroscopy (XPS) and the results are shown in Table 4-2 and 
Figure 4-4. By comparing the normalized area of oxygen from the carboxylic acid 
functional ligand to that of sulfur from all the thiolate ligands, it is possible to determine 
how many carboxylic acid group ligands are on the nanoparticle surface. The results 
indicate that approximately 3% of the ligands on the nanoparticle surface are 11-
mercaptoundecanoic acid (Table 4-2). This exchange level is consistent with what was 
observed in our previously reported NMR study for monofunctional GNPs prepared 
using Wang resin as the solid support, indicating that only a minimum number of 
bifunctional thiol ligands were attached to nanoparticle surface.4 It should be noted here 
that so far there is no analytical technique available to provide exclusive evidence on the 
monofunctional group identity of these solid phase-modified GNPs. The key barrier is 
that one can not obtain nanoparticles with absolute monodispersity at the nanometer scale 
range using the existing chemical synthesis methods. Without a monodispersed size and 
molecular weight of the nanoparticles, an accurate quantitative analysis of the number of 
functional groups attached to the particle surface cannot be conducted. So far we found 
that the most reliable method to determine the relative purity of monofunctional 
nanoparticle product is by conducting a diamine coupling reaction to the solid phase 
modified nanoparticles and using TEM to analyze the coupled product. The fewer 
amounts of nanoparticle trimers, tetramers and other oligomers appeared in the TEM 
images correspond to a higher purity of monofunctional nanoparticles in the product, as 
explained in much detail in our previous work.6 
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Figure 4- 4. O 1s and S 2p regions from the XPS spectrum of monofunctional GNPs 




Through this study, we demonstrated that bifunctional thiol ligands can be 
effectively loaded to polymer support by noncovalent interactions. After place exchange 
reaction, GNPs with a single functional group on the surface were obtained as the major 
product by cleaving from polymer support under very mild conditions. This mild 
condition will allow the use of this solid phase method for controlled chemical 
functionalization of a wider range of nanoparticles. The purification process was also 
simplified significantly. Compared to the previously reported solid-phase modification 
based on covalent bond chemistry, the current modification can be completed in a much 
shorter period of time and is much more cost effective. The scale-up preparation of 
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CHAPTER 5. EXTINCTION AND SCATTERING 
PROPERTIES OF GOLD NANOPARTICLES AT THEIR 
SURFACE PLASMA RESONANCE BAND 
5.1 Introduction 
GNPs are among one of the most extensively studied nanomaterials. Since the 
first report of gold colloids more than 100 years ago by Faraday,1,2 numerous studies 
have been reported on the synthesis, property study and application development of gold 
clusters, colloids, and nanoparticles.3-6 GNPs exhibit many unique and interesting 
physical and optical properties such as surface plasmon resonance (SPR), surface 
enhanced Raman scattering (SERS), nonlinear optical properties (NLO), and quantized 
charging effect.7-9 The surface plasmon resonance of GNPs is an optical property that 
holds promising potentials in biosensing, molecular imaging, and photothermal treatment 
of diseases. Mirkin et al. demonstrated the use of GNPs as an optical probe to detect 
DNA molecules based on the color change of individually scattered nanoparticles and the 
complementary DNA-hybridized nanoparticle aggregates.10 Recently the photothermal 
conversion property of GNPs and nanoshells has attracted a keen interest from the 
scientific community.11 GNPs or nanoshells that are irradiated by a laser beam at a 
wavelength around the SPR band can efficiently convert the photon energy to thermal 
energy, which leads to the destruction of biological cells such as tumor and bacteria.12,13 
The analysis of SPR band can also provide valuable information on the size, structure and 
aggregation properties of GNPs. We herein present in our study of using UV-Vis 
absorption spectroscopy and transmission electron microscopy to determine the 
extinction coefficients of GNPs with different sizes and different capping ligand 
monolayer. The extinction coefficient is an important parameter that can be used to 
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calculate the nanoparticle concentration or estimate the nanoparticle size. Although this 
may appear to be a trivial issue, the accurate calculation or estimation of the molar 
concentration of nanoparticles is actually a challenge. The main reason is that 
nanoparticles are not monodispersed. For some particles synthesized from one batch to 
another, the size and size dispersity may vary significantly. Recently, El-Sayed et al. 
reported a theoretical calculation of extinction coefficient of GNPs and its dependence on 
the nanoparticle size.14 Experimental studies reported by the same group earlier on a 
citrate-stabilized GNPs were in accordance with these theoretical calculations.15 In our 
study, we examined three different types of GNPs, citrate-stabilized GNPs with size 
ranging from approximately 5 to 250 nm; oleylamide-protected GNPs with an average 
diameter around 8 nm; and a decanethiol-stabilized gold nanoparticle with an average 
core diameter of 4 nm. Our analysis revealed that despite the different capping ligands 
and the solvents used to dissolve GNPs, the logarithms of extinction coefficient and 
nanoparticle core diameter follow a linear relationship. This correlation can be used as an 
effective rule-of-thumb to estimate nanoparticle concentration or core size.  
5.2 Experimental 
5.2.1 Chemicals and materials 
 Citrate stabilized GNPs (CiGNPs) (with sizes at ~5 nm, ~10 nm, 20 nm, 40 nm, 
60 nm, 80 nm, 100 nm, 150 nm, 200 nm and 250 nm) were purchased from Aldrich. 
Oleylamine (C19H37NH2; tech., 70%), decanethiol, tetraoctylammonium bromide, sodium 
borohydride, trisodium citrate and all solvents (ACS Reagents) were purchased from 
Aldrich (Milwaukee, WI). Hydrogen tetrachloroaurate (III) hydrate (HAuCl4·xH2O) was 
purchased from Strem Chemicals (Newburyport, MA).  
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5.2.2 Synthesis of DtGNPs, OAGNPs and CiGNPs  
1-Decanethiol protected GNPs (DtGNPs) were synthesized according to a 
modified Brust-Schiffrin reaction.16 Briefly, HAuCl4·xH2O (310 mg, 1 equiv) was 
dissolved in 25 mL nanopure water and phase transferred to 80 mL toluene using 1.5 g of 
tetraoctylammonium bromide. Following the addition of 1-decanethiol (17 μL, 1/11 
equiv) and aqueous solution of NaBH4 (0.38 g, 10 equiv, in 25 mL nanopure water) into 
the organic phase, the reaction solution was stirred at room temperature for 3h. 
Oleylamide-protected GNPs (OAGNPs) were synthesized by following a reported 
method .17 Typically, 35 mg of HAuCl4·xH2O was dissolved in 80 mL nanopure water 
and heated up to 80 oC before addition of 200 μL oleylamine by a syringe. The reaction 
was allowed to continue for 3h. After the reaction mixture was cooled down to room 
temperature, 240 mL methanol was added to the solution and nanoparticles were 
collected by precipitation and washing a few times with a copious amount of methanol. 
The 25.67 nm and 34.36 nm CiGNPs were synthesized according to Turkevich method.18 
5.2.3 High Resolution Transmission Electron Microscopy (HRTEM) 
TEM grids were treated with polylysine solution first before depositing 
nanosphere water solutions onto grids. The HRTEM images of each sample were 
obtained using a FEI TECNAI F30 transmission electron microscope. The accelerating 
voltage used in the measurement was 300 keV. The 400 mesh carbon/formvar-coated 
copper grids for citrate-stabilized nanoparticles were first treated with a poly-L-lysine 
(M.W. 93800, Sigma) solution (0.0381 g/mL in 1:3 H2O: MeOH mixture solvents). TEM 
sample grids were then prepared by extracting 5 μL sample solution, casting onto 
polylysine treated grids and vacuum dried. Average gold core diameter (D), size 
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distributions and standard deviations were calculated for each nanoparticle sample by 
averaging 200 particles from the TEM images using ImageJ software (developed at the 
National Institutes of Health). 
5.2.4 UV-Vis spectroscopy 
All UV-Vis spectra were recorded using a Cary 300 Bio double-beam UV-Vis 
spectrophotometer at a 300 nm/min scanning rate from 300-700 nm. For each sample, 
UV-vis spectra at five different concentrations were recorded by directly diluting the as-
prepared nanoparticle solution with appropriate solvents to the expected relative 
concentrations. For CiGNPs samples (diameters at 4.61, 8.55, 20.6, 25.67, 34.46 nm), 
solutions with relative concentrations of 1.0, 0.8, 0.6, 0.4, and 0.2 to the initial 
concentrations were prepared using Nanopure water as solvent. For CiGNPs at other sizes, 
the original solutions were measured. For DtGNPs, relative concentrations of 0.088, 0.070, 
0.053, 0.035 and 0.018 to the initial concentration of the as-prepared sample were 
obtained by diluting the sample with toluene. For OAGNPs sample, THF was used as the 
solvent to dilute the as-prepared sample to achieve relative concentrations of 0.064, 0.124, 
0.244, 0.515 and 1.040 to the initial concentration. The extinction coefficient at the 
corresponding SPR peak wavelength was calculated according to the Beer’s Law. 
5.2.5 Size and scattering intensity measurements of CiGNPs solutions by Dynamic 
Light Scattering 
 Solutions of CiGNPs at sizes 40, 60, 80, 100, 150, 200, and 250 nm were 
measured by a Malvern ZetaSizer NanoZS DLS system. All DLS measurements were 
done under the same parameter setup: sample volume 40 µL, measurement angle 13o, 
fixed sample position 4.65 µm, and fixed attenuation 11. The intact CiGNPs solutions 
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were diluted to different concentrations. The concentrations of GNPs were calculated 
according to the product description from the vendor and also the dilution factors used in 
this study. For each sample measured by DLS, the size and the DLS scattering intensity 
were recorded. Detection limits of GNPs by DLS were calculated using the standard 3σ 
method. 
5.3 Results and Discussions 
5.3.1 Calculation of average number of gold atoms per GNP 
The average number of gold atoms per nanoparticle may be calculated from TEM 
analysis. The HRTEM images of four nanoparticle product synthesized in this study are 
shown in Figure 5-1. Using ImageJ software, the average core diameters of the particles 
(D/nm) were measured and summarized in Table 5-1. Assuming a spherical shape and a 
uniform fcc structure,19 the average number of gold atoms (N) for each type of 
nanosphere was calculated by equation (5-1), where ρ is the density for fcc gold (19.3 



















Figure 5- 1. High resolution transmission electron microscopy images of (a) 3.76 nm 1-
decanethiol-capped AuNPs; (b) 4.61 nm citrate-stabilized AuNPs; (c) 7.58 nm 
oleylamide-protected AuNPs and (d) 25.67 nm citrate-stabilized AuNPs. (Copyright ® 
2007 Elsevier B.V.) 
 
5.3.2 Determination of molar concentrations of nanoparticle solution 
The molar concentration of the nanosphere solutions were calculated by dividing the 
total number of gold atoms (Ntotal, equivalent to the initial amount of gold salt added to 
the reaction solution) over the average number of gold atoms per nanosphere (N) 
according to equation (5-2), where V is the volume of the reaction solution in liter and NA 
is the Avogadro’s constant. It is assumed that the reduction from gold (III) to gold (0) 
was 100% complete. The concentrations of each diluted solution may be calculated from 
this initial concentration according to their relative concentration as stated in the 
experimental section. Concentrations of all sizes GNPs were calculated by either this 
method or as provided by the product vendor (Table 5-1). 
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Table 5- 1. The extinction coefficients (ε) of gold nanoparticles with different core sizes 











Extinction Coefficient ε 
(M-1cm-1) 
Decanethiol Toluene 3.76±0.65 506 9.45E-06b (3.61±0.08) E+6 
Citrate Water 4.61±0.48 517 9.42E-08 b (8.56±0.09) E+6 
Citrate Water 8.55±0.79 517 1.49E-88 b (5.14±0.07) E+7 
Oleylamine THF 8.76±1.11 520 1.30E-07 b (8.79±0.03E+7 
Citrate Water 20 521 1.16E-09c 7.62E+08 
Citrate Water 20.60±1.62 521 1.07E-09 b (8.78±0.06) E+8 
Citrate Water 25.67±5.62 526 4.92E-10 b (2.93±0.02E+9 
Citrate Water 34.46±4.34 529 2.22E-10 b (6.06±0.03) E+9 
Citrate Water 40 530 1.49E-10 c 7.07E+09 
Citrate Water 60 531 4.32E-11 c 2.92E+10 
Citrate Water 80 545 1.83E-11 c 5.58E+10 
Citrate Water 100 564 9.30E-12 c 9.14E+10 
Citrate Water 150 642 2.82E-12 c 1.47E+11 
Citrate Water 200 571 1.16E-12 c 3.15E+11 
Citrate Water 250 600 5.98E-13 c 4.78E+11 
a Values with standard deviations were the average size of 200 GNPs from TEM images, 
respectively for each size GNPs. Values without standard deviations were cited from the 
product description provided by the vendor. 
b Values obtained according to Equations (5-1) and (5-2). 
c Values obtained according to the product description provided by the vendor. 
 
5.3.3 Extinction coefficients 
5.3.3.1 Calculations of extinction coefficients 
The extinction coefficient of each nanoparticle sample was determined according to 
Lambert-Beer Law, equation (5-3). The as-prepared or purchased GNP solution was 
diluted into solutions into different concentrations as stated in the experimental section. 
The absorption spectrum of each solution was measured. The absorbance at 506 nm was 
recorded for each sample and plotted versus the molar concentration of the solution. The 
extinction coefficient can be obtained from the slope of the linear region of the 
absorbance-concentration curve. Other samples were analyzed in the similar way.  




 (a)                                                                         (b) 
 
(c)                                                                          (d) 
 
Figure 5- 2. Extinction spectra of (a)1-decanethiol and (c) oleylamide-protected gold 
nanoparticles at different relative concentrations. (b) and (d) are plots of experimental 
data of maximum extinction around 520 nm versus corresponding concentration and the 
linear fitting curves for decanethiol and oleylamide-protected gold nanoparticles, 
respectively. (Copyright ® 2007 Elsevier B.V.) 
Figure 5-2a-d is an illustration of the UV-Vis absorption spectra and the linear 
fitting curve of absorbance-concentration plots for decanethiol and oleylamide-protected 
GNPs. Both curves are linear with a correlation coefficient very close to 1.0. A good 
linear fitting of the experimental data was found for all other nanoparticle samples. The 
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types of nanoparticles analyzed and the extinction coefficients calculated from the linear 
fitting curve were summarized in Table 5-1.  
5.3.3.2 Shift of the SPR extinction peak 




























GNP size (nm)  
Figure 5- 3. Changes the SPR peak wavelengths of GNPs at increased GNP sizes (3.76 
nm to 150 nm) (Lorentz fitting: Y=485.01704+(2*148589.239/π)*(85.20574/(4*(X-
255.01039)2+85.205742)); R2=0.98777) 
 
The SPR band peak wavelength (λmax)of GNPs showed a red-shift from 506 nm 
for the 3.76 GNPs to 642 nm for the 150 nm GNPs. This red-shift trend is in accordence 
with theoretical calculations made by Yuegubide et al.24 They calculated that λmax will 
increased from 535 nm for 20 nm GNPs to the maxima of 665 nm for 160 nm (Table 1-1). 
Our results illustrated the red-shift tread but showed lower λmax values than predicted, 
probably due to effects from surface ligands of GNPs and the solvent. For the size range 
between 3.76 nm to 150 nm, the change of the λmax over the GNP size can be fitted very 
well with Lorentz fitting, as shown in Figure 5-3. For GNPs with sizes larger than 150 
nm, λmax showed a blue-shift, which agrees with the trend predicted in theory. 
5.3.3.3 Intensity of extinction coefficients 
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From Table 5-1, one can notice immediately that the extinction coefficients of 
GNPs are orders of magnitude higher than organic dye molecules. The measured 
extinction coefficients of citrate-stabilized GNPs are approximately in line with what has 
been reported by El-Sayed et al.14 For example, the extinction coefficient values for a 20 
nm citrate-stabilized gold nanoparticle obtained from this study, the experimental and 
theoretical study by El-Sayed et al are 8.8E8, 1.36E9, and 7.6E7 M-1cm-1, respectively. 
Between the three values, there is approximately an order of magnitude difference. Our 
data is between the experimental and theoretical value as reported by El-Sayed et al.  
From Table 5-1, another important result to notice is that the increase in core 
diameter of GNPs introduced dramatic and continuous increase in the extinction 
coefficients. From a core diameter of ~4 nm to 35 nm, the extinction coefficient increased 
three orders of magnitude. From the double logarithm plot of extinction coefficient 
against the nanoparticle size in diameter, a good linear relationship was found and can be 
expressed in equation (5-4), Where ε is extinction coefficient in M-1cm-1, D is the core 
diameter of the nanoparticles, and k=2.85232, a=11.86382. The linear fitting of the 
experimental data gives a correlation coefficient of 0.99324. 




Figure 5- 4. The  linear correlation between the extinction and the GNP size in double 
log scale. (ln(ε)=11.86382+2.85232lnD; R2=0.99324) 
 
This finding is also in accordance with the Mie theory as well as the study 
reported by El-Sayed et al. The k and a value obtained from our study is 3.32 and 10.8, 
respectively, while the values for these two parameters are 2.75 and 11.7 from the 
experimental study, and 3.36 and 8.1 from the theoretical study as reported by El-Sayed 
et al. Comparing these values, it appears that our experimental result is closer to the 
theoretical value as calculated by El-Sayed et al. The discrepancy between different 
studies is most likely due to the slight difference in the average core size and size 
dispersity of the nanoparticles.15  
The experimental study reported by El-Sayed was on citrate-stabilized GNPs that 
were soluble in water. Our results suggest that the linear relationship of the double 
logarithm of extinction coefficient versus nanoparticle core diameter can be extended to 
most GNPs independent of the capping ligands used to protect the nanoparticles and the 
solvents used to dissolve the nanoparticles. The solvents used to dissolve the three types 
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of nanoparticles synthesized in this study, toluene for decanethiol-protected nanoparticles, 
THF for oleylamide-protected nanoparticles, and water for citrate-stabilized nanoparticles, 
have very different dielectric constants (as listed in Table 5-1), varying from 2.4 to 78. 
The stabilization effect by the capping agents for these three types of nanoparticles is also 
quite different. The citrate-stabilized nanoparticles rely on electrostatic interactions 
between the ligands and the nanoparticle core. The decanethiol-protected GNPs are 
stabilized by covalent bonding between thiolate groups and surface gold atoms, while the 
oleylamide-protected GNPs depend on hydrogen bonding network formation between 
amide groups to create a stable environment for nanoparticle core. Although Mie theory 
indicates that the plasmon resonance absorption of a nanoparticle is related to the 
dielectric constant of the environmental media around the nanoparticles (which include 
both solvents and the capping ligands), these effects do not appear to make significant 
contribution to the extinction coefficient of the surface plasmon resonance band.7,22  
5.3.3.4 Application of extinction coefficients for GNP concentration determination 
Because of the general applicability of the relation of nanoparticle extinction 
coefficient versus nanoparticle size, one can use the extinction coefficient-core diameter 
double logarithm curve established in this study as a calibration curve to calculate or 
estimate the nanoparticle concentration or average diameter of a nanoparticle solution 
sample. For example, by determine the average size of a nanoparticle sample using TEM, 
one can obtain the extinction coefficient of the sample. By taking UV-Vis absorption 
spectra of the sample, the concentration of the sample can be calculated. This will be 
useful for determining the concentration of biomolecules such as proteins when labeled 
with GNPs.23 Most organic molecules and biomolecules have much lower extinction 
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coefficient than GNPs. By labeling biomolecules with GNPs, the biomolecules can be 
detected at concentrations as low as sub- nanomolar to picomolar range. This could lead 
to a very powerful tool at detection of biomarker molecules using a simple 
spectrophotometer. On the other hand, if the concentration and extinction coefficient of a 
nanoparticle sample can be determined, the size of the particle may be estimated without 
imaging analysis by TEM. 
5.3.4 Light scattering property of GNPs studied using DLS 
 After investigating the extinction property of GNPs around their SPR band, we 
studied the light scattering property of GNPs using DLS. For each size GNP solution, the 
scattered light intensities at different concentrations were recorded by DLS. The results 
for GNPs at various sizes ranging from 40 nm to 250 nm were summarized in Figure 5-5. 
  
 





















[GNP] (M)  
Figure 5- 5. The linear relationship between the DLS intensity and the concentration, 
respectively for each size GNP 
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There are some important points to be discussed from Figure 5-5 about the light 
scattering property of GNPs. First, it can be seen that the light scattering intensity 
increased linearly along GNP concentration increases. Such linear relationships were 
observed for GNPs at all sizes investigated in this study. Linear regression curves for the 
scattering intensity and the GNP concentration were summarized in Table 5-2. These 
results were different from reported results by reported by Yuegubide et al.24 In Figure 1-
11, the light scattering intensity was linearly dependent with the GNP concentration in 
double logarithmic scales, respectively for 52, 78, 87 and 118 nm GNPs. In our study, 
however, the light scattering intensity was directly linearly related to the GNP 
concentration, respectively for GNPs at sizes from 40 to 250 nm. The discrepancy 
between these two studies may come from the differences in the experimental setup for 
the light scattering intensity measurements. 
 
Table 5- 2. GNP detection limits under DLS measurements and linear regression curves 
between the DLS intensity and the GNP concentration 
  Y=A+BX 
GNP size (nm) LLOD* (M) A B R2 
40 5.95E-13 0.8593 2.37E+12 0.9998 
60 1.79E-13 0.784 8.30E+12 0.99739 
80 1.73E-14 0.91723 7.80E+13 0.99952 
100 3.97E-15 0.80292 3.69E+14 0.99972 
150 1.25E-15 0.8739 1.12E+15 0.99883 
200 5.14E-16 0.85075 2.76E+15 0.99811 
250 1.60E-16 0.85743 8.82E+15 0.98628 
*LLOD: Low limit of detection; Y: DLS intensity (kcps); X: GNP concentration (M) 
 
Second, we can see that the light scattering intensity was different for GNPs 
solutions at the same concentration but different sizes. Larger size GNPs showed higher 
light scattering intensity values. According to the Rayleigh theory, the light scattering 
cross section of a small GNP (D<0.05 λ) is proportional to the 6th power of its diameter 
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(equation 1-8). As a result, when the size of GNP increases, the scattering intensity 
increases dramatically. For large GNPs (D<0.05 λ), the scattering cross section still 
increases along the particle size with a correlation smaller that 6th power. In our study, the 
relative light scattering efficiency for GNPs from 40 to 250 nm was characterized by the 
slope of the linear regression curve. Results were shown in Table 5-2 and plotted in 
Figure 5-6. The correlation between the light scattering efficiency and the GNP size can 
be fitted very well with Lorentz fitting. From Figure 5-6, the light scattering efficiency 
increases along the GNP size. These results were in accordance with the theoretical 
calculations by Yuegubide et al.24  
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Figure 5- 6. Relative scattering efficiency of GNPs (red curve: Lorentz fitting). 
 
Third, we need to notice that GNPs can be detected by DLS at very low 
concentrations without any amplification steps. As shown in Figure 5-5, GNPs at 
concentrations in the range of pM can be detected very easily by DLS. Detection limits of 
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GNPs in this study were summarized in Table 5-2. For example, the detection limit for 
100 nm GNPs is as low as ~4 fM. Such high sensitivities of GNPs detection by DLS are 
due to the strong scattering property of GNPs. As discussed in section 1.3.2.1, the 
scattering cross section of GNPs is 4-6 orders of magnitude larger than that of small 
fluorescence molecules, polystyrene beads or biomolecules. As a result, under a laser 
irradiation GNPs scatter more lights to be captured by the DLS detector. The strong light 
scattering property of GNPs and thus the ultra sensitivity in DLS detection make them 
very promising to be used as ultra sensitive probes in biomolecular detection applications. 
Based on this, we investigated the applications of GNPs in biomolecular detection in 
Chapter 6, Chapter 7, and Chapter 8. 
5.4 Conclusion 
In this work we studied the light extinction and scattering properties of GNPs 
with core sizes ranging from ~4-250 nm. Extinction coefficients of GNPs were 
determined by HRTEM analysis and UV-Vis absorption spectroscopic measurements. 
Three different types of gold nanoparticles were prepared and studied: citrate-stabilized 
nanoparticles in eleven different sizes; oleylamide-protected gold nanoparticles with a 
core diameter of 8 nm, and a decanethiol-protected nanoparticle with a diameter of 
around 4 nm. A linear relationship between the logarithms of extinction coefficients and 
core diameters of gold particles was found independent of the capping ligands on the 
particle surface and the solvents used to dissolve the nanoparticles. This linear relation 
may be used as a calibration curve to determine the concentration or average size of an 
unknown nanoparticle or nanoparticle-biomolecule conjugate sample. Following the 
extinction studies, we investigated the light scattering property of GNPs using DLS. We 
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found out that the light scattering of GNPs were very strong. Very low detection limits 
were reported for GNPs by DLS detection. In addition, light scattering intensities of 
GNPs were found to increase linearly along the GNP concentration and non-linearly 
along the GNP size.  
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CHAPTER 6. A WASHING-FREE AND AMPLIFICATION-
FREE ONE-STEP HOMOGENEOUS ASSAY FOR PROTEIN 
DETECTION USING GOLD NANOPARTICLE PROBES 
6.1 Introduction 
  Protein detection and analysis plays an extremely important role in in-vitro 
diagnostics. With the tremendous progresses made in proteomics in the last few decades, 
there has been a growing demand for highly sensitive, fast and simple techniques for 
protein analysis using minimum volume of samples and cost effective instrumentations. 
Many protein biomarkers associated with cancer and other diseases exist in biological 
fluids and systems with low abundance, typically in the range of fg/mL to ng/mL.1 How 
to detect these low abundance biomarker proteins has raised tremendous challenges for 
bioanalytical chemists. Traditional methods address this difficulty by using amplification 
labels such as enzymes, radioactive isotopes or fluorescent probes to achieve the required 
high sensitivity.2-3 These methods, however, often involve many steps in the assay, 
including labeling, multiple washing and separation cycles, signal amplification and 
measurement. These complicated procedures not only make it difficult to automate the 
assay, but also increase the cost of protein analysis.  
       Since the middle 1990s, gold nanoparticles (GNP) have been investigated 
extensively for biomolecular imaging and detection.4-9 The unique optical properties of 
GNPs, including their strong absorption and intense light scattering at the surface 
plasmon resonance wavelength region, aggregation-induced color change,4 and the 
surface-enhanced Raman scattering,5 have been studied in much details in both direct and 
amplified biomolecular assays.6 GNPs, when conjugated with a detector antibody, may 
be used in a traditional heterogeneous sandwich-type immunoassay. The GNP probes 
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immobilized on a surface due to antibody-antigen binding may be detected optically or 
electrochemically.6,7 GNPs have also been used to develop homogeneous biomolecular 
assays.4,9 Such assays are based on the detection of nanoparticle aggregation caused by 
protein-protein interactions or DNA hybridization. GNP aggregation or de-aggregation 
often leads to optical property changes such as wavelength shifts of the surface plasmon 
resonance (SPR) bands (or color change),4 melting temperature increases of the 
hybridized DNA,6 fluorescence quenching or enhancement,8 and surface enhanced 
Raman scattering.5 Homogeneous assays offer some unique advantages compared to 
heterogeneous assays, especially in the simplicity of the assay. However, the sensitivity 
of homogeneous assays, including the assays involving GNPs as mentioned above, is 
often not as high as heterogeneous amplification assays. Mirkin et al. developed a bio-
bar-code amplification method using DNA bar-code modified GNPs for both protein and 
DNA detection. Although this method has extremely high sensitivity, the assay involves a 
complicated multiple-step process that is very difficult to conduct and automate. 
Laser light scattering immunoassays (LIA) have been known for more than 3-4 
decades.12,13 Most of these assays are based on immunoaffinity interaction-induced 
particle aggregation. The level of particle aggregation may be measured using turbidity, 
nephelometry, angle-dependent scattering intensity, or dynamic light scattering technique. 
Turbidity and nephelometry are still used substantially in medical diagnostic and 
environmental testing labs for biomolecule and microorganism detection. In these two 
assays, light transmitted through or scattered from a turbid assay solution due to particle 
aggregation is measured and correlated to analyte concentration. However, these two 
assays typically have very low sensitivity, and are mostly used for high abundance 
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protein analysis. Dynamic light scattering (DLS), a technique used extensively for 
characterizing particle size and size distribution, was also applied for particle 
agglutination-based immunoassays in late 1970s.13 However, this technique never took 
off as a main stream immunoassay method for protein analysis due to multiple limitations. 
First and most important above all, these LIAs including DLS, turbidity, and 
nephelometry assays, use micron or submicron polymer beads such as latex particles as 
light scattering enhancers. The light scattering intensity of polymer latex particles, 
although substantially stronger than biomacromolecules, is still not strong enough to 
overcome the background scattering from sample matrices. Biological fluids such as 
blood serum or plasma contain large amounts of nanoparticles and micron scale particles. 
The intense light scattering from these matrix particles can cause significant interference 
to the assay. Second, when early attempts were made on using DLS for latex particle-
based light scattering immunoassays, DLS was still a relatively high cost instrument, 
difficult to operate, with limited sensitivity and data analysis capability. Due to these 
multiple reasons, DLS was not considered as a promising tool for immunoassay 
applications.  
          Recently, the extensive study and further understanding on the optical properties 
of gold nanoparticles (GNPs) has opened many new doors in biomolecular imaging and 
detection. Gold nanoparticles, including spherical particles, nanorods and nanoshells with 
a size ranging from 10s to 100s nanometers, are known to have a large light absorption 
and scattering cross section in the surface plasmon resonance (SPR) wavelength region.14 
In normalized terms, the scattering cross section of a 30 nm gold particle at its SPR 
region is about 250 times larger than a 30 nm polystyrene particle. As compared to 
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fluorophores, the scattering light intensity from a 60 nm gold nanoparticle is four to five 
orders of magnitude higher than a strongly fluorescent fluorescein molecule.14 
Furthermore, the scattering light from nanoparticles does not suffer from the many 
problems of fluorophores, such as photobleaching, extreme sensitivity to environmental 
changes. The strong light scattering of gold nanoparticles has enabled many important 
and promising applications in biomedical field, such as molecular and cell imaging,15 
biosensing, and bioassays.16 
  
Scheme 6- 1. Illustration of a one-step homogeneous biomolecular assay using gold 




            With its strong light scattering, we hypothesized that GNPs could be an excellent 
light scattering enhancer to replace polymer latex particles for immunoassay development 
using light scattering techniques. We recently conducted some exploratory studies to 
demonstrate the proof-of-concept of using GNPs for light scattering assay of both 
proteins and DNA targets as illustrated in Scheme 6-1. Using a non-competitive assay 
format, a sandwich type antibody-antigen binding or DNA hybridization was transduced 
into GNP aggregation formation, which was detected by DLS and subsequently 
correlated to the target analyte concentration. Due to the extremely strong light scattering 
intensity of GNPs around their SPR band region, this assay can potentially become a 
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highly sensitive for biomolecular detection and analysis. It is a single-step, washing-free 
and amplification free process, therefore, very easy to conduct and automate. In addition, 
the assay involves the use of very small volumes of samples and GNP probes (total 10 µL 
or less), which can lead to substantial cost reduction.  High throughput 96- or 384-
microtiter plate reader is becoming a standard feature of current DLS instruments, which 
means the new assay developed in our research can be easily adapted for high throughput 
biomolecular analysis.   
        In the present work, we conducted a systematic study to examine the sensitivity 
and dynamic range of this new immunoassay technique, and further developed two 
formats of competitive and non-competitive homogeneous assays using mouse IgG and 
goat anti-mouse IgG as a pair of model proteins. This study also revealed some important 
insights on the nanoparticle aggregation kinetics and its effects on the performance of the 
immunoassay, especially the dynamic range of the assay. We demonstrated that by 
properly adjusting the probe concentration and assay conditions, protein analytes may be 
detected at concentrations as low as pg/mL without any amplification steps.   
6.2 Experimental Section 
6.2.1 Chemicals and materials 
0.01M phosphate buffer saline (NaCl 0.138 M; KCl 0.0027 M, pH 7.4), bovine 
serum albumin (BSA) powder, and Sepharose CL-2B gel and BiotinTagTM biotinylation 
kit (cat# B-TAG) were purchased from Sigma-Aldrich (Milwaukee, WI). ChromPure 
Mouse IgG (whole molecule, IgG concentration 5.5 mg/mL, buffer: 10 mM sodium 
phosphate, 250 mM NaCl, pH 7.6, preservative: none) was from Jackson 
ImmunoResearch Laboratories, Inc. (West Grove, PA). Citrate-stabilized GNPs (core 
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diameter 100 nm), goat anti-mouse IgG (H+L) (AH)-conjugated GNPs (GNP-anti-IgG, 
core diameter of 40 nm) and streptavidin-conjugated GNPs (GNP-STV, core diameter 40 
nm) were purchased from Ted Pella Inc. (Redding, CA). Nanopure water with a 
conductivity of 18 MΩ·cm was obtained from a Nanopure DiamondTM system (Barnstead 
International, Dubuque, Iowa). 
6.2.2 Preparation of mouse IgG conjugated GNPs (GNP-IgG) and bovine serum 
albumin-conjugated GNPs (GNP-BSA) 
Mouse IgG was labeled with biotin by following the instruction of the 
biotinylation kit BiotinTagTM from Sigma. 0.75 mL of purified biotin-labeled mouse IgG 
solution was obtained at a concentration of ~0.7 mg/mL using this kit. To 0.5 mL of 0.1 
nM streptavidin-stabilized GNP in PBS buffer, 7 µL of biotin-labeled mouse IgG was 
added and incubated for 1 h, then centrifuged at 9000 rpm for 4 min and recovered into 
PBS buffer solution. Bovine serum albumin conjugated gold nanoparticles (GNP-BSA) 
were prepared using citrate protected 40 nm gold nanoparticles according to a literature 
report.10 
6.2.3 Instrumentation 
A set of micropipettes (0.5-10 µL, 10-100 µL and 100-1000 µL) from Eppendorf 
International (Hamburg, Germany) was used for liquid transfer and dilution. A Cary 300 
Bio UV-Visible spectrophotometer from Varian Inc. (Palo Alto, CA) was used for UV-
Vis spectroscopic study. A PD2000DLSPLUS Dynamic Light Scattering Detector and 
PDDLS/CoolBatch 40T Dynamic Light Scattering detector system from Precision 
Detectors Inc. (Bellingham, MA) was used for DLS measurement. The DLS instrument 
was operated under the following conditions: temperature 20oC, detector angle 90o, 
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incident laser wavelength 683 nm, laser power 100 mW. The DLS data was processed 
using the Precision Deconvolution software. Each assay solution was diluted into 1.50 
mL of nanopure water to the appropriate concentrations and mixed well for 2 min before 
DLS measurement. 
6.2.4 Sensitivity study of a 100 nm GNP by dynamic light scattering 
The initial concentration of the 100 nm GNPs as purchased from Ted Pella, Inc. 
was determined by UV-Vis spectroscopy according to a reported method.11 The light 
scattering intensities of nanoparticles at serial dilutions were then measured by DLS with 
three repeats for each concentration. Lower limit of detection (LLOD) of the 100 nm 
GNP was calculated from linear fitting curve using s+3σ method.  
6.2.5 Kinetic study and temperature effect on the aggregation of goat anti-mouse 
IgG conjugated GNPs (GNP-anti-IgG) and mouse IgG conjugated GNP (GNP-IgG) 
100 µL of 0.1 nM GNP-anti-IgG and 100 µL of 0.1 nM GNP-IgG solutions were 
mixed together and incubated at 37 °C from 1 min up to 19 h. The average diameter of 
GNPs in solution was monitored by DLS periodically during this time. A control sample 
was prepared by substituting GNP-IgG with streptavidin-conjugated GNP-STV. Each 
concentration was run in duplicates. For temperature effect study, an equal volume 
mixture of GNP-IgG and GNP-anti-IgG was incubated at 4, 25 and 37 °C, respectively. 
The average diameter of GNPs in the mixture solution was regularly recorded from 1 min 
up to 24 hours. 
6.2.6 A direct assay for mouse IgG using GNP-anti-IgG probes 
A mouse IgG stock solution with a concentration of 5.5 mg/mL was used to 
prepare mouse IgG solutions at concentrations 50000, 5000, 500, 50, 5.0, 0.50, 0.05, and 
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0.005 ng/mL by serial dilutions. In the process, a 0.1% BSA solution (buffer: 10 mM 
PBS, 0.154 M NaCl, pH=7.4) after filtering through a 0.2 µm membrane was used as the 
sample dilutant and also as the control sample. The stock solution of 1 nM GNP-anti-IgG 
was purified by column chromatography using a Sepharose CL-2B gel column to 
eliminate any non-conjugated goat anti-mouse IgG. The purified solution was filtered 
through a 0.2 µm membrane and then diluted into 0.1, 0.01 and 0.001 nM solutions. In a 
first assay, 20 µL of mouse IgG solution was mixed with 60 µL of GNP-anti-IgG probe 
solution at a concentration of 0.1 nM, and the assay solution was incubated at 37 °C for 2 
hours. The average hydrodynamic diameter of the assay solution between 20 and 400 nm, 
Dh, was then measured by DLS. Particles with sizes beyond this range were not included 
in the data analysis. A control study was performed under the same conditions using BSA 
conjugated GNP probes (GNP-BSA). In a second and third assay, the concentration of 
GNP-anti-IgG was reduced to 0.01 nM or 0.001 nM by 0.1% BSA solution, with all other 
conditions remained the same as used in the first assay.  
6.2.7 A competitive assay for mouse IgG detection 
60 µL of 0.1 nM GNP-anti-IgG solution, 60 µL of 0.1 nM GNP-IgG, and 20 µL 
of mouse IgG solutions with different concentration were mixed together and incubated 
at room temperature for 4.5 h. Particle size of the incubated solution was then measured 
by DLS.   
6.3 Results and Discussions 
6.3.1. Sensitivity of GNP detection by dynamic light scattering 
We previously reported that the detection limits for a 40 nm spherical GNP, and a 
10 by 40 nm gold nanorod (GNR) can reach 0.02 and 0.4 pM, respectively. In the present 
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study, we further examined the detection limit of a 100 nm spherical GNP by DLS. For 
our assay purpose, what actually needs to be detected is nanoparticle aggregates instead 
of individual gold nanoparticles. Since the GNP probes used in this study has an average 
diameter of 40 nm, a GNP with a diameter of 100 nm can be viewed as approximately 
equivalent to a dimer of a 40 nm GNP, the smallest aggregate to be present in the assay 
solution. Therefore, the detection limit of 100 nm GNPs is a good indication of the 
potential sensitivity of the immunoassay investigated in this study. The detection limit 
study of the 100 nm GNPs is shown in Figure 6-1. Similar to smaller size GNPs, there is 
a linear relationship between nanoparticle concentration and scattered light intensity. The 
lower limit of detection (LLOD) of this 100 nm GNP was determined to be around 0.7 
fM, a 30 fold improvement compared to the 40 nm GNP. According to theoretical 
calculations,14 the light scattering cross section of GNPs increases dramatically when the 
diameter of GNPs is above 80-100 nm. The sensitivity of DLS for GNP detection is also 
related to the wavelength and power of the laser. By increasing the gold nanoparticle size 
and varying the instrumental set-up, it is possible that GNPs can be detected at 
concentrations lower than fM, even at attomolar and zeptomolar (aM and zM) ranges. 
Furthermore, because the light scattering intensity is proportional to the particle size, the 
sensitivity of DLS for nanoparticle aggregation can be significantly higher than 
individual nanoparticles. Gold nanoparticles should be excellent light scattering 




Figure 6- 1. Light scattering intensity of a 100 nm gold nanoparticle at different 
concentrations as determined from DLS measurement. (y=0.02758+119.47x, 
R2=0.99212; LLOQ=0.7 fM according to 3σ, error bar: standard deviation; each data is 




Figure 6- 2. Particle size and size distribution of a 1:1 mole ratio mixture of goat anti-
mouse IgG conjugated GNPs (GNP-anti-IgG) and mouse IgG conjugated GNPs (GNP-
IgG) measured immediately after mixing and after incubation at room temperature for 24 




6.3.2 Kinetics of nanoparticle aggregation between two complementary GNP 
immunoprobes 
In particle agglutination immuoassays, a good understanding on the whole 
nanoparticle aggregation process is ultimately important for the assay development. 
Using a pair of primary and secondary antibody as model proteins, we first studied the 
aggregation kinetics of two GNP particles: one is GNPs conjugated with goat anti-mouse 
IgG (GNP-anti-IgG), and the other one is GNPs conjugated with mouse IgG (GNP-IgG). 
The GNP-IgG particles were prepared by conjugating biotinylated mouse IgG to a 
streptavidin-coated GNPs. The core diameter of the GNP probes is around 40 nm. When 
these two particles are mixed together, the binding between mouse IgG and goat anti-
mouse IgG should cause nanoparticle aggregation. Shown in Figure 6-2 is a size 
distribution graph of the mixed particle solution as measured by DLS. With increased 
incubation time, the average size of the particle solution increased clearly. Figure 6-3 is 
the measured average particle size, expressed in hydrodynamic diameter Dh, of the 
solution recorded at different time. Over 24 hours, the average particle size increased 
almost linearly from 42 nm to 90 nm. In a control experiment, when GNP-anti-IgG was 
mixed with streptavidin-coated GNPs (GNP-STV) and incubated for the same amount of 
time, the average particle size of the solution remained the same as the initial solution 
through out the whole incubation period. This experiment demonstrates the capability of 
DLS to quantitatively detect and monitor the immunoaffinity interaction-induced 
nanoparticle aggregation process. We also examined the incubation temperature effect on 
this process. An equal amount of mixture of GNP-IgG and GNP-anti-IgG was incubated 
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at three temperatures: 4, 25, and 37 oC, respectively. At elevated temperature, the 









Figure 6- 3. The hydrodynamic diameter change of gold nanoparticle in two mixed 
nanoparticle probe solutions over 19 hours of incubation at ambient conditions. (-○-: 
mixture of GNP-anti-IgG and GNP-IgG; -□-: mixture of GNP-anti-IgG and GNP-STV. 
Linear fitting from 1 to 250 min: y=44.20632+0.11925x, R2=0.98915; error bar: standard 




Figure 6- 4. The growth of nanoparticle size for an equal volume mixture of 0.1 nM 
GNP-anti-IgG and 0.1 nM GNP-IgG incubated at different temperatures for up to 24 
hours. (-□-: 4 oC; -○-: 25 oC; -∆-: 37 oC; error bar: standard deviation; each data is the 




















Figure 6- 5. The hydrodynamic diameter change of assay solutions of mouse IgG mixed 
with two different gold nanoparticle probes after incubating at 37 oC for 2 hours. (-□-: a 
control made of mouse IgG with 0.1 nM BSA conjugated GNPs; -∆-: mouse IgG mixed 
with a 0.1 nM goat-anti mouse conjugated GNPs; rrror bar: standard deviation; each data 
is the average of two experiments) (Copyright ® 2009 Elsevier B.V.) 
 
6.3.3 Detection of mouse IgG using goat anti-mouse IgG conjugated GNPs 
           Goat anti-mouse IgG, a secondary antibody, can bind with primary antibody 
mouse IgG on its Fab, Fab’ or Fc region. Because of these multiple binding sites, mouse 
IgG can cross link nanoparticle probes into oligomers or larger aggregates. A 
homogeneous immunoassay for mouse IgG can be designed and developed using the 
secondary antibody conjugated GNPs. Mouse IgG solutions with concentrations covering 
a six-orders of magnitude range from 0 ng/mL to 50,000 ng/mL were assayed. The assay 
solution was incubated at room temperature for 2h. As shown in Figure 6-5, overall, the 
nanoparticle size increased with increasing mouse IgG concentration. From mouse IgG 
concentration 0.05 to 50 ng/mL, the particle size increase was rather limited, and between 
50 to 500 ng/mL, the particle size increase became significant. When the concentration of 
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mouse IgG was further increased to 5,000 and 50,000 ng/mL, the particle size actually 
decreased, leading to an interesting bell-shaped curve. Such a response curve is similar to 
a well known immuno-precipitation assay curve from antigen-antibody binding and 
referred to as the Heidelberger-Kendall curve.16 This phenomenon is also known as the 
“hook effect”, which is commonly observed in particle agglutination immunoassays. The 
antibody-antigen binding-induced particle aggregation process can be divided into three 
different zones. At relatively low antigen concentrations (here is the mouse IgG), the 
particles will form relatively small oligomers/clusters due to the crosslinking effect of 
small amount of antigens. In this zone, the average particle size increases linearly or 
logarithmically with increased antigen concentration. At a certain antigen concentration, 
such nanoparticle size increase will reach a maximum, the so-called “hook point”. 
Further increase of antigen concentration will lead to a decreased degree of particle 
aggregation, because there are enough antigens to bind with each antibody on the 
nanoparticle surface, therefore, less particle crosslinking will occur. The relative ratio of 
the nanoparticle probes versus antigen in an assay solution determines when the “hook 
point” shall occur.  
        For particle agglutination assays, the “hook point” is approximately the upper limit 
of the dynamic range of the assay. The “hook point” for the assay as shown in Figure 6-5 
appeared at a mouse IgG concentration around 500 ng/mL. “Hook point” also affects the 
precision of an assay. When substantial nanoparticle aggregation starts to form, the 
precision of the analysis through particle size measurement will typically decrease. This 
was clearly noticed from the results as shown in both Figure 6-3 and 6-4. However, at 
relatively low antigen concentration, the particle size change of the assay solution was 
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not very significant, as the case shown in Figure 6-5, due to relatively high concentration 












Figure 6- 6. A direct assay for mouse IgG detection using 0.01 nM goat anti-mouse IgG 
conjugated GNPs. Measured data was fitted into a logistic model using a four parameter 
Logistic fitting without weighting. (LLOD=0.0078 ng/mL, 3σ, R=2; 
y=187.55435+(35.46758-187.55435)/(1+x/46.97037)0.6302, R2=0.9994;  error bar: 
standard deviation; each data is the average of two experiments) (Copyright ® 2009 
Elsevier B.V.) 
         
To improve the sensitivity of the assay at low analyte concentration range, we 
diluted the GNP probes 10 times from 0.1 nM to 0.01 nM and mouse IgG solutions with 
a concentration from 0 to 50 ng/mL were assayed. As shown in Figure 6-6, the particle 
size increase at low mouse IgG concentrations became much more obvious. At the same 
antigen concentration, the percentage of nanoparticle aggregation increases naturally with 
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a lower nanoparticle probe concentration, leading to improved sensitivity of the 
detection. The growth of the nanoparticle hydrodynamic diameter Dh can be fitted into a 
Logistic model, with a CV% of the fitting curve below 10% for all points.18 The dynamic 
range of this assay for mouse IgG is estimated to cover four to five orders of magnitude 
from 0.0078 to 50 ng/mL. This dynamic range and the sensitivity are on par with or 
substantially better than ELISA and some other sandwich immunoassays. This example 
of study illustrates that by selecting the appropriate nanoparticle probe concentration, one 




Figure 6- 7. A competitive assay for mouse IgG detection using two nanoparticle probes, 
GNP-IgG and GNP-anti-IgG. The concentration of both GNP probes was 0.1 nM. Each 
assay solution was incubated at room temperature for 4.5 hours. Measured data was fitted 
into a logistic model using a four parameter Logistic fitting without weighting. 
(LLOD=283.0036 ng/mL, 3σ, R=2; y=42.21247+(71.12096-
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42.21247)/(1+x/5023.40461)0.76428, R2=0.9895, error bar: standard deviation; each data is 
the average of two experiments) (Copyright ® 2009 Elsevier B.V.) 
 
6.3.4 A competitive immunoassay for mouse IgG using two nanoparticle probes 
Other than adjusting the nanoparticle probe concentration and manipulating the 
assay conditions, an alternative approach to eliminate the problem of “hook effect” is to 
use a competitive assay format. Competitive assays have been reported previously for 
microparticle or nanoparticle-based assays.4,9,12 In this study, a one step competitive 
homogenous assay for mouse IgG detection was performed by using two matching GNP 
probes, GNP-IgG and GNP-anti-IgG. Aggregation of these two GNP probes would reach 
the maximum when there is no mouse IgG in the sample solution, while no aggregation 
should be observed when there are excess amounts of mouse IgG in the sample solution. 
Indeed, as revealed from particle size measurement as shown in Figure 6-7, the average 
hydrodynamic diameter of the assay solution decreased with increased mouse IgG 
concentration. The particle size decrease versus analyte concentration curve may also be 
fitted into a logistic model, with a relative CV% less than 10% for all the data points.18 
Although the decrease of particle size at low analyte concentration is relatively small and 
the sensitivity of the assay is not as good as the sandwich-type assays, this approach 
avoided the “hook effect” encountered in the non-competitive assay. Another advantage 
of competitive assays is that the assay does not require at least two independent binding 
sites on the analyte molecules or two matched monoclonal antibodies. This advantage is 
especially useful when only one antibody is available for a target antigen. In principal, a 
secondary antibody-conjugated GNP and a primary antibody conjugated-GNP can be 
paired together to develop competitive assay for essentially any protein antigen 
 132 
molecules. With these two important advantages, competitive assays are as promising as 
non-competitive assays and merit further investigation and development.  
6.4 Conclusion 
In summary, through this study, we demonstrate that gold nanoparticles with their 
strong light scattering property can be used as a highly sensitive optical probe to replace 
traditional polymer latex particles for laser light scattering immunoassay applications. 
The sensitivity and dynamic range of such assays can be adjusted very conveniently to 
the expected range by selecting appropriate nanoparticle probe concentrations and assay 
conditions. Both competitive and non-competitive assay formats may be considered in 
the actual assay development for each individual protein analyte. With the extremely high 
sensitivity of DLS for gold nanoparticle and nanoparticle aggregation detection, 
modernized DLS instruments and high throughput sample handling capability, we believe 
laser light scattering immunoassay can be re-vitalized into a very powerful bioanalytical 
technique for protein analysis.  
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CHAPTER 7. A ONE-STEP HOMOEGENOUS 
IMMUNOASSAY FOR CANCER BIOMARKER 
DETECTION USING GOLD NANOPARTICLE PROBES 
COUPLED WITH DYNAMCI LIGHT SCATTERING 
7.1 Introduction 
Highly sensitive detection and accurate analysis of biomarker molecules in human 
fluid samples are essential for early detection, treatment and management of cancer. For a 
typical sandwich-type immunoassay which is routinely used for protein biomarker 
detection, a capture antibody against a specific biomarker protein is first immobilized on 
a microtiter plate. After the binding of antigen from a sample solution, a labeled detector 
antibody is allowed to bind with the immobilized antigen. The concentration of the 
antigen can then be determined by indirectly measuring the concentration of the probe 
attached to the detector antibody, which include enzymes, fluorescence tags, DNA-
barcodes, etc.1 A typical heterogeneous immunoassay involves antibody immobilization, 
multiple steps of incubation and washing cycles, followed by the signal amplification and 
reading step. From the initial antibody immobilization to the final reading of the assay 
results, the entire immunoassay can usually take hours to days to complete. A traditional 
immunoassay is rather time-consuming and labor-intensive. To overcome these 
problems, the development of single-step, washing-free homogeneous immunoassays has 
been of tremendous interest and value to the scientific community.2  
GNPs, including spherical particles, nanorods and nanoshells with a size ranging 
from 10s to 100s nanometers, are known to have a large light absorption and scattering 
cross section in the surface plasmon resonance wavelength region.3 The magnitude of 
light scattering by a gold nanoparticle can be orders of magnitude higher than light 
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emission from strongly fluorescing dyes. This unique property has enabled many 
important and promising applications of metal nanoparticles in biomedical field, such as 
molecular and cell imaging, biosensing, bioassays, and photothermal therapy.4 However, 
the strong light scattering property of GNPs has been mainly applied to optical 
microscopic imaging of biological cells for qualitative evaluation, but much less 
frequently for quantitative analysis and assays.     
Dynamic light scattering (DLS), also known as photon correlation spectroscopy 
or quasi elastic light scattering, is a technique used widely for particle size and size 
distribution studies. This technique is based on the Brownian motion of spherical 
particles which causes a Doppler shift of incident laser light. The diffusion constant of 
particles are measured and the size of the particles is calculated according to the Stokes-
Einstein relation.5 DLS is used routinely to analyze the size and size distribution of 
polymers, proteins, colloids and nanoparticles. Because of the strong light scattering 
property of GNPs, it is natural to hypothesize that DLS can be a very sensitive technique 
for quantitative detection and analysis of nanoparticle probes at low concentration.6 
Indeed, it has been demonstrated that DLS can be used to monitor the gold nanoshell 
concentration in whole blood samples after intravenous injection of nanoparticles in a 
murine tumor model6a and enzyme to quantum dots interactions.6b Although extensive 
studies have been reported on bioconjugation of GNPs and biomolecular interaction-
directed nanoparticle assembling, to our surprise, DLS has not been used in conjunction 
with gold nanoparticle probes for homogeneous and quantitative immunoassay. DLS can 
distinguish individual nanoparticles versus nanoparticle dimers, oligomers or aggregates 
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because of their particle size differences, and this capability makes DLS a potential 
analytical tool for a quantitative immunoassay. 
 
Scheme 7- 1. A schematic illustration of a homogeneous immunoassay using antibody-
conjugated nanoparticles and nanorods coupled with dynamic light scattering 
measurement (GNP: citrate-protected GNPs, DAB: anti-f-PSA detector antibody, GNR: 
gold nanorods, CAB: anti-f-PSA capture antibody) 
 
 
Prostate specific antigen (PSA), is an FDA-approved biomarker for prostate 
cancer diagnosis. The total PSA concentration of a healthy male is in the range of a few 
ng/mL and the free PSA (f-PSA) concentration is typically less than 1 ng/mL, in the 
range of 10% of the total PSA.7 Free PSA is the unbound form of prostate specific 
antigen. Studies have shown that the percentage of f-PSA in total PSA is lower in patients 
with prostate cancer than those with benign prostate hyperplasia. The free to total PSA 
ratio is now being introduced and studied as an additional tool for prostate cancer 
diagnosis. We herein report the development of a highly sensitive one-step homogeneous 
immunoassay for free PSA detection using gold nanoparticle probes coupled with 
dynamic light scattering analysis. As illustrated in Scheme 7-1, two different types of 
GNPs (here one is a spherical nanoparticle and one is a nanorod), are to be conjugated 
with an anti-f-PSA antibody pair, one with a capture antibody and one with a detector 
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antibody. When these two bioconjugated nanoparticles are mixed in a sample solution 
that contains antigen f-PSA, the binding of f-PSA will cause nanoparticles to form 
dimers, oligomers, or aggregates, depending on the concentration of the antigen. Through 
DLS analysis, the relative ratio of nanoparticle dimers, oligomers, or aggregates versus 
individual nanoparticles can be measured quantitatively. This ratio should increase 
accordingly with increased amount of antigen in sample solution, and such a correlation 
will form the analytical basis of a homogeneous immunoassay. 
7.2 Experimental  
7.2.1 Chemicals and materials 
Hydrogen tetrachloroaurate(III) hydrate (HAuCl4) was purchased from Strem 
Chemicals (Newburyport, MA). Trisodium citrate, 0.01M phosphate buffer saline (NaCl 
0.138 M; KCl 0.0027 M, pH 7.4), poly-L-lysine (M.W. 93,800), dialysis tubing cellulose 
membrane (MWCO 3,500) and 70% nitric acid (redistilled, 99.999+%) were purchased 
from Sigma-Aldrich (Milwaukee, WI). Goat anti-mouse IgG (H+L) (AH) conjugated 5 
nm GNPs (product #: 15750) were purchased from Ted Pella Inc. (Redding, CA). Mouse 
anti-human PSA monoclonal antibody (capture antibody) (cat. # T40081A, clone # 
CHYH1), mouse anti-human PSA monoclonal antibody (detector antibody) (cat. # 
T40081B, clone # CHYH2), ELISA kits for human free-PSA (Cat.# 10050) and ELISA 
kits for CA125 were obtained from Anogen-YES Biotech Laboratories Ltd. (Mississauga, 
Canada). The 10 ng/mL free-PSA standard solution was used for preparation of free-PSA 
solutions with lower concentrations obtained using sample dilutant provided in the 
ELISA kit. The 10 ng/mL free-PSA standard solution was prepared in a protein matrix 
solution according to the WHO standard by the vendor. Free-PSA antigen standards, 
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CA125 antigen standards, and monoclonal antibodies were reconstituted with appropriate 
volumes of nanopure water according to the procedure provided by the vendor. Nanopure 
water was obtained from a Nanopure DiamondTM system (Barnstead International, 
Dubuque, Iowa). Aqueous solutions of 1.0% magnesium nitrate and 0.2% palladium 
nitrate were purchased from Buck Scientific (East Norwalk, CT) and used for the 
preparation of matrix modifier solutions for graphite furnace atomic absorption 
spectroscopy (GFAAS) analysis of GNPs. 
7.2.2 Instrumentation  
A set of micropipettes (0.5-10 uL, 10-100 uL and 100-1000 uL) from Eppendorf 
International (Hamburg, Germany) was used for liquid transfer and dilution. A 
conductivity meter, TwinCond Conductivity Meter B-173 (Horiba, Japan), was used to 
monitor the purification of GNPs from residual ions in product solution. High resolution 
transmission electron microscopic study (HRTEM) was conducted on a FEI Tecnai F30 
TEM (FEI Company) at an acceleration voltage of 200 keV. Samples for HRTEM 
analysis were prepared by pipeting 5 uL sample solution on a poly-L-lysine (0.0381 g/mL 
in 1:3 H2O:MeOH mixture solvent) treated 400 mesh carbon/formvarcoated copper grids 
followed by vacuum drying for 30 min and put in room temperature for at least one 
overnight before HRTEM measurements. Average size and size distribution of GNPs and 
gold nanorods were analyzed by ImageJ software. A Cary 300 Bio UV-Visible 
spectrophotometer from Varian Inc. (Palo Alto, CA) was used for UV-Vis spectroscopic 
study. A PD2000DLSPLUS Dynamic Light Scattering Detector and a PDDLS/CoolBatch 
4oT Dynamic Light Scattering detector system from Precision Detectors Inc. 
(Bellingham, MA) were used for dynamic light scattering (DLS) measurement. The DLS 
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instrument was operated under the following conditions: temperature 20oC, detector 
angle 90o, incident laser wavelength 683 nm, laser power 100 mW. The DLS data 
without molecular normalization was processed using the Precision Deconvolve software. 
Samples for DLS analysis were diluted in 1.50 mL nanopure water to the appropriate 
concentration and mixed well and sit for 2 min before each measurement. The graphite 
furnace atomic absorption spectroscopy (GFAAS) analysis of gold nanoparticle and 
nanorod products was conducted using a Model 210-VGF Atomic Absorption 
Spectrometer from Buck Scientific (East Norwalk, CT). Matrix modifier for GFAAS 
analysis was prepared by mixing 1.00 mL of 1.0% magnesium nitrate solution, 1.00 mL 
of 0.2% palladium nitrate solution and 2.00 mL of wt.2% nitric acid solution (70%, 
redistilled, 99.999+%). The atomization temperature was set as 2300 oC for gold element 
analysis. For each measurement, 20.0 uL of samples solution was mixed with 5.0 uL of 
matrix modifier into the furnace tube to optimize atomic absorption intensities. 
7.2.3 Gold nanoparticle (GNP) synthesis, purification and conjugation to antibodies 
Citrate-stabilized GNPs with an average diameter 37 nm were synthesized 
according to Turkevich method (1, 2). Briefly, 6 mg of hydrogen tetrachloroaurate(III) 
hydrate was dissolved in 50 mL of nanopure water in a round bottom flask and boiled for 
15 minutes, followed by addition of 0.5 mL 38 mM trisodium citrate solution in nanopure 
water. Boiling was extended for another 15 minutes and then the solution was cooled 
down to ambient temperature. Residual free ions in solution were removed by dialysis of 
the solution using a cellulose membrane (MWCO=3500) against nanopure water for 2 
days and monitored with ionic conductivity measurement. Conductivity of the 
nanoparticle solution was measured to be 18 ms/cm before dialysis and below 1 μs/cm 
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after dialysis was completed. TEM and DLS analysis revealed an average diameter of 37 
nm of the nanoparticle product. 
To prepare nanoparticle-antibody conjugates, 500 uL of the citrate-stabilized 
nanoparticle solution was added dropwise into a 1.00 mL of diluted detector antibody 
(DAB) solution, which was prepared from dilution of 100 uL of rehydrolyzed DAB 
solution at 1.0 mg/mL with 900 uL of 0.01 M phosphate buffer saline (NaCl 0.138 M; 
KCl 0.0027 M, pH 7.4). After gentle shaking, the mixture solution was incubated at 37 oC 
for 30 min and then centrifuged for 10 min at 6000 rpm for 3 times (washing buffer: 1% 
BSA in 0.01M PBS at pH=7.4 after centrifugation 15 min at 8000 rpm).  
The concentration of GNP and GNP-DAB conjugates was calculated according to 
the elemental gold content as determined by GFAAS. The average weight of each 
individual gold nanoparticle was first estimated from the following equation by assuming 









4( DDRVm ρππρπρρ =×=×=×=                                                      (7-1) 
where m is the average weight of one gold nanoparticle, ρ is the density of GNPs (19.3 
g/cm3 for fcc structure), V is the average volume of GNPs, R is the average radius of 
nanoparticles, and D is the average diameter of nanoparticles. The average diameter of 
GNPs was calculated from the average of 200 GNPs on HRTEM micrographs using the 
ImageJ software (NIH). The average weight of one gold nanoparticle is thus calculated to 
be 5.12×10-7 ng for GNPs with average diameter of 37 nm. Then, the gold nanoparticle 
solution was diluted to an appropriate concentration (10-100 ppb) by 2% of nitric acid 
solution (70%, redistilled, 99.999+%) and the gold content in 20 μL of sample solution 
was analyzed by GFAAS.  Each sample was repeated for three times and the average was 
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taken to calculate the gold content (in the unit of ppb) in diluted sample solution. The 
gold content in initial solution was calculated by multiplying the gold content in the 
diluted solution with the dilution factor. The concentration of GNPs in initial solution 





'                                                                                                                    (7-2) 
where c is the concentration of GNPs (mol/mL), m’ is the gold content in the purified 
gold nanoparticle solution as determined by GFAAS (in the unit of ppb or ng/mL), m is 
5.12×10-7 ng for 37 nm GNPs and NA is 6.023×1023.The concentration of GNP-dAb was 
determined in the same way as pure GNPs. 
7.2.4 Gold nanorods (GNR) synthesis, purification and conjugation to antibodies 
GNRs with a longitudinal length of 40 nm and an aspect ratio 4:1 were 
synthesized according to a literature report (3) and purified by the similar way as used for 
GNPs. Gold nanorod to capture antibody conjugate (GNR-CAB) solution was prepared 
by adding 200 uL of the as-prepared GNR solution dropwise to 1.00 mL of 0.1 mg/mL 
capture antibody solution (cAb) in 0.01 M phosphate buffer saline (NaCl 0.138 M; KCl 
0.0027 M, pH 7.4) with gentle shaking. The GNR-cAb conjugates were purified by 
centrifugation 3 times at 6000 rpm for 10 min (washing buffer: 1% BSA in 0.01M PBS at 
pH=7.4 after centrifugation 15 min at 8000 rpm). The concentration of the GNR and 
GNR- CAB conjugates were determined using the similar method as used for GNP-DAB 
conjugates and described above, but the average volume of gold nanorods was calculated 
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where V’ is the average volume of one gold nanorod, R is the average transverse radius of 
the nanorods (10 nm), and L is the average longitude length of nanorods (40 nm). The 
average weight of one gold nanorod was calculated using equation (1) and (3). The 
concentrations of GNRs and GNR-CAB were determined in the same way as used for 
GNPs and GNP-DAB (2). 
7.2.5 Immunoassay of free-PSA using GNP-DAB and GNR-CAB conjugates  
A volume of 20 μL of 0.10 nM GNP-DAB conjugate solution and 20 μL of 0.25 
nM GNR-CAB conjugates were added into a 1.5 mL sterilized polypropylene tube and 
mixed well. To each mixed nanoprobe solution, 20 μL solution of free-PSA antigen 
standard at different concentrations was added, mixed well and incubated for 30 min at 
37 oC. Five free-PSA sample solutions at the following concentrations were tested: 0, 0.1, 
0.5, 1.0, 10.0 ng/mL and an unknown concentration (0.5 ng/mL, prepared by a different 
researcher). All standards were prepared from diluting the thawed 10 ng/mL standards 
with sample dilutant solution provided in the ELISA kit. Each concentration was repeated 
three times. After incubation, sample solutions were analyzed by DLS. DLS samples 
were prepared by diluting 10 uL of the assay solution into 1.5 mL of nanopure water in a 
plastic curvette (c=0.5 cm). After standing for 2 min, the sample solution was analyzed 
twice by DLS. The numeric ratio of nanoparticle oligomers versus individual particles at 
each concentration was calculated according to size distribution curve. Each data was an 
average of total 6 data points (from two DLS measurements of three samples).  
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7.2.6 DLS data processing and calculation of numeric ratios of nanoprobe oligomers 
to individual nanoprobes 
DLS measurements recorded the hydrodynamic diameters, size distributions, and 
relative scattering intensity percentages of particles in the analyzed sample solution. DLS 
data file for each sample was exported to ASCII file. The numeric ratios of nanoprobe 
oligomers versus individual nanoprobes were calculated by EXCEL software (Microsoft, 
Redmond, WA) or Origin (OriginLab Corp., Northampton, MA) from the exported 
ASCII file as following: (a) Particles were first classified into two groups according to 
their hydrodynamic diameter: individual nanoprobes (20-60 nm) and nanoprobe 
oligomers (60-500 nm). (b) For each group, the sum of multiples of 3rd order of each 
recorded hydrodynamic diameter and its corresponding relative light scattering intensity 
was calculated. (c) The numeric ratios of nanoprobe oligomers to individual nanoprobes 
were obtained by dividing the sum of multiples from the nanoprobe oligomer group by 














                                                                                                            (7-4) 
Where R is the numeric ratio of nanoprobe oligomers to individual nanoprobes, Im is the 
intensity percentage of nanoprobe oligomers at each corresponding hydrodynamic 
diameter Dm, and In is the intensity percentage of individual nanoprobes at each 
corresponding hydrodynamic diameter Dm.   
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7.2.7 Comparative immunoassay of CA125 using GNP-DAB and GNR-CAB 
conjugates 
The procedure of comparative assay of CA125 was the same as that of free-PSA 
immunoassay. 20 μL of 0.10 nM GNP-DAB conjugate solution and 20 μL of 0.25 nM 
GNR-CAB conjugates were added into a 1.5 mL sterilized polypropylene tube and mixed 
well. Four CA-125 antigen standards, 0 UmL, 15 U/mL, 100 U/mL and 400 U/mL, were 
reconstituted by nanopure water according to the provided procedure. To each mixed 
nanoprobe solution, 20 μL of CA125 antigen standard solution with different 
concentrations was added, mixed well and incubated for 30 min at 37 oC. Each 
concentration was repeated for three times. After incubation, DLS samples were prepared 
by diluting 10 uL of the assay solution into 1.5 mL of nanopure water in a plastic curvette 
(c=0.5 cm). After standing for 2 min, the sample solution was analyzed twice by DLS. 
The numeric ratio at each concentration was calculated as the average of the 3 repeating 
samples (each sample was analyzed twice by DLS) using the same protocol as described 
above.  
 7.2.8 Conjugation of 5 nm GNPs onto nanoprobe oligomers 
10 μL goat anti-mouse IgG (H+L) (AH) 5 nm gold conjugates were added into 20 
μL nanoprobe oligomers solution and incubated for 1 h at 37oC. Nanoprobe oligomers 
solutions were prepared at four f-PSA antigen concentrations: 0.1 ng/mL, 0.5 ng/mL, 1 
ng/mL and 2 ng/mL. Solutions after incubation were centrifuged 3 times at 6000rpm for 
10 min, washed by the washing buffer (1% BSA in 0.01M PBS at pH=7.4) and recovered 
back to 0.01M PBS buffer. Solution was further diluted and ~5 μL of diluted solution 
were casted on a poly-L-lysine (0.0381 g/mL in 1:3 H2O:MeOH mixture solvent) treated 
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400 mesh carbon/formvar coated copper grid. After vacuum drying for 30 min and 
standing in ambient conditions for at least 12 hours, the sample was analyzed under 
HRTEM. 
7.3 Results and Discussions 
7.3.1 Sensitivity of GNPs by DLS measurements 
To demonstrate the feasibility and sensitivity of DLS for immunoassay using gold 
nanoparticle probes, we first conducted a DLS analysis of nanoparticle materials used in 
this study. Two types of GNPs, a citrate-stabilized gold nanoparticle (GNP) and a 
cetyltrimethyl ammonium bromide (CTAB)-protected gold nanorod (GNR), were 
synthesized following the literature procedures.8 The GNPs have an average core 
diameter of 37 nm, and the nanorods have a dimension of 10 by 40 nm, as determined 
from TEM analysis (Figure 7-1a and b). The actual concentrations of the as-synthesized 
GNPs and nanorods were determined by a graphite furnace atomic absorption 
spectroscopy, combined with UV-Vis absorption spectroscopy. The nanoparticle and 
nanorod solutions were then diluted to appropriate concentrations for DLS analysis. 
Figure 7-1c is the plots of the average scattered light intensity versus nanoparticle and 
nanorod concentration as measured by DLS. Both GNPs and nanorods demonstrate a 
linear increase of scattered light intensity versus concentration in the picomolar range. A 
detection limit of 0.02 pM (low fM range) for GNPs and 0.4 pM for gold nanorods was 
established, which is similar to the reported result of gold nanoshell.6a These detection 
limits are nine magnitudes lower than protein or DNA molecules and four magnitude 
lower than sensors based on light absorption.9 By attaching a metal nanoparticle probe to 
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biomacromolecules such as antibody, it is possible to develop a highly sensitive 
immunoassay using the DLS technique.  
 
 
Figure 7- 1. TEM micrographs of (a) GNPs (scale bar: 50 nm), (b) gold nanorods (scale 
bar: 60 nm), and (c) DLS intensity responses and detection limits for different 
nanoparticles (-□-: 40 nm×10 nm gold nanorods, LLOQ=0.4 pM, y=0.04717+0.16099x, 
R2=0.99559; -○-: 37 nm GNPs, LLOQ=0.02 pM, y=0.10525+0.28012x, R2=0.99564; -◊-: 
40 nm silver nanoparticles, LLOQ=0.21 pM, y=0.06337+0.23509x, R2=0.99061; -∆-: 98 
nm GNPs, LLOQ=0.7 fM, y=0.02758+119.47x, R2=0.99212). (Linear fitting, 3σ, R=5 for 
all groups) (Copyright ® 2008 American Chemical Society) 
 
7.3.2 Conjugation of antibodies to GNP probes 
For the immunoassay development, the citrate-protected spherical nanoparticles 
were conjugated with a detector antibody (GNP-DAB), while the CTAB-protected gold 
nanorods were conjugated with the capture antibody (GNR-CAB).10 Through our study, 
it was found that because of the surface positive charge of the CTAB-stabilized gold 
nanorods, the capture antibody can be conjugated more effectively to nanorods than the 
citrate-stabilized nanoparticles, while the detector antibody can be conjugated more 
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effectively to the negatively charged citrate-stabilized GNPs. The successful conjugation 
of nanoparticles with detector antibody and nanorods with capture antibody was first 
confirmed by DLS measurement and UV-Vis spectral analysis (Figure 7-2 and Figure 7-
3). After conjugation with the primary antibodies, the average diameter of GNPs 
increased from 37 to 57 nm, while the hydrodynamic dimension of nanorods increased 
from 30 to 37 nm. The UV-Vis spectra revealed a slight shift of the surface plasmon 
resonance in both intensity and wavelength. For GNPs, the SPR band shifted from 535 
nm to 541 nm upon antibody conjugation. This shift is most likely caused by the surface 
chemistry change of the nanoparticles from a citrate-ligand layer to an antibody layer. For 
the gold nanorods, changes in the SPR band peak wavelengths as well as relative ratio of 
the two SPR bands were observed. The longitudinal SPR band at 733 nm blue shifted to 
725 nm and the transverse SPR band at 516 nm red shifted to 518 nm. The relative 
intensity of the longitudinal versus the transverse band decreased from 2.7 to 1.6, 
corresponding to what has been observed previously from a gold nanorod bioconjugate 
reported by Rayavarpu et al.11 
 
Figure 7- 2. UV-Vis spectra of GNPs and gold nanorods and their conjugates with 
primary antibodies: (a) citrate-protected GNPs (GNP); (b) f-PSA detector antibody 
conjugated GNPs (GNP-DAB); (c) CTAB-protected gold nanorods (GNR); and (d) f-
PSA capture antibody conjugated gold nanorods (GNR-CAB) (Copyright ® 2008 




Figure 7- 3. Sizes and size distributions of nanoprobes measured by DLS: (a) 5 pM 
citrate-protected GNPs (GNP), (b) 5 pM gold nanorods (GNR), and their corresponding 
correlation functions for (c) GNPs and (d) gold nanorods. (Copyright ® 2008 American 
Chemical Society) 
To further confirm the successful conjugation of the two antibodies to the 
nanoparticles and nanorods, we analyzed the coupling product of the nanoparticle probes 
with antigen f-PSA in solution using TEM. A 1:2.5 mixture solution of the two 
nanoprobes, GNP-DAB:GNR-CAB, was added to a buffer solution of f-PSA with a 
concentration of 2 ng/mL. The mixed solution was incubated for 30 min at 37 oC, and 
then drop cast on a copper grid and examined by TEM. During the imaging, we observed 
a large amount of nanoparticle-nanorod dimers as shown in Figure 7-4a. These 
nanoparticle dimer and oligomers are believed to be formed through antigen binding with 
capture antibodies from the nanorods and detector antibodies from the spherical 
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nanoparticles. With increased f-PSA concentration, the amount of such nanoparticle-
nanorod pairs and aggregates increased accordingly. To further verify that the 
nanoparticle-nanorod pairs and oligomers were formed from the binding between antigen 
f-PSA and the primary antibodies attached to nanoprobes, we added a secondary anti-
mouse IgG-labeled gold nanoparticle (5 nm) into the mixed nanoparticle, nanorods and f-
PSA solution. After incubation for 60 min, the solution was cast on a copper grid and 
examined by TEM. The TEM micrographs as shown in Figure 7-4d revealed that most 5 
nm GNPs appeared on the surface or vicinity of large nanoparticles and nanorods, due to 
the binding of secondary antibody from the 5 nm nanoparticles to the primary antibodies 
on the surface of large nanoparticles and nanorods.  
 
 
Figure 7- 4. TEM micrographs of: (a-c) nanoparticle oligomers formed from a mixture of 
primary antibodies conjugated GNPs and gold nanorods with the addition of f-PSA 
antigens (2 ng/mL) in the mixed nanoprobe solution; and (d-f) same nanoparticle 
oligomers, but with additional conjugations of 2nd antibody-coated 5 nm GNPs to the 





Figure 7- 5. Hydrodynamic diameter distribution plots as determined by DLS 
measurements: (a) nanoparticle-detector antibody conjugates (GNP-DAB, 5 pM); (b) 
nanorod-capture antibody conjugates (GNR-CAB, 5 pM); (c) a 1:2.5 mixture of GNP-
DAB:GNR-CAB in the presence of f-PSA (1.0 ng/mL); and (d) the calculated numerical 
ratio of nanoparticle oligomers in the size range of 60-500 nm (peak area A) versus 
individual particles in the size range of 20-60 nm (peak area B) according to DLS 
measurement at different f-PSA level (the unknown sample has a concentration of 0.5 
ng/ml, data labeled with an asterisk). (Copyright ® 2008 American Chemical Society) 
 
7.3.3 Immunoassay for f-PSA using antibody coated GNP probes 
The homogeneous immunoassay of f-PSA was then conducted in solution using 
the conjugated nanoparticles and nanorods coupled with dynamic light scattering 
measurement. The two nanoprobes were mixed in 1:2.5 (GNP-DAB:GNR-CAB) ratio 
and then added to the standard f-PSA solutions with different concentrations. After 
incubating for 30 min, the solutions were diluted to appropriate concentrations for DLS 
analysis. Figure 7-5 a and b are the size distribution of pure conjugated nanoparticles and 
nanorods, respectively, while Figure 7-5 c is the size distribution of mixed nanoprobe 




conjugates, only one size of particles was observed from the distribution. With f-PSA 
added to the nanoprobe solution, DLS measurement detected two particle sizes (peak area 
A and B), one is centered at below 60 nm representing individual nanoparticles and 
nanorods, and one above 100 nm corresponding to nanoparticle-nanorod oligomers. The 
relative ratio of nanoparticle oligomers in the size range of 60-500 nm versus individual 
nanoparticles in the size range of 20-60 nm range can be numerically calculated from the 
size distribution curve. Figure 7-5 d is the plot of this numerical ratio versus f-PSA 
concentration. With increased concentration of f-PSA, the relative percentage of 
nanoparticle oligomers increased while the percentage of individual nanoprobes 
decreased. Using the same nanoprobes in buffer solution, we conducted the analysis of an 
unknown sample solution (f-PSA concentration at 0.5 ng/mL). The determined 
concentration corresponds very well to the true concentration of the sample (Figure 7-5 d, 
data indicated with an asterisk). It is very important to mention here that the standard f-PSA 
solutions, including the control solution, were actually prepared in a protein matrix 
solution to simulate the protein content of human serum samples. It was noticeable that 
when the two nanoprobes were added to the control solution with 0 ng/mL f-PSA, a 
certain level of nanoparticle oligomer formation was observed, according to DLS analysis. 
The aggregation is most likely caused by the high content of proteins and high ionic 
strength of the matrix solution. However, our study demonstrated that even with a small 
level of nanoparticle instability and aggregation, a quantitative immunoassay is still 
possible in complex biological fluids using our developed approach. Recently, it was 
reported by Liu C.-H. et al.2e that the light scattering by metal nanoparticles can be 
detected directly by a fluorescence spectrometer and further used for quantitative DNA 
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detection. In this study, we obtained the average scattered light intensity of each assay 
solution from DLS measurement; however, we did not find a clear correlation between 
the average scattered light intensity versus antigen concentration in solution. The 
comparative ratio of nanoparticle oligomers versus individual particles as determined by 
DLS measurement appears to provide a more accurate bioassay.  
We also conducted a control experiment to demonstrate the selectivity of the 
assay. The mixed nanoprobe solution was added to solutions that contain a different 
cancer biomarker, CA125. The oligomer versus individual nanoparticle ratio remained 
unchanged at different concentrations of CA125 (Figure 7-6). This comparison study 












Figure 7- 6. A comparative immunoassay of biomarker CA125 using GNP-DAB and 
GNR-CAB (the DAB and CAB are anti f-PSA primary antibodies): the calculated 
numerical ratio of nanoprobe oligomers in the size range of 60-500 nm versus individual 
nanoprobes in the size range of 20-60 nm according to DLS measurements. Three sample 
solutions were prepared for each antigen concentration, and each sample solution was 
measurement twice by DLS. Each data presented here is the average of six data points. 





In summary, we demonstrated here a promising one-step homogeneous 
immunoassay. By taking advantage of the large scattering cross section of GNPs and the 
high sensitivity of DLS measurement, biomarker proteins or other biotargets can be 
detected at very low concentration using gold nanoparticle probes. As opposed to the 
traditional plate-based immunoassay, our assay is conducted in solution, which allows a 
much better mixing and antibody-antigen interaction. The assay does not involve any 
washing cycle and the assay result can be read as soon as the nanoprobe-sample 
incubation is completed. Moreover, extremely small amount of samples are needed for 
the assay. With further improvement on the stability of nanoparticle bioconjugates and 
the light scattering intensity of nanoparticle probes, the accuracy and detection limit of 
the assay can be further improved. The research on cancer biomarker detection directly 
from human serum samples using the method reported here is currently underway.  
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CHAPTER 8. SURFACE MODIFICATION OF GOLD 
NANOPARTICLES BY POLY(ETHYLENE GLYCOL) 
POLYMERS AND APPLICATIONS IN BIOMOLECULAR 
DETECTION 
8.1 Introduction 
 GNPs are a class of plasmonic materials under intense research and development 
for broad biological applications, especially in ultrasensitive biomolecular detection.1 
Since 1990s, investigations on controlled synthesis and functionalization of GNPs have 
grown exponentially.2 GNPs can be synthesized with strictly controlled geometries and 
sizes, ranging from a few to several hundreds of nanometers in both aqueous solution as 
well as in organic solvents.3 GNPs after synthesis are normally protected by a shell of 
stabilizing molecules, through either physical adsorptions or chemical interactions to 
GNP surface. For example, GNPs prepared by the well-known citrate reduction method 
are protected with physically adsorbed citrate ions.4 These surface molecules are crucial 
to keep GNPs dispersed in solution. The success in synthetic preparation and stabilization 
by surface ligands provides essential colloidal GNP probes for applications. 
 To apply GNPs for biological applications, GNPs need to be conjugated with 
biomolecules. A type of commonly used methods to conjugate biomolecules with GNPs 
is through physical adsorption. For example, proteins, with charges on their surface, can 
be adsorbed onto GNP surface through electrostatic interactions.5 This method is widely 
used due to the easy procedure. Commercially available antibody-conjugated GNP 
probes (referred as “immunogold”) are prepared through physical adsorption methods 
and have been applied for cell imaging and flow cytometry applications.6 Substantial 
studies using GNP probes prepared by physical adsorption methods were reported for the 
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detection of proteins, DNA, aptamers, etc.7 In Chapter 6 and Chapter 7, we have used the 
physical adsorption method in the preparation of antibody-conjugated spherical 40 nm 
GNPs and 40 nm by 10 nm gold nanorods and applied these GNP probes in sensitive 
detection of mouse IgG and PSA antigens. 
 While physical adsorption methods possess the advantage of procedure simplicity, 
there are several limitations existing for these methods. Protein-GNP conjugates prepared 
by these adsorption methods rely on the equilibrium between GNP-conjugated antibodies 
and free antibodies in the solution. These GNP probes have low protein repellency and 
are susceptible to dissociation of original proteins from the GNP surface. This can result 
to diminished labeling efficiency. GNP probes tend to aggregate out from the solution 
due to non-specific interactions of proteins or dissociation of proteins. 8  Moreover, 
because these conjugates are based on non-specific electrostatic interactions, they are not 
resistant to high ionic strength or extreme pH conditions in solution thus lack the long 
term stability. Such prepared GNP probes are then not very stable in buffer solutions or 
biological fluids. As a consequence, these limitations on stability and biomolecular 
conjugation for physically adsorbed GNP probes will inevitably cause serious problems 
in biomolecular assays. 
 To improve the stability and bio-specific functionality of biomolecules-
conjugated GNP probes, surface modification on GNPs is necessary. 9  Surface 
modifications generally result to a dense layer of molecules on the GNP surface with 
higher binding affinity between the GNP surface and surface ligands. In one approach, 
original stabilizing molecules on GNPs can be place exchanged by polymers. 10  For 
example, thiolated polymers can be anchored onto GNPs, by replacing original citrate 
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molecules on GNPs due to the strong binding affinity between gold surface and thiol 
groups. Polymers can thus form a protecting layer on GNP surface and contribute to 
improve colloidal stability of GNPs probes.10  
 In addition to surface modification of GNP surface, covalently conjugate proteins 
to GNPs can help in preparing stable and biospecific GNP probes with resistance to 
nonspecific interactions or aggregations.9 In a comparison to nonspecific interactions in 
physiadsorption methods, covalent bondings between GNPs and biomolecules are much 
less susceptive to solution condition variations, such as other proteins, solution ionic 
strength or pH values. These covalently conjugated GNP probes can maintain high 
stability as well as bio-specificity. Surface biomolecules are not in equilibrium with free 
biomolecules in solution. GNP probes prepared through such a covalent coupling 
methods have been demonstrated to be more stable and robust in biological 
applications.10b 
 The combination of surface modifications and covalent coupling of biomolecules 
to GNPs has been proven to be effective in using robust GNP probes for biological 
applications. However, yet there is no systematic and quantitative study on the effects of 
surface modification to the stability of GNPs with respects to GNP sizes and solution 
conditions. Motivated by this, in this study we prepared polymer modified GNPs and 
investigated their stabilities at different GNP core sizes and solution conditions. Through 
this study, we aimed to reveal the effects of different solution conditions to the stability 
of GNP probes and to provide pratical guides in the preparation of robust GNP probes. 
Thiolated bi-functional poly(ethylene glycol) (PEG) polymers were chosen as polymeric 
supports due to their proven effectiveness to render nonspecific interactions between 
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biomolecules and to improve bio-compatibility and stability of GNPs in biological 
environment.10b The stability of all tested PEG-GNPs showed substantial increases over 
unmodified citrate-stabilized GNPs. 
To further investigate the performance of these PEG-GNP probes and to apply 
them in biological detection applications, we conjugated these PEG-GNPs with 
antibodies through covalent coupling reactions and applied them in the detection of f-
PSA antigens. The covalent conjugation of antibodies to PEG-GNP was verified in a 
simple and effective aggregation assay. We then applied the 100 nm PEG-GNPs as 
immunoassay probes for the detection of f-PSA antigens, with a one-step immunoassay 
format similar to these demonstrated in Chapter 6 and Chapter 7. Sensitivity and 
reproducibility of the immunoassay using PEG-GNPs were improved significantly. 
8.2 Experimental 
8.2.1 Chemicals, materials and instruments 
 Citrate-protected GNPs (CiGNPs) in a range of core sizes and 40 nm goat anti-
mouse IgG conjugated GNPs (GNP-anti-IgG) were purchased from Ted-Pella. Thiolated 
and carboxylated poly(ethylene glycol) polymer (COOH-PEG-SH) (M.W.=3000) were 
obtained from RAPP Polymere. The ELISA kit and antibodies for PSA or f-PSA were 
from Anogen Inc. All other materials were from Aldrich.  
8.2.2 Preparation and purification of poly(ethylene glycol) coated GNPs 
 Poly(ethylene glycol) polymer coated GNPs (PEG-GNPs) were prepared by 
adding 1.5 mL COOH-PEG-SH solution (0.6 mg/mL)  into 10 mL intact CiGNPs solution 
and keeping in gentle shaking for one week. 
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 In stability tests, the as-prepared PEG-GNPs were purified by centrifugation and 
washed by DI water for three times. Different centrifugation conditions were used for 
PEG-GNPs at different sizes (20 and 40 nm: 13.4k rpm for 6 min; 60 and 80 nm: 13k 
rpm for 3 min; 100, 150, 200, and 250 nm: 8k rpm for 2 min). 
 In biomolecular conjugation and immunoassays, the crude 40 nm or 100 nm PEG-
GNPs were purified by column chromatography instead of centrifugation. A volume of 
400 μL PEG-GNP solution was passed through a Sepharose CL-2B column, with a gel 
height of ~10 cm and PBS buffer (PBS 10 mM; NaCl 0.138 M; KCl 0.0027 M, pH 7.4) 
as the mobile phase. The collected PEG-GNPs were filtered by a membrane (hole size: 
200 nm) to exclude large aggregates. UV-Vis and DLS were used in the purification and 
antibody conjugation process to monitor the size and stability of PEG-GNPs probes. 
8.2.3 Stability tests for PEG-GNPs at various NaCl concentrations 
NaCl solutions at concentrations 0, 0.2, 0.3, 0.4, 0.8 M were prepared. The 
stability test was performed as following: 100 μL centrifugation purified PEG-GNP 
solution and 100 μL NaCl solution were mixed in a well and the absorbance of each 
mixed solution at corresponding SPR peak wavelength (according to Table 5-1) was 
measured, respectively at each GNP size and each NaCl concentration. Each sample was 
duplicated and the average hydrodynamic diameter was calculated. 
8.2.4 Stability tests for PEG-GNPs at various pH values or buffer conditions 
 The pH values of centrifugation purified PEG-GNP solutions were adjusted from 
4 to 10 using 1 M HCl or 1 M NaOH solutions (Table 8-2). For buffer solutions, equal 
volume of purified PEG-GNP solution and the buffer solution (PBS or Tris buffer) were 
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mixed. The absorbance of each sample at the corresponding SPR peak wavelength was 
monitored, respectively.  
8.2.5 Biomolecular conjugation and aggregation assay of 40 nm PEG-GNPs 
 The 40 nm -COOH functionalized PEG-GNPs were conjugated to two PSA 
antibodies (PSA-CAB and PSA-DAB, respectively), with the use of covalent coupling 
reagents EDC (Ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride) and sulfo-
NHS (N-hydroxysulfosuccinimide). The purified PEG-GNP probe solution 450 μL was 
added by 5 μL EDC/sulfo-NHS mixture solution (25.7 mM/51 mM) and gently shaked 
for 30 min, then passed through a Sephadex G-25 column. Solutions were equally 
divided into two portions, with each portion added by 5 μL of PSA antibody solutions, 
respectively for PSA-CAB and PSA-DAB. Solutions were gently shaked for 3 hours at 
RT and purified using a Sepharose 4B column.  
The aggregation assay was performed by mixing 100 μL of 40 nm GNP-anti-IgG 
solution (0.1 nM) with 100 μL PEG-GNP probes (respectively for PEG-GNP-CAB and 
PEG-GNP-DAB). Mixture solutions were incubated at 37 oC and the average size of the 
GNP probes in each mixture solution was monitored by DLS along time. All 
measurements were performed at a detection angle of 90o. 
8.2.6 Immunoassay of for f-PSA detection using 100 nm PEG-GNPs 
The purified 100 nm PEG-GNP solution 450 μL was covalently conjugated with 
two paired anti-f-PSA antibodies, denoted as CAB and DAB respectively. The procedure 
of conjugation and purification was similar to the one in section 8.2.5. These two PEG-
GNP probes were then used in the immunoassay for the detection of f-PSA antigens. The 
procedure was similar to that in section 7.2.5. The f-PSA antigen solutions with f-PSA 
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levels lower than 0.1 ng/mL were prepared from serial dilutions of 10 ng/mL f-PSA stock 
solution. After the anti-f-PSA conjugated PEG-GNP probes and f-PSA antigen solutions 
were prepared, the one-step immunoassay was performed. At each f-PSA concentration, 
30 μL of each of the two PEG-GNP probe solutions were mixed and added by 10 μL of 
antigen solution to a total volume of 70 μL. Samples were incubated at 37 oC for 1 hour 
and read out by DLS at a measurement angle of 13o. The test was triplicated at each f-
PSA concentration.  
8.3 Results and Discussions 
8.3.1 Improved stability of PEG-GNPs 
Citrate-protected GNPs are known to form irreversible aggregates upon addition 
of salts into the solution. The aggregation process results to a decrease in the SPR 
absorbance intensity and also a broadening of the SPR band.11 For example, the SPR 
peak absorbance of 40 nm CiGNPs shows a significant drop within minutes when the 
NaCl concentration in the CiGNP solution is above 20 mM. Meanwhile, an observable 
color change for the GNP solution from purplish to blue can be seen. However, covering 
the surface of GNPs with thiol molecules, polymers or biomolecules could improve the 
GNP stability significantly. Applications based on this property have been investigated 
for the detection of metal ions, thiol molecules such as cystein, or biomolecules.7,12 The 
monitoring, or the detection, in these early studies relied on visible color changes as a 
qualitative standard or quantitative measurement with UV-Vis spectrometers. These 
detection assays showed easiness in material preparation and procedure, but lack the 
ultra-high sensitivity and detection reproducibility. They also implied that ultrahigh 
sensitivity is possible with better prepared GNP probes. In this study, we measured the 
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UV-Vis spectra of surface-modified PEG-GNPs at various GNP sizes and solution to 
study the stability of these PEG-GNPs. 
 
Table 8- 1. Relative absorbance of 100 nm PEG-GNPs in NaCl solutions 
Relative Absorbance 
(%)  
[NaCl] in mixture solution (mM) 
0 100 150 200 400 
20 min 100% 96% 98% 98% 98% 
30 min 96% 94% 95% 94% 95% 
40 min 98% 93% 94% 95% 96% 
60 min 99% 93% 95% 95% 96% 
120 min 97% 91% 93% 94% 94% 
180 min 95% 91% 92% 92% 92% 











































Figure 8- 1. Relative absorbance of 100 nm PEG-GNPs in NaCl solutions along mixing 
time 
 
8.3.1.1 Stability of 100 nm PEG-GNPs in NaCl solutions 
We first tested the stability of 100 nm PEG-GNPs along time in various NaCl 
solutions. From Table 8-1 and Figure 8-1, we can see that the 100 nm PEG-GNPs 
pertained >90% of their original absorbances at all four tested NaCl concentrations up to 
3 hours. At the time 19 hours, the absorbances decreased more but were still at least 86% 
to the control. These results were in a sharp comparison to that of bare CiGNPs in NaCl 
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solutions and revealed out the excellent salt resistance and colloidal stability of 100 nm 
PEG-GNPs. Furthermore, there were no significant differences in the stability of 100 nm 
PEG-GNPs at [NaCl] from 100 mM to 400 mM. Considering that biological fluids have 
NaCl concentrations within the tested range, such robust PEG-GNPs are promising to 
have excellent colloidal stability in biological fluids. 
8.3.1.2 Stability of different size PEG-GNPs in NaCl solutions  
 The high stability of 100 nm PEG-GNPs in NaCl solutions indicated that surface 
modification by PEG polymers to CiGNPs is very useful in the preparation for robust 
GNP probes. Following this, we extended the investigation to differently sized PEG-
GNPs. Table 8-2 and Figure 8-2 summarize the relative absorbance of different size 
PEG-GNPs at their corresponding SPR peak wavelengths when mixed with NaCl 
solutions. PEG-GNPs with sizes up to 100 nm were shown to be stable at all tested NaCl 
concentrations. However, for large size PEG-GNPs (core diameter >100 nm), significant 
decreases in their SPR peak absorbances were observed, indicating that 150, 200 and 250 
nm PEG-GNPs did not have as good stability as smaller size PEG-GNPs. These results 
imply that thiolated PEG polymers with a molecular weight of 3000 can effectively 
protect GNPs in high NaCl concentration solutions for GNPs with sizes up to 100 nm. 
The reduced stability for larger size PEG-GNPs is possibly related to the surface 
coverage percentage and the packing density of PEG polymers on the GNP surface. 
Because larger size GNPs have larger surface areas which are proportional to the square 
of the GNP diameter, it would become more difficult for PEG polymers to fully shield 
the surface of larger size GNPs and to protect them from attacks by salt ions in solution. 
Due to this, the packing density of PEG polymers on larger PEG-GNP surface and results 
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to higher susceptibility to salt attacks. These observations and analyses can be helpful in 
the selections of GNP core size and PEG polymer length during robust PEG-GNP 
preparations. 
 
Table 8- 2. Relative absorbance of PEG-GNPs at various NaCl concentrations 
PEG-GNP size (nm) Abs wavelength 
[NaCl] (mM) 
0 100 150 200 400 
20 525 nm 100% 97% 95% 95% 98% 
60 533 nm 100% 96% 98% 97% 95% 
40 535 nm 100% 99% 97% 99% 98% 
80 549 nm 100% 97% 99% 93% 92% 
100 570 nm 100% 97% 94% 95% 91% 
150 639 nm 100% 67% 76% 77% 76% 
200 572 nm 100% 73% 71% 69% 69% 

















Figure 8- 2. Relative absorbance of PEG-GNPs in solutions at different NaCl 
concentrations measured by UV-Vis  
 
 
8.3.1.3 Stability of PEG-GNPs in solutions at different pH values or buffer conditions 
After examining the stability of PEG-GNPs in NaCl solutions, we evaluated the 
stability of PEG-GNPs in solution at different pH or buffer conditions. Table 8-3 and 
Figure 8-3 show the relative absorbance of PEG-GNPs in pH 4-10 solutions and two 
buffer solutions. PEG-GNPs solutions at pH=7 were used as controls. From these results, 
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it can be seen that PEG-GNPs at all tested sizes were stable in solutions with pH values 
6-10. However, in pH 4 or 5 solutions, PEG-GNPs were not very stable and showed large 
decreases in the absorbance. This indicated that these carboxylic group functionalized 
PEG-GNPs did not prefer acidic conditions. In the pH range 6-10, the stability of PEG-
GNPs was found to be related to the GNP size. PEG-GNPs with sizes from 20 to 150 nm 
are stable in this pH range, but larger size 200 nm and 250 nm PEG-GNPs were not as 
stable as smaller size PEG-GNPs. These results revealed that PEG polymers used in this 
study can stabilize GNPs with sizes up to 150 nm in pH 6-10 solutions. 
The stability of PEG-GNPs in buffer solutions was exemplified by testing them in 
two of the most common buffers, PBS and Tris buffers (Table 8-3 and Figure 8-3). Note 
that the 100 nm PEG-GNP showed the highest stability in these two buffers, while all 
other size PEG-GNPs had obvious stability decreases in either one or both buffers. Such 
superior stability of 100 nm PEG-GNPs in all these tested ionic strength, pH and buffer 
conditions suggests that the 100 nm PEG-GNPs as prepared here are very promising to be 
used as robust GNP probes in biological applications. 
 
Table 8- 3. Relative absorbance of PEG-GNPs in solutions at different pH or buffer 
condition after mixed for 4 h 
Size (nm) 
pH 
PBS Tris 4 5 6 7 8 9 10 
20 69.2% 84.6% 101.3% 100.0% 101.3% 98.7% 100.0% 76.9% 79.5% 
40 60.7% 66.4% 100.9% 100.0% 100.9% 101.9% 100.9% 72.0% 65.4% 
60 93.4% - 105.5% 100.0% 101.6% 100.5% 101.6% 88.5% 94.0% 
80 72.9% 83.7% 100.0% 100.0% 99.2% 102.3% 101.6% 89.9% 97.7% 
100 67.1% 82.0% 103.0% 100.0% 103.0% 102.4% 100.0% 94.0% 94.0% 
150 93.2% 83.1% 89.8% 100.0% 101.7% 101.7% 98.3% 89.8% 89.8% 
200 77.5% 70.0% 67.5% 100.0% 92.5% 85.0% 72.5% 55.0% 50.0% 














































Figure 8- 3. Relative absorbance of PEG-GNPs in solutions at different pH or buffer 
condition after mixed for 4 h 
 
We interpret the substantial stability improvement of PEG-GNPs due to four main 
reasons. First, the strong gold-thiol binding can protect the GNP core from outside ion 
attack. Second, the thiol end group on the PEG polymer can anchor the polymer molecule 
to the GNP surface firmly.2,5 Third, PEG polymers on PEG-GNPs can form a steric layer 
to prevent PEG-GNPs from ion attacks and thus render PEG-GNPs more difficult to 
aggregate out.13 Fourth, the backbone of PEG polymers is neutral in charge, which makes 
PEG-GNPs less sensitive to salt concentrations or pH value changes. Due to the 
combination of these four effects, the stability of PEG-GNPs showed significant 
improvements. In addition, these PEG polymers have another advantage in minimizing 
non-specific interactions for biomolecules. These excellent properties, including robust 
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colloidal stability and low non-specific bimolecular interactions, motivated us to use 
PEG-GNPs probes in biological detection applications.  
8.3.2 Covalent conjugation of antibodies to PEG-GNPs 
Antibodies conjugated PEG-GNPs probes were prepared through a simple 
covalent conjugation procedure, by an amide reaction between the carboxyl groups on the 
PEG ligands and the amino groups on antibodies through the EDC/sulfo-NHS protocol. 
To verify that antibodies can preserve their bioactivity and bio-specificity after covalently 
conjugated to PEG-GNPs, two GNP aggregation reactions were designed. 40 nm PEG-
GNPs were conjugated with a pair of mouse anti-human PSA antibodies, CAB and DAB 
respectively. The two kinds of PEG-GNP probes were named as PEG-GNP-CAB and 
PEG-GNP-DAB (Figure 8-4). The size of 40 nm was chosen to match the size of the 
other GNP probe, whish was the goat anti-mouse IgG antibody conjugated 40 nm GNPs 
(GNP-anti-IgG) purchased from Ted Pella. Note that these GNP-anti-IgG probes were 

















Figure 8- 4. The aggregation assay between 40 nm goat anti-mouse IgG conjugated 
GNPs (anti-mouse-GNP) and 40 nm mouse anti-human PSA antibody conjugated PEG-
GNPs (CAB and DAB are matched pair antibodies for human PSA) 
 
If the covalent conjugation was successful, the PEG-GNP-CAB (or the PEG-
GNP-DAB) should form aggregates when mixing with GNP-anti-IgG probes. The 
aggregation reactions are through the specific bio-recognition reactions between the 
mouse IgG antibody on the PEG-GNP-CAB surface (or the PEG-GNP-DAB surface) and 
the goat anti-mouse IgG antibody on the GNP-anti-IgG surface. The aggregation reaction 
will result to size increases of GNP probes. Such size changes of GNP probes can be 
sensitively monitored by DLS. The results shown in Figure 8-4 revealed out the kinetic 
growth of the GNP aggregates in two probe solutions up to 3 h, respectively for PEG-
GNP-CAB and PEG-GNP-DAB. The average hydrodynamic diameters of GNP probes 
increased continuously from the original ~40 nm to ~80 nm during 3 h. We conclude 
such size increases were due to the oligomer formation of PEG-GNP probes. These 
oligomers were dimmers, trimers, and higher order aggregates and they grew along time 
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to larger sizes. Through these results, we confirmed that the bioactivity and specificity of 
antibodies on PEG-GNPs were preserved. In a closer comparison for PEG-GNP-CAB 
and PEG-GNP-DAB probes solutions, we can also see that these two kinds of antibody-
conjugated GNP probes had similar size increasing rates, while PEG-GNP-DAB showed 
slightly faster size increasing rate. This indicated that PEG-GNP-DAB had slight higher 
activity than PEG-GNP-CAB to goat anti-mouse IgG antibodies. These two aggregation 
reactions may be used in applications of fast antibody activity studies. 
8.3.3 Immunoassay application of 100 nm PEG-GNPs for free-PSA (f-PSA) 
detection 
From the above results in 8.3.1 and 8.3.2, we have showed that the improved 
stability of PEG-GNPs and successful covalent antibody conjugation to PEG-GNPs. We 
then applied these PEG-GNPs in bimolecular detection applications. We used the 100 nm 
PEG-GNPs for the detection of f-PSA antigen using a one-step amplification-free and 
washing-free assay format.  
The core size of 100 nm was selected due to a balance between the colloidal 
stability and sensitivity of the immunoassay. From results in section 8.3.2, the 100 nm 
PEG-GNPs have the highest stability in NaCl solutions, acidic or basic solutions or buffer 
solutions. Such excellent colloidal stability is essential in using PEG-GNPs for biological 
applications. In the other side, DLS detection prefers larger size GNPs. Larger size GNPs 
can scatter light stronger so have better sensitivity in DLS detection. This is beneficial to 
improve the sensitivity of GNP-based immunoassays. The three larger size 150, 200 or 
250 nm are better for this purpose but they had lower colloidal stability in tested salt and 
pH conditions so were not used in the immunoassay applications in this study. 
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Table 8- 4. Immunoassay for f-PSA using 100 nm PEG-GNP probes 
f-PSA (ng/mL) D (nm) Stdev (nm) 
0.000 171.8 8.7 
0.001 173.9 18.9 
0.010 186.3 21.1 
0.100 206.4 37.4 
1.000 245.1 34.5 
2.000 280.7 60.5 
5.000 337.5 26.3 

















Figure 8- 5. Immunoassay for f-PSA detection using 100 nm PEG-GNP probes (second 
order exponential decay fitting: y = -168.858*exp(-x/3.00203) + -27.5137*exp(-
x/0.01413) + 368.1954; R2= 0.99933; LLOD: 0.046 ng/mL) 
 
 As already discussed in section 7.1, f-PSA is the unbound form of PSA. While 
the PSA level for normal male is <4 ng/mL, the f-PSA level is typical lower than PSA 
and in the range of 10% of the PSA level.14 It is thus more difficult to precisely measure 
the f-PSA level in biofluids than to measure the PSA level. Due to this, we focused on the 
challenges to use 100 nm PEG-GNPs for the detection of f-PSA antigens and 
demonstrate the superior stability, bioactivity and specificity of PEG-GNP probes. The 
principle of the immunoassay was based on a sandwich type reaction between f-PSA 
antigens and the two mouse anti-f-PSA antibodies-conjugated PEG-GNP probes, similar 
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to the reaction as illustrated in Scheme 7-1. Because all PEG-GNPs were multi-covalent, 
the addition of f-PSA solution into the mixture of the two probe solution can introduce 
the aggregation of PEG-GNPs. The extent of the aggregation reaction was correlated with 
the concentration of the f-PSA and the size changes of these PEG-GNPs were shown in 
Table 8-4 and Figure 8-5. 
By increasing the level of f-PSA in the solution from 0 to 10 ng/mL, the average 
size of the PEG-GNP probes in solution increased from 171 nm to 340 nm. The 
correlation between the size and the f-PSA level can be best fitted with a second order 
exponential decay (Figure 8-5, caption). Ultrahigh sensitivity as well as a good dynamic 
range for f-PSA detection were demonstrated in this simple and fast immunoassay. Using 
the standard 3σ method, the lower limit of detection (LLOD) of the immunoassay was 
determined to be 0.046 ng/mL. The immunoassay showed a dynamic range from 0.046 
ng/mL to 5 ng/mL. To our best knowledge, such sensitivity has not been reported in an 
amplification-free and washing-free assay. In fact, such sensitivity and dynamic range are 
close to those of currently commonly used methods, such as ELISA. For example, the 
ELISA kit from Anogen for f-PSA measurements has a claimed sensitivity of 0.022 
ng/mL and a dynamic range up to 10 ng/mL. However, such sensitivity and dynamic 
range are achieved with multiple sample washing and signal amplification steps. The new 
immunoassay in our study showed comparable sensitivity and dynamic range but had 
much simplified procedure as well as much reduced sample volume (from 50 µL to 10 
µL). Thus the new PEG-GNP based immunoassay is very promising for fast and simple 
detection of f-PSA antigens. 
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In the current study, we only exemplified the biological detection applications of 
PEG-GNP probes in f-PSA detection. However, with slightly modified protocols, the 
immunoassay should fit for the detection of other biomolecules as well. The general and 
simple biomolecular conjugation protocol for PSA and f-PSA antibodies can be applied 
easily to other biomolecules. For immunoassays, the simple one-step assay would also 
dramatically shorten the assay development time because it avoids many issues in 
traditional heterogeneous immunoassay development, such as substrate selection, enzyme 
selection and conjugation. Considering that these selection and optimization steps 
typically will take 4-6 months, the new immunoassay in this work would greatly save the 
assay development time and cost, while also providing better reliability due to less 
parameters to be optimized.15 In addition, the sensitivity of the new immunoassay can 
fulfill the requirements in bimolecular detection. In fact, the diagnostic ranges of many 
clinical important protein biomarkers identified yet fall into the pg/mL-ng/mL range. 
Such sensitivity and dynamic range were demonstrated to be achievable in the new 
immunoassay. We believe these advantages would make the new immunoassay to be 
very competitive to traditional assays in biomolecular detection and other biological 
applications. 
8.4 Conclusions 
 In this contribution, we reported the stability improvements of GNPs after surface 
modification by thiolated PEG polymer and exemplified biomolecular detection 
applications of these PEG-GNP probes using f-PSA as an example target analyte. It was 
found that PEGlylation significantly improved the stability of GNPs in NaCl solutions 
(with [NaCl] up to 400mM), acidic or basic solutions (pH from 6 to 10) and buffer 
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solutions. The 100 nm PEG-GNPs were found to have the best stability in all tested 
conditions. After PEGlylation, we demonstrated that antibodies could be conjugated with 
PEG-GNPs through a simple covalent coupling reaction. The 100 nm PEG-GNPs 
conjugated with anti-f-PSA antibodies were then used in a one-step washing-free and 
amplification-free immunoassay for the detection of f-PSA antigens. The immunoassay 
showed an ultra sensitivity to as low as 0.046 ng/mL, which is comparable with the 
sensitivity of commercial products but with a much simplified procedure and reduced 
sample volume. This new immunoassay shows promises in meeting the highly desired 
demand for a simple, fast, small sample consumption, and cost-effective in situ 
immunoassay.  
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CHAPTER 9. ENHANCED IMAGING AND ACCELERATED 
PHOTOTHERMALYSIS OF A540 HUMAN LUNG CANCER 
CELLS BY GOLD NANOSPHERES UNDER LASER 
IRRADIATION 
9.1 Introduction  
Since 1999, cancer has surpassed heart disease and become the number one cause 
of mortality for people younger than 85 years old in US.1, 2 In 2008, it is estimated that 
1.2 million people will be diagnosed with cancer. By far, lung and bronchus cancer 
represents about 29% of all cancer cases, and lung cancer has the highest death rate 
among cancer patients in both men (31%) and women (26%).3 The early detection and 
effective treatment of lung cancer has remained as a significant challenge. New imaging 
techniques and therapeutic methods/agents, including nanomaterials and nanotechnology, 
are being explored extensively for cancer study and treatment.4-10 
GNPs, including nanospheres, nanorods and nanoshells with a size ranging from 1 
to 100 nanometers, are known to have large light absorption and scattering cross sections 
in the surface plasmon resonance (SPR) wavelength region.11 The light absorption and 
scattering cross sections around the SPR band of a gold nanoparticle can be a few orders 
of magnitude higher than the fluorescence emission of traditional organic dyes. The 
strong absorption of GNPs, and nanoparticle aggregation-induced SPR wavelength shift, 
has been studied extensively for biosensor and immunoassay applications.12,13 As a strong 
light scatterer, GNPs are being used effectively for optoacoustic imaging and dark field 
imaging of biological cells.14, 15 Recently, the light scattering property of GNPs has been 
reported for the development of a homogeneous immunoassay using dynamic light 
scattering (DLS).16 In addition to elastic scattering, inelastic scattering such as surface-
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enhanced Raman scattering is another area of strong interest.13,17 Relatively large GNPs 
with a diameter above 10 nm, are not photo luminescent. Therefore, GNPs are excellent 
photothermal energy converters and have been explored for photothermal therapy of 
tumor cells and for controlled destruction of bacteria and protein aggregates.18-21 The dual 
function of GNPs, namely, the strong light scattering property for dark field optical 
imaging and the highly efficient photothermal energy conversion for photothermalysis of 
cancer cells, make GNPs particularly attractive for cancer research.  
In this study, we investigated the use of a gold nanoparticle probe for optical 
imaging and accelerated photothermalysis of the human lung cancer cell A549. A549 
cells are derived from lung carcinoma with properties of type II alveolar epithelial cells, 
and may serve as well established cell model in the studies of lung cancer biomarkers.21,22 
GNPs used in this study were conjugated with a layer of anti-human IgG on the surface. 
After incubating the cells with the GNPs, the loading of GNPs by tumor cells was imaged 
using a dark field optical microscope. The photothermalysis of tumor cells with and 
without the loading of GNPs was studied using a viability test kit under a confocal 
microscope. 
9.2 Materials and Methods 
9.2.1 GNPs and characterizations  
Goat anti-human IgG conjugated GNPs (Prod # 15775D-4G) were purchased 
from Ted Pella (Redding, CA). The nanoparticle concentration was adjusted to 5 fM in a 
pH=7.4 PBS saline solution (NaCl 0.138 M; KCl 0.0027 M) by the vendor. High 
resolution transmission electron microscopic study (HRTEM) of the nanoparticles was 
conducted on a FEI Tecnai F30 TEM (FEI Company) at an acceleration voltage of 200 
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keV. Samples for HRTEM analysis were prepared by pipeting 5 uL of sample solution to 
the surface of a poly-L-lysine (0.0381 g/mL in 1:3 H2O:MeOH mixture solvent) treated 
400 mesh carbon/formvar coated copper grid. Following vacuum drying for 30 min, the 
grid was placed in a desiccator at room temperature for at least overnight before 
conducting HRTEM analysis. A Cary 300 Bio UV-Visible spectrophotometer from 
Varian Inc. (Palo Alto, CA) was used for UV-Vis spectroscopic study. A 
PD2000DLSPLUS Dynamic Light Scattering Detector and a PDDLS/CoolBatch 40T 
Dynamic Light Scattering detector system from Precision Detectors Inc. (Bellingham, 
MA) were used for the particle size measurement. The DLS instrument was operated 
under the following conditions: temperature 20oC, detector angle 90o, incident laser 
wavelength 683 nm, laser power 100 mW. The DLS data was processed using the 
Precision Deconvolve software. Samples for DLS analysis were diluted in 1.50 mL 
nanopure water to appropriate concentrations, mixed well and stabilized before 
measurement.16 
9.2.2 Cell line culture 
A549 (ATCC. No. CCL-185) human lung cancer cell line, derived from 
adenocarcinoma of the male lung, was cultured in a Roswell Park Memorial Institute 
(RPMI) media with 10% Fetal Bovine Serum, 1% L-Glutamine, 1% Hepes, and 1% 
penicillin-streptomycin. All cultures were maintained in humidified incubators at 37 °C 
in an atmosphere of 5.0% CO2. 24 Hours prior to laser irradiation treatments, the cells 
were plated on round cover slips (Bioptechs, 40 mm, Butler, PA) in culture plates (60 
mm × 15 mm Fisherbrand, Pittsburgh, PA) and treated with GNPs for each treatment 
regimen. The controls were untreated A549 cells, incubated in culture media without 
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GNPs. The cell concentration was 10 million cells per ml of the media for all cell study 
experiments. In the regimen with gold nanoparticle treatment, A549 cells were incubated 
in the same amount of culture media as the controls, with the addition of GNPs to a final 
concentration of 0.25 pM. The plated cells were incubated in humidified incubators at 
37 °C in atmosphere of 5.0% CO2 for 24 hours. 
9.2.3 Dark field imaging 
The cells on plates were washed with PBS saline 5 times and dried in ambient 
condition before being mounted on a glass slide. Dark field images were obtained using 
an Olympus U-DCW condenser and an UPlanFL N 100x/1.30 oil iris with an Olympus 
BX51 microscope. All dark field images were taken by the Analysis Imager 5.0 software 
at the exactly same imaging conditions (incident light intensity, gain, exposure time, etc.).   
9.2.4 Laser irradiation condition and viability assay 
A549 cells, after being exposed in the cell culture with GNPs for 24 hours, were 
stained using a Violet Live/Dead Viability Fixable Assay Kit (Invitrogen, Carlsbad, CA 
Cat# 34955) for half an hour. According to the protocol, 1 uL of dilutant with violet dye 
was added to 1 mL of media in plates containing cover slips seeded with live cells and 
incubated for 30 minutes. Cover slips with cells on them were transferred to a Live Cell 
Microscopy Environmental Control System from Bioptechs (Butler PA). Viability tests 
for both control cells and samples cells after gold nanoparticle exposure were monitored 
with a DMI6000 inverted Leica TCS AOBS SP5 tandem scanning confocal microscope 
with a 63x/1.40NA oil immersion objective. A 52.5 mW 405 nm diode laser (Lasos, San 
Jose, CA) tuned to a 1% output power (0.525 mW) was used to excite the violet viability 
stain, and the fluorescence emission at 450 nm was collected. A Helium-Neon 5 mW 
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diode laser at 633 nm (Lasos, San Jose, CA) (1.0 W/cm2) was used for irradiation of the 
cells. Images, Z-stacks and time lapse experiments were performed with dual 
photomultiplier detectors and the LAS AF version 1.5.1.889 software suite.  Cell death 
was assessed in real time by imaging the cells constantly at a 400Hz rate of one 
1024x1024 frame, which refreshes a newly scanned image every 5.179 seconds for the 
length of the time lapse.  Images over time were converted to .avi files for ease of 
comparison and viewing. Image Pro Plus V6.2.0 (Media Cybernetics, Bethesda, MD) was 
used to quantify the intensity of individual cells in every fifth frame of the time lapse. 
Total cellular intensity was determined by the average of dynamic range values for each 
pixel within individual cells.  Viability tests for both control and sample cells were 
studied at different power levels of 633 nm laser (0.50 mW, 1.25 mW, 2.50 mW, 3.75 
mW and 5.00 mW). 
9.2.5 Relative viability drop curves and normalized relative viability drop rate 
curves  
Relative viability of cells at each imaging time was computed as the relative 
percentage of fluorescence intensity at specified irradiation time over the initial 
fluorescence intensity by the Microsoft® Office EXCEL 2003 SP3 and the OriginPro 
SR1 v7.5776 (B776) software. Relative viability drop curves for both control cells and 
sample cells after gold nanoparticle exposure were plotted along the irradiation time of 
633 nm laser. For each different power level irradiation, the corresponding curve was 
established. The relative viability drop curves at 0 mW for both control cells and samples 
cells were taken as baselines for the following calculations of normalized viability drop 
rate curves, respectively. The relative viability drop rate curves were constructed by 
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calculating the slopes of each relative viability drop at corresponding irradiation time and 
plotted over irradiation time up to 58 seconds.  The normalized viability drop rate curves 
were obtained after subtracting corresponding baselines, for control cells and sample cells 
after gold nanoparticle exposure, respectively.  
9.3 Results and Discussions 
In this work, gold nanospheres were chosen for the dark field imaging and 
photothermalysis study of cancer cells. Compared to many other types of nanoparticles 
such as quantum dots, gold nanorods and nanoshells etc., gold nanospheres are more 
stable, easy to make, and have low cytotoxicity.10,17,18 Although the SPR of individual 
gold nanospheres is in the visible light region, 520-530 nm, this band can red-shift to near 
infrared region upon nanoparticle aggregation. Spherical GNPs therefore are still very 
attractive optical probes for cell imaging and photothermalysis study.22,23 Gold 
nanospheres with a core diameter of 40 nm were chosen for this study. This size was 
previously reported as the optimum size for photothermalysis of cancer cells.23,25 The 
gold nanospheres were prepared by coating a layer of goat anti-human IgG antibody on 
the surface of a citrate-protected gold nanoparticle (from the Vendor’s product 
information). The citrate-protected gold nanospheres are not stable in high salt content 
buffer solutions such as cell culture media, and quickly precipitate out of the solution at 
salt concentration above 30 mM. The anti-human IgG layer makes the nanospheres stable 
in the cell culture media. Furthermore, the anti-human IgG from the nanoparticles can 
bind with the human IgG molecules on the surface or inside the tumor cells, allowing 




Figure 9- 1. Goat anti-human IgG conjugated gold nanospheres and their dark field 
images. (A) Schematic illustration, (B) HRTEM micrograph, (C) size and size 
distribution measured by DLS, (D)-(F) dark field images at incremental concentrations 
from 1, 10 to 100 fM, respectively. (Copyright ® 2008 Future Medicine Ltd.) 
 
A HRTEM image and UV-Vis absorption spectrum of gold nanoparticle 
conjugates are shown in Figure 9-1 and Figure 9-2, respectively. The gold nanospheres 
exhibit an SPR band centered at 530 nm. DLS measurement confirmed the narrow size 
distribution of gold nanospheres used in the study (Figure 9-1c).  The gold nanoparticle 
solution was drop cast on a glass slide and then visualized under a dark field optical 
microscope. The micrographs revealed bright nanoparticle dots on the glass slide.16 With 
increased nanoparticle concentration, from Figure 9-1d to f, the number and the scattering 
intensity of gold nanospheres increased significantly due to nanoparticle aggregation.  
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Figure 9- 2. UV-Vis spectrum of well dispersed gold nanoparticle probes. UV-Vis 
spectrum of 40 nm goat anti-human IgG conjugated gold nanospheres with a SPR band 
peaked at 530 nm (irradiation laser wavelength at 633 nm, imaging laser wavelength at 
405 nm). (Copyright ® 2008 Future Medicine Ltd.) 
   
Dark field optical microscopy was then used to examine the loading of gold 
nanospheres by cancer cells. Without incubation with gold nanospheres, it was found that 
the cancer cells were weak light scatterers and could be visualized under the dark field 
microscope (Figure 9-3a-c). However, the contrast of the images was rather poor. After 
incubation with gold nanospheres in the cell culture media, the contrast of the images was 
enhanced significantly when compared with images of cancer cells that were not exposed 
to gold nanospheres in the cell culture media (Figure 9-3d-f). It needs to be noted here 
that all images were taken under exactly the same conditions including incident light 
intensity, gain, exposure time, etc. This enhancement effect is a strong indication of an 
effective loading of gold nanospheres to the cancer cells. From these dark field images, it 
is not discernable whether the gold nanospheres were mainly located on the surface or 
inside the tumor cells. However, previous reports support that nanospheres are mainly 
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located on the cell surface, with a small amount found inside the cells through 
endocytosis.8,25  Because the gold nanospheres used in this study are coated with a layer 
of anti-human IgG on the particle surface, gold nanospheres can be effectively loaded to 
the tumor cells. The dark field images revealed that the uptake of gold nanospheres by the 
nuclei was none or extremely low. 
 
 
Figure 9- 3. Dark field images of lung tumor cell A549 without (a-c) and with (d-f) gold 
nanospheres loaded to the cells. All images were obtained using exactly the same 
imaging setup. The final concentration of gold nanospheres added to the lung tumor cell 
culture was 0.25 pM for all three samples. (Copyright ® 2008 Future Medicine Ltd.) 
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After verifying the effective loading of gold nanospheres by the A549 lung cancer 
cells, confocal microscopy was used to study the photothermalysis of cancer cells under 
the irradiation of a 5 mW 633 nm laser beam. The power of the laser was adjusted from 0 
to 0.5, 1.25, 2.5, 3.75 and 5 mW to optimize the photothermalysis condition, respectively. 
The viability drop of cells upon laser irradiation was monitored by a Violet Live/Dead 
Viability Fixable Assay Kit with a 0.5 mW 405 nm laser for fluorescence excitation and 
followed by emission detection at 450 nm. The assay used a fluorescent dye that is 
reactive towards cellular amines. The dye can binds only to the surface amines of viable 
cells, but react with free amines in both interior and cell surface of necrotic cells (product 
description). When cell membrane destruction occurs, the accumulated dyes on the 
cellular membrane will be dissociated and consequently result in a decrease of 
fluorescence intensity on cell membrane. The decrease of fluorescence intensity, which 
was monitored by imaging at each 5.179 seconds interval for up to 58 seconds, was 
interpreted and assessed as the viability drop of cells in this study. Fluorescence emission 
intensity information from such obtained images were extracted and plotted versus 
irradiation time to give the relative viability drop curves.  
As revealed from the UV-Vis spectrum of the gold nanospheres solution (Figure 
9-2), gold nanospheres exhibited SPR band peaked around 530 nm and absorptions at 
both 405 nm and 633 nm. During our initial study, it was found that a significant 
interference to cell viability was arisen from the irradiation of the imaging laser (405 
nm). Therefore, the imaging laser was operated at a significantly decreased power level 
(0.525 mW). The viability drop curves for both control cells and nanoparticle-loaded 
cancer cells caused by imaging laser irradiation at 405 nm were used as baselines and 
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subtracted from viability drop curves under the 633 nm laser irradiations respectively to 
give the normalized relative viability drop curves. Normalized relative viability drop rates 
of cancer cells were then calculated according to the slopes of the normalized relative 
viability drop curves.  
 
 
Figure 9- 4. Effect of 633 nm laser irradiation on A549 tumor cells at different power 
levels. Normalized relative viability drop rate of lung A549 cells during the irradiation 
(square: control cells without gold nanopsphere incubation; circle: sample cells with gold 
nanosphere incubation) (Copyright ® 2008 Future Medicine Ltd.) 
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Although nanoparticle-enhanced photothermalysis effects for tumor cells were 
reported previously, the kinetic characteristic behavior of the viability changes during 
irradiation has not been examined closely.6-8,18 In this study, a real time monitoring of 
cancer cell viability was performed. In Figure 9-4, normalized relative viability drop rates 
versus irradiation time were summarized for both control cells and nanosphere-loaded 
cells at different laser power levels. For control cells (black curves), the laser irradiation 
at 633 nm caused a roughly constant small viability drop rate around 0.75 %/s during the 
whole 58 seconds irradiation period for power levels from 0.5 mW to 3.75 mW. The 
small viability drop rate was most probably coming from the photobleaching effect of 
viability dyes under the 633 nm laser irradiation. At the power level of 5 mW, a large 
viability drop rate was observed for control cells. This large viability drop rate could due 
to an enhanced photobleaching of the viability dyes by 633 nm laser irradiation, or from 
laser induced photothermalysis of cells. For gold nanosphere-loaded A549 cancer cells, 
viability drop rates (red curves) were significantly higher than the rates of control cells, 
especially within the first 30 seconds of irradiation. The initial relative viability drop rates 
at zero seconds were observed to increase from 3.72 %/s to the maximum of 5.00 %/s 
when the power of the laser was increased from 0.5 to 3.75 mW. In contrast, the relative 
viability drop rates of control cells remained at ~0.75 %/s for power levels from 0.5 mW 
to 3.75 mW. The photothermalysis of gold nanosphere-loaded cancer cells was 
accelerated significantly due to the enhancement effect of gold nanospheres. Comparing 
the relative viability drop rates for both control and nanospheres-loaded cells at different 
power levels, the optimum power level for gold nanospheres accelerated 
photothermalysis of A549 human cancer cells was found to be 3.75 mW, at which level 
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the initial relative viability drop rate was 5.00 %/s for nanoparticle-loaded cells and only 
0.75 %/s for control cells. At this power level, the initial relative viability drop rate of 
nanosphere-loaded tumor cells was accelerated by a factor of 6.6. 
 
 
Figure 9- 5. Viability drop of tumor cells after irradiation for 58 seconds using a 633 nm 




After irradiation by the 633 nm laser for 58 seconds, the accumulated relative 
viability drops at different power levels for both control cells and gold nanospheres-
loaded cells are presented in Figure 9-5. The nanospheres-induced hyperthermia effect 
and thus the accumulated destruction effect on cancer cells can be verified by comparing 
the viabilities of control cells and sample cells. The relative viabilities of nanospheres-
loaded cells dropped to be around ~8-18% after irradiation for 58 seconds at laser power 
between 0.5-3.75 mW, while the viabilities of control cells remained at 60% or above 
after equivalent dose of irradiation. A minimum viability of 8% was observed from 
nanosphere-loaded cells after irradiation at a laser power of 3.75 mW.  
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Upon closer examination, it is noticed that at zero power of the irradiation laser 
(633 nm), the viability of nanospheres-loaded cells decreased to 60% while the control 
cells remained almost intact. It is believed that this difference is due to the nanosphere-
accelerated photothermalysis of tumor cells under the irradiation of imaging laser at 405 
nm. Although the maximum absorption of the SPR of gold nanospheres is centered at 
520-530 nm, the nanospheres exhibit significant absorption at 405 nm as well, as 
revealed from the UV-Vis spectrum of 40 nm gold nanospheres in Figure 9-2. This 
absorption caused the accelerated death rate of the nanosphere-loaded cells.  
When the power level of the irradiation laser was increased to 5 mW, it was found 
that the relative viability drop rate was almost the same for control and nanoparticle-
loaded cells (Figure 9-4). At this power level, the viability of control cells decreased to 
20%, close to what was observed from the nanosphere-loaded cells, 12% (Figure 9-5). 
Two possible reasons may account for the observed large viability drop of the control 
sample: one possibility is that the relatively high power of the 633 nm laser irradiation 
induced a significant photobleaching to the fluorescence dye used for viability study, 
which makes the cells appear to be dead. On the other hand, it is also possible that under 
high power laser irradiation, photothermalysis of control cells has occurred. For 
photothemal therapy, it is important to use a laser with a power level as low as possible to 
avoid unexpected damages to healthy and normal tissues and cells. Based on our current 
study, it can be seen that the photothemalysis of nanosphere-loaded tumor cells has 
reached its maximum effect with a laser power level between 1.25-3.75 mW. There is no 
need to further increase the power of the irradiation laser to beyond 3.75 mW. Our 
conclusion is that by carefully controlling the power of the laser during photoirradiation, 
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it is possible to selectively increase the photothermalysis of gold nanoparticle-loaded 
tumor cells while minimize the photothermalysis of normal cells without or with less 
nanospheres.  
The mechanism of gold nanosphere-accelerated photothermalysis of tumor cells 
was reported to start from the photon energy absorption from laser beam irradiation by 
gold nanospheres and their aggregates.23, 26 The conversion of the photon energy to 
thermal energy by gold nanospheres and their clusters introduced a hyperthermia effect 
around the local cell membrane. This effect resulted in the formation of micrometer sized 
cavities on the cell membrane. A recent study revealed that extracellular calcium cations 
played a critical role in cavity formation during gold nanorods-assisted photothermalysis 
of tumor cells.10 The growing of these cavities was found to be the main cause for lysis of 
cells, besides the hyperthermia effect. For individual gold nanospheres, irradiation at the 
SPR band peak wavelength should have the highest photothermal conversion efficiency. 
In this study, the wavelength of laser irradiation beam for viability tests was at 633 nm 
instead of 530 nm. However, the accelerated photothermalysis of A549 tumor cells by 
gold nanospheres was still significant. We believe this effect is a result of the formation 
of nanosphere aggregates around the cell membranes, as supported by the dark field 
imaging study. Upon aggregation, the SPR band of nanoparticles can red-shift 
significantly to higher wavelength.23,24 
9.4 Conclusion 
In conclusion, 40 nm gold nanospheres were used to accelerate the cell death of 
A549 human lung cancer cells by laser irradiation at 633 nm. The loading of gold 
nanospheres to tumor cells on cell membrane and partial internalization was observed 
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under a dark field optical microscope. Viability tests of tumor cells under the irradiation 
of a 633 nm laser showed that gold nanospheres could significantly accelerate the cell 
death rates of tumor cells up to a factor of 6.6 compared to control cells. The kinetic 
characteristics of the viability drop of tumor cells caused by gold nanoparticle-enhanced 
photothermalysis were examined closely. The optimized laser power for 
photothermalysis of A549 human cancer cells was found to be 1.25-3.75 mW. After 58 
seconds of irradiation, the viability of gold nanoparticle-loaded tumor cells decreased to 
only 8% of their original viability, while the majority of control cells were still alive.  
We demonstrated here a potential application of gold nanospheres for the imaging 
and treatment of human lung cancer cells. The stability and surface functionality of gold 
nanospheres used in this study make them as suitable candidates for future in vivo 
investigations. The strong scattering property of gold nanospheres enables their use as 
optical probes for dark field microscopy imaging of tumor cells with much improved 
contrast.  Compared to fluorescence probes, the light scattering of GNPs are not 
subjected to photobleaching and many other interfering factors. The strong absorption 
properties of nanospheres and aggregated clusters can significantly accelerate the 
photothermalysis of tumor cells upon laser irradiation. Our next step is to prepare gold 
nanosphere-antibody conjugates which can specifically target the A549 lung cancer cells 
and further increase the efficiency and specificity of the photothermal therapy process. 
The ultimate goal of this research is the development of a dual imaging/therapy method 
which can allow a one-step imaging and eradication of lung tumor tissue through 
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